"pdb","title","DOI","resolution","Mean_B_Factor","oligo","oligo_sequence","residue_links","oligo_mean_B_Factor","comments","warnings","errors"
"1A7C","HUMAN PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1 IN COMPLEX WITH A PENTAPEPTIDE","10.1016/S0969-2126(98)00064-1 ",1.95,33.17,"1a7c_oligo1","DGlcpNAcb1-4[DArapb1-6]DGlcpNAcb1-ASN","RIP(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(265_A_)",47.6844,"","",""
"1AH1","CTLA-4, NMR, 20 STRUCTURES","10.1038/NSB0797-527 ","2.95026e-39","1.15243e-41","1ah1_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(111_A_)",0,"","",""
"1BRR","X-RAY STRUCTURE OF THE BACTERIORHODOPSIN TRIMER/LIPID COMPLEX","10.1073/PNAS.95.20.11673 ",2.9,58.2,"1brr_oligo3","DGalp[3S]b1-6DManpa1-2DGlcpa1-C43O3","SGA(3_E_)-MAN(2_E_)-GLC(1_E_)",73.2818,"","",""
"1BRR","X-RAY STRUCTURE OF THE BACTERIORHODOPSIN TRIMER/LIPID COMPLEX","10.1073/PNAS.95.20.11673 ",2.9,58.2,"1brr_oligo2","DGalp[3S]b1-6DManpa1-2DGlcpa1-C43O3","SGA(3_D_)-MAN(2_D_)-GLC(1_D_)",77.7748,"","",""
"1C1Z","CRYSTAL STRUCTURE OF HUMAN BETA-2-GLYCOPROTEIN-I (APOLIPOPROTEIN-H)","10.1093/EMBOJ/18.22.6228 ",2.87,55.3,"1c1z_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NDG(2_C_)-NAG(1_C_)-ASN(174_A_)",118.151,"","",""
"1DEO","RHAMNOGALACTURONAN ACETYLESTERASE FROM ASPERGILLUS ACULEATUS AT 1.55 A RESOLUTION WITH SO4 IN THE ACTIVE SITE","10.1016/S0969-2126(00)00118-0 ",1.55,0,"1deo_oligo1","DManpa1-3[DManpa1-6]DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[MAN(5_B_)]-BMA(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(182_A_)",33.3305,"","",""
"1DIY","CRYSTAL STRUCTURE OF ARACHIDONIC ACID BOUND IN THE CYCLOOXYGENASE ACTIVE SITE OF PGHS-1","10.1126/SCIENCE.289.5486.1933 ",3,0,"1diy_oligo6","DManpa1-3DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(144_A_)",64.1649,"","",""
"1DN2","FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE PEPTIDE DCAWHLGELVWCT-NH2","10.1126/SCIENCE.287.5456.1279 ",2.7,0,"1dn2_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",42.0837,"","",""
"1DN2","FC FRAGMENT OF HUMAN IGG1 IN COMPLEX WITH AN ENGINEERED 13 RESIDUE PEPTIDE DCAWHLGELVWCT-NH2","10.1126/SCIENCE.287.5456.1279 ",2.7,0,"1dn2_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",40.4411,"","",""
"1DP5","THE STRUCTURE OF PROTEINASE A COMPLEXED WITH A IA3 MUTANT INHIBITOR","10.1038/72378 ",2.2,0,"1dp5_oligo1","DManpb1-2DManpa1-2[DManpa1-6]DManpa1-3[DManpb1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(9_C_)-MAN(8_C_)-[MAN(7_C_)-[BMA(6_C_)-MAN(5_C_)]-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(67_A_)",41.1271,"","",""
"1DZE","STRUCTURE OF THE M INTERMEDIATE OF BACTERIORHODOPSIN TRAPPED AT 100K","10.1016/J.JMB.2004.06.080 ",2.5,36,"1dze_oligo1","DGalpb1-6DManpa1-2DGlcpa1-C40O3","GAL(3_B_)-MAN(2_B_)-GLC(1_B_)-L2P(270_A_)",83.6209,"","",""
"1E4K","CRYSTAL STRUCTURE OF SOLUBLE HUMAN IGG1 FC FRAGMENT-FC-GAMMA RECEPTOR III COMPLEX","10.1038/35018508 ",3.2,95.1,"1e4k_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",73.1865,"","",""
"1E4M","MYROSINASE FROM SINAPIS ALBA","10.1074/JBC.M006796200 ",1.2,14.5,"1e4m_oligo3","DXylpb1-2[DManpa1-3][LGulpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",22.7357,"","",""
"1E71","MYROSINASE FROM SINAPIS ALBA WITH BOUND ASCORBATE","10.1074/JBC.M006796200 ",1.5,19.8,"1e71_oligo4","DXylpb1-2[DManpa1-3][LGulpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",31.513,"","",""
"1E73","2-F-GLUCOSYLATED MYROSINASE FROM SINAPIS ALBA WITH BOUND L-ASCORBATE","10.1074/JBC.M006796200 ",1.5,20.2,"1e73_oligo4","DXylpb1-2[DManpa1-3][LGulpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcx1-","MAN(6_C_)-[MAN(5_C_)]-[XYP(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(7_C_)]-NAG(1_C_)",33.0363,"","",""
"1F8R","CRYSTAL STRUCTURE OF L-AMINO ACID OXIDASE FROM CALLOSELASMA RHODOSTOMA COMPLEXED WITH CITRATE","10.1093/EMBOJ/19.16.4204 ",2,24.5,"1f8r_oligo7","DGlcpNAca1-4[LAllp[6H]b1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(172_C_)",54.8791,"","",""
"1FE2","CRYSTAL STRUCTURE OF DIHOMO-GAMMA-LINOLEIC ACID BOUND IN THE CYCLOOXYGENASE CHANNEL OF PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1.","10.1074/JBC.M009378200 ",3,0,"1fe2_oligo5","DManpa1-3DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(144_A_)",62.8149,"","",""
"1FI1","FHUA IN COMPLEX WITH LIPOPOLYSACCHARIDE AND RIFAMYCIN CGP4832","10.1016/S0969-2126(01)00631-1 ",2.9,68.4,"1fi1_oligo1","DGlcpa1-2DGlcpa1-3[DGalpa1-6]DGlcpa1-3[GMH1-7]GMH1-3GMH1-5[DKdopa2-4]DKdopa2-6DGlcp[2<R1>,3<R2>,4P]b1-6DGlcp[2<R3>,3<R4>]a1-O7P2","GMH(10_B_)-[GLA(9_B_)-[GLC(8_B_)-GLC(7_B_)]-GLC(6_B_)]-GMH(5_B_)-GMH(4_B_)-[KDO(11_B_)]-KDO(3_B_)-GCN(2_B_)-PA1(1_B_)",87.83,"","",""
"1FIW","THREE-DIMENSIONAL STRUCTURE OF BETA-ACROSIN FROM RAM SPERMATOZOA","10.1016/S0969-2126(00)00523-2 ",2.1,37.83,"1fiw_oligo1","LGulpb1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(5_B_)-[MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(169_A_)",63.0545,"","",""
"1FIZ","THREE DIMENSIONAL STRUCTURE OF BETA-ACROSIN FROM BOAR SPERMATOZOA","10.1016/S0969-2126(00)00523-2 ",2.9,47.03,"1fiz_oligo1","DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(4_B_)-[BMA(3_B_)-NDG(2_B_)]-NAG(1_B_)-ASN(169_A_)",94.9614,"","",""
"1FZJ","MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN","10.1016/S1074-7613(01)00105-4 ",1.9,29.2,"1fzj_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(176_A_)",52.0064,"","",""
"1FZK","MHC CLASS I NATURAL MUTANT H-2KBM1 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN","10.1016/S1074-7613(01)00105-4 ",1.7,24.2,"1fzk_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(176_A_)",49.5524,"","",""
"1FZM","MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND VESICULAR STOMATITIS VIRUS NUCLEOPROTEIN","10.1016/S1074-7613(01)00105-4 ",1.8,30.9,"1fzm_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(176_A_)",55.7297,"","",""
"1FZO","MHC CLASS I NATURAL MUTANT H-2KBM8 HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND SENDAI VIRUS NUCLEOPROTEIN","10.1016/S1074-7613(01)00105-4 ",1.8,26.2,"1fzo_oligo2","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_C_)-NAG(1_C_)-ASN(176_A_)",49.5223,"","",""
"1G1S","P-SELECTIN LECTIN/EGF DOMAINS COMPLEXED WITH PSGL-1 PEPTIDE","10.1016/S0092-8674(00)00138-0 ",1.9,0,"1g1s_oligo1","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-6[DGalpb1-3]DGalpNAca1-THR","SIA(4_E_)-GAL(3_E_)-[FUC(5_E_)]-NAG(2_E_)-[GAL(6_E_)]-NGA(1_E_)-THR(616_C_)",50.8761,"","",""
"1G1S","P-SELECTIN LECTIN/EGF DOMAINS COMPLEXED WITH PSGL-1 PEPTIDE","10.1016/S0092-8674(00)00138-0 ",1.9,0,"1g1s_oligo2","DNeup5Aca2-3DGalpb1-4[LFucpa1-3]DGlcpNAcb1-6[DGalpb1-3]DGalpNAca1-THR","SIA(4_F_)-GAL(3_F_)-[FUC(5_F_)]-NAG(2_F_)-[GAL(6_F_)]-NGA(1_F_)-THR(616_D_)",44.7282,"","",""
"1GW0","CRYSTAL STRUCTURE OF LACCASE FROM MELANOCARPUS ALBOMYCES IN FOUR COPPER FORM","10.1038/NSB823 ",2.4,24.6,"1gw0_oligo2","DManpa1-3[DManpb1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(6_C_)-[MAN(5_C_)]-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(88_A_)",60.3469,"","",""
"1H3T","CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (MN2F)2","10.1016/S0022-2836(02)01250-0 ",2.4,0,"1h3t_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",63.6266,"","",""
"1H3U","CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (M3N2F)2","10.1016/S0022-2836(02)01250-0 ",2.4,0,"1h3u_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",63.5065,"","",""
"1H3U","CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (M3N2F)2","10.1016/S0022-2836(02)01250-0 ",2.4,0,"1h3u_oligo1","DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_D_)-[MAN(5_D_)-[BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",91.4576,"","",""
"1H3V","CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G2F)2,SG P212121","10.1016/S0022-2836(02)01250-0 ",3.1,0,"1h3v_oligo1","DGalpb1-4DGlcpNAcb1-2DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(8_D_)-[GAL(6_D_)-NAG(5_D_)-BMA(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",79.6368,"","",""
"1H3V","CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G2F)2,SG P212121","10.1016/S0022-2836(02)01250-0 ",3.1,0,"1h3v_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",48.3753,"","",""
"1H3W","STRUCTURAL ANALYSIS OF HUMAN IGG-FC GLYCOFORMS REVEALS A CORRELATION BETWEEN GLYCOSYLATION AND STRUCTURAL INTEGRITY","10.1016/S0022-2836(02)01250-0 ",2.85,0,"1h3w_oligo1","DGlcpNAcb1-2DManpb1-6DManpb1-4DGlcpNAca1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_A_)-[NAG(5_A_)-BMA(4_A_)-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(297_M_)",94.8221,"","",""
"1H3X","CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G0F)2","10.1016/S0022-2836(02)01250-0 ",2.44,0,"1h3x_oligo1","DGlcpNAca1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",90.2742,"","",""
"1H3X","CRYSTAL STRUCTURE OF THE HUMAN IGG1 FC-FRAGMENT,GLYCOFORM (G0F)2","10.1016/S0022-2836(02)01250-0 ",2.44,0,"1h3x_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",58.5281,"","",""
"1H3Y","CRYSTAL STRUCTURE OF A HUMAN IGG1 FC-FRAGMENT,HIGH SALT CONDITION","10.1016/S0022-2836(02)01250-0 ",4.1,0,"1h3y_oligo2","DGalpa1-4DGlcpNAca1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpa1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_C_)-[GLA(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",73.9137,"","",""
"1H3Y","CRYSTAL STRUCTURE OF A HUMAN IGG1 FC-FRAGMENT,HIGH SALT CONDITION","10.1016/S0022-2836(02)01250-0 ",4.1,0,"1h3y_oligo1","DGalpa1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GLA(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",36.1271,"","",""
"1H4P","CRYSTAL STRUCTURE OF EXO-1,3-BETA GLUCANSE FROM SACCHAROMYCES CEREVISIAE","10.1038/NSMB715 ",1.75,28,"1h4p_oligo1","DManpb1-2DManpa1-3[DManpa1-2DManpb1-6]DManpa1-6[DManpb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_C_)-BMA(7_C_)-[BMA(6_C_)-MAN(5_C_)]-MAN(4_C_)-[BMA(10_C_)-BMA(9_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(165_A_)",83.5686,"","",""
"1H4P","CRYSTAL STRUCTURE OF EXO-1,3-BETA GLUCANSE FROM SACCHAROMYCES CEREVISIAE","10.1038/NSMB715 ",1.75,28,"1h4p_oligo3","DManpb1-2DManpb1-3[DManpb1-3[DManpb1-6]DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(8_E_)-[BMA(7_E_)]-BMA(6_E_)-[BMA(5_E_)-BMA(4_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(165_B_)",80.0983,"","",""
"1H4P","CRYSTAL STRUCTURE OF EXO-1,3-BETA GLUCANSE FROM SACCHAROMYCES CEREVISIAE","10.1038/NSMB715 ",1.75,28,"1h4p_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-[BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(325_A_)",89.9071,"","",""
"1HWM","EBULIN,ORTHORHOMBIC CRYSTAL FORM MODEL","10.1002/PROT.1043 ",2.8,0,"1hwm_oligo1","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(186_B_)",19.4704,"","",""
"1I1A","CRYSTAL STRUCTURE OF THE NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC","10.1016/S1097-2765(01)00230-1 ",2.8,78.2,"1i1a_oligo2","LFucpb1-6DGlcpNAca1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(104_A_)",161.802,"","",""
"1I1A","CRYSTAL STRUCTURE OF THE NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC","10.1016/S1097-2765(01)00230-1 ",2.8,78.2,"1i1a_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_G_)-[NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_C_)",121.533,"","",""
"1I1A","CRYSTAL STRUCTURE OF THE NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC","10.1016/S1097-2765(01)00230-1 ",2.8,78.2,"1i1a_oligo4","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_H_)-[NAG(7_H_)-MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_D_)",199.986,"","",""
"1I1A","CRYSTAL STRUCTURE OF THE NEONATAL FC RECEPTOR COMPLEXED WITH A HETERODIMERIC FC","10.1016/S1097-2765(01)00230-1 ",2.8,78.2,"1i1a_oligo3","DGlcpNAca1-2DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(6_F_)-[NDG(5_F_)-MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(128_A_)",131.845,"","",""
"1I1C","NON-FCRN BINDING FC FRAGMENT OF RAT IGG2A","10.1016/S1097-2765(01)00230-1 ",2.7,41.2,"1i1c_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",91.0807,"","",""
"1I1C","NON-FCRN BINDING FC FRAGMENT OF RAT IGG2A","10.1016/S1097-2765(01)00230-1 ",2.7,41.2,"1i1c_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",100.324,"","",""
"1IAU","HUMAN GRANZYME B IN COMPLEX WITH AC-IEPD-CHO","10.1016/S1074-5521(01)00018-7 ",2,42.9,"1iau_oligo1","DGlcpNAcb1-4[DManpb1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[BMA(5_C_)-[NAG(4_C_)]-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(98_A_)",87.9146,"","",""
"1IGT","STRUCTURE OF IMMUNOGLOBULIN","10.1021/BI962514+ ",2.8,52,"1igt_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(314_B_)",67.7962,"","",""
"1IGT","STRUCTURE OF IMMUNOGLOBULIN","10.1021/BI962514+ ",2.8,52,"1igt_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(9_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[NAG(8_F_)-MAN(7_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(314_D_)",142.475,"","",""
"1IGX","CRYSTAL STRUCTURE OF EICOSAPENTANOIC ACID BOUND IN THE CYCLOOXYGENASE CHANNEL OF PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1.","10.1074/JBC.M105982200 ",3.1,0,"1igx_oligo5","DManpa1-3DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(144_A_)",64.8125,"","",""
"1IGY","STRUCTURE OF IMMUNOGLOBULIN","10.1006/JMBI.1997.1508 ",3.2,57.1,"1igy_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NDG(2_E_)]-NAG(1_E_)-ASN(314_B_)",79.4591,"","",""
"1IGY","STRUCTURE OF IMMUNOGLOBULIN","10.1006/JMBI.1997.1508 ",3.2,57.1,"1igy_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(9_F_)-[GAL(6_F_)-NAG(5_F_)-MAN(4_F_)-[NAG(8_F_)-MAN(7_F_)]-BMA(3_F_)-NDG(2_F_)]-NAG(1_F_)-ASN(314_D_)",77.3494,"","",""
"1IGZ","CRYSTAL STRUCTURE OF LINOLEIC ACID BOUND IN THE CYCLOOXYGENASE CHANNEL OF PROSTAGLANDIN ENDOPEROXIDE H SYNTHASE-1.","10.1074/JBC.M105982200 ",2.9,0,"1igz_oligo5","DManpa1-3DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(144_A_)",69.8235,"","",""
"1ING","INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA109 INHIBITOR","10.1021/JM00017A005 ",2.4,0,"1ing_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(146_A_)",32.55,"","",""
"1ING","INFLUENZA A SUBTYPE N2 NEURAMINIDASE COMPLEXED WITH AROMATIC BANA109 INHIBITOR","10.1021/JM00017A005 ",2.4,0,"1ing_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(4_H_)-[BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(146_B_)",32.55,"","",""
"1IVC","STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE","10.1021/BI00010A003 ",2.4,0,"1ivc_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(146_A_)",31.3625,"","",""
"1IVC","STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE","10.1021/BI00010A003 ",2.4,0,"1ivc_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(4_H_)-[BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(146_B_)",31.3625,"","",""
"1IVD","STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE","10.1021/BI00010A003 ",1.9,0,"1ivd_oligo6","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(146_A_)",14.8736,"","",""
"1IVD","STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE","10.1021/BI00010A003 ",1.9,0,"1ivd_oligo7","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(4_H_)-[BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(146_B_)",14.8736,"","",""
"1IVE","STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE","10.1021/BI00010A003 ",2.4,0,"1ive_oligo8","DXylpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(146_A_)",25.6728,"","",""
"1IVE","STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE","10.1021/BI00010A003 ",2.4,0,"1ive_oligo9","DXylpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(4_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(146_B_)",25.6728,"","",""
"1IVF","STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE","10.1021/BI00010A003 ",2.4,0,"1ivf_oligo6","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(4_H_)-[BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(146_B_)",46.5595,"","",""
"1IVF","STRUCTURES OF AROMATIC INHIBITORS OF INFLUENZA VIRUS NEURAMINIDASE","10.1021/BI00010A003 ",2.4,0,"1ivf_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(146_A_)",46.5595,"","",""
"1IW6","CRYSTAL STRUCTURE OF THE GROUND STATE OF BACTERIORHODOPSIN","10.1016/S0022-2836(02)01110-5 ",2.3,56.4,"1iw6_oligo1","DGalpb1-6DManpa1-2DGlcpb1-C43O3","GAL(3_B_)-MAN(2_B_)-GLC(1_B_)-L2P(270_A_)",101.678,"","",""
"1IW9","CRYSTAL STRUCTURE OF THE M INTERMEDIATE OF BACTERIORHODOPSIN","10.1016/J.JMB.2004.06.080 ",2.5,47,"1iw9_oligo1","DGalpb1-6DManpa1-2DGlcpb1-C43O3","GAL(3_B_)-MAN(2_B_)-GLC(1_B_)-L2P(270_A_)",73.3915,"","",""
"1IXF","CRYSTAL STRUCTURE OF THE K INTERMEDIATE OF BACTERIORHODOPSIN","10.1016/S0022-2836(02)01110-5 ",2.6,60.49,"1ixf_oligo1","DGalpb1-6DManpa1-2DGlcpb1-C38O3","GAL(3_B_)-MAN(2_B_)-GLC(1_B_)-L2P(270_A_)",101.318,"","",""
"1JDN","CRYSTAL STRUCTURE OF HORMONE RECEPTOR","10.1126/SCIENCE.1062246 ",2.9,65.8,"1jdn_oligo1","DManpb1-4DManpa1-4[DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAca1-ASN","BMA(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NDG(2_B_)-NAG(1_B_)-ASN(248_A_)",86.0976,"","",""
"1JS8","STRUCTURE OF A FUNCTIONAL UNIT FROM OCTOPUS HEMOCYANIN","10.1006/JMBI.1998.1647 ",2.3,0,"1js8_oligo3","DManpa1-3[DManpb1-6]DManpx1-","BMA(3_E_)-[MAN(2_E_)]-MAN(1_E_)",49.2162,"","",""
"1JSH","CRYSTAL STRUCTURE OF H9 HAEMAGGLUTININ COMPLEXED WITH LSTA RECEPTOR ANALOG","10.1073/PNAS.201401198 ",2.4,0,"1jsh_oligo3","DGlcpNAcb1-4[DGlcpNAcb1-6]DGlcpNAcb1-ASN","NAG(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(280_A_)",72.1339,"","",""
"1JSI","CRYSTAL STRUCTURE OF H9 HAEMAGGLUTININ BOUND TO LSTC RECEPTOR ANALOG","10.1073/PNAS.201401198 ",2.4,0,"1jsi_oligo4","DGlcpNAcb1-4[DGlcpNAcb1-6]DGlcpNAcb1-ASN","NAG(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(280_A_)",71.547,"","",""
"1JZ8","E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ALLOLACTOSE","10.1021/BI011727I ",1.5,0,"1jz8_oligo3","DGalpb1-6DGlcpb1-ROH","GAL(2_G_)-BGC(1_G_)",47.4105,"","",""
"1JZ8","E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ALLOLACTOSE","10.1021/BI011727I ",1.5,0,"1jz8_oligo4","DGalpb1-6DGlcpb1-ROH","GAL(2_H_)-BGC(1_H_)",49.9195,"","",""
"1JZ8","E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ALLOLACTOSE","10.1021/BI011727I ",1.5,0,"1jz8_oligo1","DGalpb1-6DGlcpb1-ROH","GAL(2_E_)-BGC(1_E_)",51.1227,"","",""
"1JZ8","E. COLI (LACZ) BETA-GALACTOSIDASE (E537Q) IN COMPLEX WITH ALLOLACTOSE","10.1021/BI011727I ",1.5,0,"1jz8_oligo2","DGalpb1-6DManpb1-ROH","GAL(2_F_)-BGC(1_F_)",32.7595,"","",""
"1K7T","CRYSTAL STRUCTURE ANALYSIS OF CROSSLINKED-WGA3/GLCNACBETA1,6GAL COMPLEX","10.1016/S0304-4165(01)00231-8 ",2.4,28.5,"1k7t_oligo3","DGlcpNAcb1-6DGalpb1-ROH","NAG(2_C_)-GAL(1_C_)",41.1495,"","",""
"1K7T","CRYSTAL STRUCTURE ANALYSIS OF CROSSLINKED-WGA3/GLCNACBETA1,6GAL COMPLEX","10.1016/S0304-4165(01)00231-8 ",2.4,28.5,"1k7t_oligo4","DGlcpNAcb1-6DGalpb1-ROH","NAG(2_D_)-GAL(1_D_)",42.2068,"","",""
"1K7V","CRYSTAL STRUCTURE ANALYSIS OF CROSSLINKED-WGA3/GLCNACBETA1,6GALBETA1, 4GLC","10.1016/S0304-4165(01)00231-8 ",2.2,19.13,"1k7v_oligo3","DGlcpNAcb1-6DGalpb1-4DGlcpb1-ROH","NAG(3_C_)-GAL(2_C_)-BGC(1_C_)",36.4833,"","",""
"1K7V","CRYSTAL STRUCTURE ANALYSIS OF CROSSLINKED-WGA3/GLCNACBETA1,6GALBETA1, 4GLC","10.1016/S0304-4165(01)00231-8 ",2.2,19.13,"1k7v_oligo4","DGlcpNAcb1-6DGalpb1-4DGlcpb1-ROH","NAG(3_D_)-GAL(2_D_)-BGC(1_D_)",34.2161,"","",""
"1L6X","FC FRAGMENT OF RITUXIMAB BOUND TO A MINIMIZED VERSION OF THE B-DOMAIN FROM PROTEIN A CALLED Z34C","",1.65,24.8,"1l6x_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(10_C_)-[GAL(9_C_)-NAG(8_C_)-MAN(7_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",34.0833,"","",""
"1LCS","RECEPTOR-BINDING DOMAIN FROM SUBGROUP B FELINE LEUKEMIA VIRUS","10.1128/JVI.77.4.2717-2729.2003 ",2.5,0,"1lcs_oligo1","DGlcpNAca1-2DManpb1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NDG(5_F_)-BMA(4_F_)-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(24_B_)",88.2067,"","",""
"1LFI","METAL SUBSTITUTION IN TRANSFERRINS: THE CRYSTAL STRUCTURE OF HUMAN COPPER-LACTOFERRIN AT 2.1 ANGSTROMS RESOLUTION","10.1021/BI00133A020 ",2.1,0,"1lfi_oligo1","DGlcpNAcb1-3[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(137_A_)",86.1964,"","",""
"1LFI","METAL SUBSTITUTION IN TRANSFERRINS: THE CRYSTAL STRUCTURE OF HUMAN COPPER-LACTOFERRIN AT 2.1 ANGSTROMS RESOLUTION","10.1021/BI00133A020 ",2.1,0,"1lfi_oligo2","LFucpb1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(478_A_)",79.6923,"","",""
"1MAA","MOUSE ACETYLCHOLINESTERASE CATALYTIC DOMAIN, GLYCOSYLATED PROTEIN","10.1074/JBC.274.5.2963 ",2.9,44,"1maa_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(350_D_)",79.4821,"","",""
"1MCO","THREE-DIMENSIONAL STRUCTURE OF A HUMAN IMMUNOGLOBULIN WITH A HINGE DELETION","10.1073/PNAS.90.9.4271 ",3.2,0,"1mco_oligo2","DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(10_A_)-[NAG(5_A_)-MAN(4_A_)-BMA(3_A_)-NAG(2_A_)]-NAG(1_A_)-ASN(282_H_)",15,"","",""
"1O0V","THE CRYSTAL STRUCTURE OF IGE FC REVEALS AN ASYMMETRICALLY BENT CONFORMATION","10.1038/NI811 ",2.6,46,"1o0v_oligo1","DManpa1-3[DManpb1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(6_D_)-[MAN(5_D_)]-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(394_B_)",76.5565,"","",""
"1OAN","CRYSTAL STRUCTURE OF THE DENGUE 2 VIRUS ENVELOPE PROTEIN","10.1073/PNAS.0832193100 ",2.75,76.1,"1oan_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(153_A_)",96.5848,"","",""
"1OAN","CRYSTAL STRUCTURE OF THE DENGUE 2 VIRUS ENVELOPE PROTEIN","10.1073/PNAS.0832193100 ",2.75,76.1,"1oan_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(153_B_)",86.4314,"","",""
"1OKE","CRYSTAL STRUCTURE OF THE DENGUE 2 VIRUS ENVELOPE PROTEIN IN COMPLEX WITH N-OCTYL-BETA-D-GLUCOSIDE","10.1073/PNAS.0832193100 ",2.4,76.5,"1oke_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(153_A_)",99.002,"","",""
"1OKE","CRYSTAL STRUCTURE OF THE DENGUE 2 VIRUS ENVELOPE PROTEIN IN COMPLEX WITH N-OCTYL-BETA-D-GLUCOSIDE","10.1073/PNAS.0832193100 ",2.4,76.5,"1oke_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(153_B_)",94.0368,"","",""
"1OQO","COMPLEX BETWEEN G0 VERSION OF AN FC BOUND TO A MINIMIZED VERSION OF PROTEIN A CALLED MINI-Z","",2.3,42.9,"1oqo_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",68.4325,"","",""
"1OQO","COMPLEX BETWEEN G0 VERSION OF AN FC BOUND TO A MINIMIZED VERSION OF PROTEIN A CALLED MINI-Z","",2.3,42.9,"1oqo_oligo1","DGlcpNAca1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[NAG(7_F_)-MAN(6_F_)-[NDG(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_B_)",55.5502,"","",""
"1OQX","G-2 GLYCOVARIANT OF HUMAN IGG FC BOUND TO MINIMIZED VERSION OF PROTEIN A CALLED Z34C","",2.6,55.8,"1oqx_oligo1","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[BMA(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_B_)",83.1185,"","",""
"1OQX","G-2 GLYCOVARIANT OF HUMAN IGG FC BOUND TO MINIMIZED VERSION OF PROTEIN A CALLED Z34C","",2.6,55.8,"1oqx_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_A_)",81.8391,"","",""
"1OW0","CRYSTAL STRUCTURE OF HUMAN FCARI BOUND TO IGA1-FC","10.1038/NATURE01685 ",3.1,98.2,"1ow0_oligo2","DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-2DManpb1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUC(8_F_)-[SIA(7_F_)-GAL(6_F_)-NAG(5_F_)-BMA(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)",186.95,"","",""
"1OW0","CRYSTAL STRUCTURE OF HUMAN FCARI BOUND TO IGA1-FC","10.1038/NATURE01685 ",3.1,98.2,"1ow0_oligo4","DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_J_)-[MAN(4_J_)]-MAN(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(58_D_)",184.379,"","",""
"1OW0","CRYSTAL STRUCTURE OF HUMAN FCARI BOUND TO IGA1-FC","10.1038/NATURE01685 ",3.1,98.2,"1ow0_oligo1","DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(58_C_)",184.379,"","",""
"1OW0","CRYSTAL STRUCTURE OF HUMAN FCARI BOUND TO IGA1-FC","10.1038/NATURE01685 ",3.1,98.2,"1ow0_oligo3","DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-2DManpb1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(8_E_)-[SIA(7_E_)-GAL(6_E_)-NAG(5_E_)-BMA(4_E_)-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)",186.95,"","",""
"1P8J","CRYSTAL STRUCTURE OF THE PROPROTEIN CONVERTASE FURIN","10.1038/NSB941 ",2.6,21.3,"1p8j_oligo1","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-4]DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(11_I_)-[NAG(10_I_)-MAN(9_I_)-[GAL(8_I_)-NAG(7_I_)-[GAL(6_I_)-NAG(5_I_)]-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(440_A_)",52.6426,"","",""
"1P8J","CRYSTAL STRUCTURE OF THE PROPROTEIN CONVERTASE FURIN","10.1038/NSB941 ",2.6,21.3,"1p8j_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(4_O_)-[BMA(3_O_)-NAG(2_O_)]-NAG(1_O_)-ASN(440_G_)",43.6261,"","",""
"1PPG","THE REFINED 2.3 ANGSTROMS CRYSTAL STRUCTURE OF HUMAN LEUKOCYTE ELASTASE IN A COMPLEX WITH A VALINE CHLOROMETHYL KETONE INHIBITOR","10.1016/0014-5793(88)80118-2 ",2.3,0,"1ppg_oligo2","DAllpa1-4DAllpNAca1-2DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_B_)-[GLC(6_B_)-NDG(5_B_)-BMA(4_B_)-[MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(109_E_)",9.54705,"","",""
"1Q4G","2.0 ANGSTROM CRYSTAL STRUCTURE OF OVINE PROSTAGLANDIN H2 SYNTHASE-1, IN COMPLEX WITH ALPHA-METHYL-4-BIPHENYLACETIC ACID","10.1016/J.JMB.2003.10.073 ",2,44.1,"1q4g_oligo2","DManpb1-6DManpb1-6DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","BMA(5_H_)-BMA(4_H_)-BMA(3_H_)-NDG(2_H_)-NAG(1_H_)-ASN(144_B_)",69.3798,"","",""
"1Q4G","2.0 ANGSTROM CRYSTAL STRUCTURE OF OVINE PROSTAGLANDIN H2 SYNTHASE-1, IN COMPLEX WITH ALPHA-METHYL-4-BIPHENYLACETIC ACID","10.1016/J.JMB.2003.10.073 ",2,44.1,"1q4g_oligo4","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(410_A_)",73.1811,"","",""
"1Q4G","2.0 ANGSTROM CRYSTAL STRUCTURE OF OVINE PROSTAGLANDIN H2 SYNTHASE-1, IN COMPLEX WITH ALPHA-METHYL-4-BIPHENYLACETIC ACID","10.1016/J.JMB.2003.10.073 ",2,44.1,"1q4g_oligo3","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_G_)-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(410_B_)",64.1464,"","",""
"1Q9W","S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX","10.1038/NSB1014 ",1.75,30.56,"1q9w_oligo1","DKdopa2-4DKdopa2-4DKdopa2-6DGlcpN[4P]b1-6DGlcpNa1-O4P1","KDO(5_E_)-KDO(4_E_)-KDO(3_E_)-GP4(2_E_)-GP1(1_E_)",26.3586,"","",""
"1QFK","STRUCTURE OF HUMAN FACTOR VIIA AND ITS IMPLICATIONS FOR THE TRIGGERING OF BLOOD COAGULATION","10.1073/PNAS.96.16.8925 ",2.8,56.7,"1qfk_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(322_H_)",62.603,"","",""
"1QKC","ESCHERICHIA COLI FERRIC HYDROXAMATE UPTAKE RECEPTOR (FHUA) IN COMPLEX DELTA TWO-ALBOMYCIN","10.1110/PS.9.5.956 ",3.1,82.4,"1qkc_oligo2","DGlcpa1-2DGlcpa1-3[DGalpa1-6]DGlcpa1-3[GMH1-7]GMH1-3GMH1-5[DKdopa2-4]DKdopa2-6DAltp[2<R1>,3<R2>,4P]b1-6DGlcp[2<R3>,3<R4>]a1-O7P2","GMH(10_B_)-[GLA(9_B_)-[GLC(8_B_)-GLC(7_B_)]-GLC(6_B_)]-GMH(5_B_)-GMH(4_B_)-[KDO(11_B_)]-KDO(3_B_)-GCN(2_B_)-PA1(1_B_)",93.3385,"","",""
"1QLR","CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A HUMAN MONOCLONAL IGM COLD AGGLUTININ","10.4049/JIMMUNOL.165.11.6422 ",2.83,43.6,"1qlr_oligo2","LFucpb1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(166_D_)",99.6109,"","",""
"1QLR","CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A HUMAN MONOCLONAL IGM COLD AGGLUTININ","10.4049/JIMMUNOL.165.11.6422 ",2.83,43.6,"1qlr_oligo1","LFucpb1-6DGlcpNAcb1-ASN","FUC(2_E_)-NAG(1_E_)-ASN(166_B_)",99.7404,"","",""
"1QM8","STRUCTURE OF BACTERIORHODOPSIN AT 100 K","10.1006/JMBI.1998.2103 ",2.5,0,"1qm8_oligo1","DGalpb1-6DManpa1-2DGlcpa1-C40O3","GAL(3_B_)-MAN(2_B_)-GLC(1_B_)-L2P(270_A_)",78.5394,"","",""
"1QPA","LIGNIN PEROXIDASE ISOZYME LIP4.65 (PI 4.65)","10.1006/JMBI.1998.2507 ",1.8,18.4,"1qpa_oligo5","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(257_B_)",72.7379,"","",""
"1RER","CRYSTAL STRUCTURE OF THE HOMOTRIMER OF FUSION GLYCOPROTEIN E1 FROM SEMLIKI FOREST VIRUS.","10.1038/NATURE02239 ",3.2,0,"1rer_oligo1","DGlcpNAcb1-2DManpb1-3DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_D_)-[NAG(5_D_)-BMA(4_D_)-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(141_A_)",134.071,"","",""
"1RER","CRYSTAL STRUCTURE OF THE HOMOTRIMER OF FUSION GLYCOPROTEIN E1 FROM SEMLIKI FOREST VIRUS.","10.1038/NATURE02239 ",3.2,0,"1rer_oligo2","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(7_E_)-[MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(141_B_)",134.96,"","",""
"1RK1","MHC CLASS I NATURAL H-2KB HEAVY CHAIN COMPLEXED WITH BETA-2 MICROGLOBULIN AND HERPES SIMPLEX VIRUS MUTANT GLYCOPROTEIN B PEPTIDE","10.1084/JEM.20040217 ",2.1,32.8,"1rk1_oligo1","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_C_)-NAG(1_C_)-ASN(176_A_)",58.9927,"","",""
"1RMG","RHAMNOGALACTURONASE A FROM ASPERGILLUS ACULEATUS","10.1016/S0969-2126(97)00209-8 ",2,20.3,"1rmg_oligo8","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(32_A_)",53.0109,"","",""
"1SZN","THE STRUCTURE OF ALPHA-GALACTOSIDASE","10.1016/J.JMB.2004.03.062 ",1.54,22.95,"1szn_oligo3","DManpb1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-MAN(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(215_A_)",51.4533,"","",""
"1T83","CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC)","10.1074/JBC.M100350200 ",3,0,"1t83_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NDG(2_E_)]-NAG(1_E_)-ASN(297_B_)",112.121,"","",""
"1T83","CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (ORTHORHOMBIC)","10.1074/JBC.M100350200 ",3,0,"1t83_oligo1","DGalpb1-4DGlcpNAca1-2DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(8_D_)-[GAL(6_D_)-NDG(5_D_)-MAN(4_D_)-[BMA(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",100.864,"","",""
"1T89","CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (HEXAGONAL)","10.1074/JBC.M100350200 ",3.5,0,"1t89_oligo1","DGalpb1-4DGlcpNAca1-2DManpa1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(8_D_)-[GAL(6_D_)-NDG(5_D_)-MAN(4_D_)-[BMA(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",72.4128,"","",""
"1T89","CRYSTAL STRUCTURE OF A HUMAN TYPE III FC GAMMA RECEPTOR IN COMPLEX WITH AN FC FRAGMENT OF IGG1 (HEXAGONAL)","10.1074/JBC.M100350200 ",3.5,0,"1t89_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(8_E_)-[NAG(7_E_)-MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NDG(2_E_)]-NAG(1_E_)-ASN(297_B_)",91.035,"","",""
"1U67","CRYSTAL STRUCTURE OF ARACHIDONIC ACID BOUND TO A MUTANT OF PROSTAGLADIN H SYNTHASE-1 THAT FORMS PREDOMINANTLY 11-HPETE.","10.1074/JBC.M403013200 ",3.1,41.1,"1u67_oligo7","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(144_A_)",76.9502,"","",""
"1UCQ","CRYSTAL STRUCTURE OF THE L INTERMEDIATE OF BACTERIORHODOPSIN","10.1016/J.JMB.2003.10.068 ",2.4,66.47,"1ucq_oligo1","DGalpb1-6DManpa1-2DGlcpb1-C38O3","GAL(3_B_)-MAN(2_B_)-GLC(1_B_)-L2P(270_A_)",105.885,"","",""
"1UZG","CRYSTAL STRUCTURE OF THE DENGUE TYPE 3 VIRUS ENVELOPE PROTEIN","10.1128/JVI.79.2.1223-1231.2005 ",3.5,75.13,"1uzg_oligo1","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_C_)-NAG(1_C_)-ASN(67_A_)",133.71,"","",""
"1W1I","CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPPIV OR CD26) IN COMPLEX WITH ADENOSINE DEAMINASE","10.1074/JBC.M405001200 ",3.03,52.46,"1w1i_oligo9","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_Q_)-[NAG(2_Q_)]-NAG(1_Q_)-ASN(85_C_)",87.2994,"","",""
"1W1I","CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPPIV OR CD26) IN COMPLEX WITH ADENOSINE DEAMINASE","10.1074/JBC.M405001200 ",3.03,52.46,"1w1i_oligo2","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(85_A_)",80.1148,"","",""
"1W1I","CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPPIV OR CD26) IN COMPLEX WITH ADENOSINE DEAMINASE","10.1074/JBC.M405001200 ",3.03,52.46,"1w1i_oligo5","LFucpb1-6DGlcpNAcb1-ASN","FUC(2_M_)-NAG(1_M_)-ASN(85_B_)",75.4341,"","",""
"1W1I","CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPPIV OR CD26) IN COMPLEX WITH ADENOSINE DEAMINASE","10.1074/JBC.M405001200 ",3.03,52.46,"1w1i_oligo14","LFucpb1-6DGlcpNAcb1-ASN","FUC(2_V_)-NAG(1_V_)-ASN(85_D_)",84.5445,"","",""
"1X0K","CRYSTAL STRUCTURE OF BACTERIORHODOPSIN AT PH 10","10.1016/J.JMB.2005.06.026 ",2.6,53.93,"1x0k_oligo1","DGalpb1-6DManpa1-2DGlcpb1-C38O3","GAL(3_A_)-MAN(2_A_)-GLC(1_A_)-L2P(270_1_)",78.7379,"","",""
"1X0S","CRYSTAL STRUCTURE OF THE 13-CIS ISOMER OF BACTERIORHODOPSIN","10.1016/J.JMB.2005.07.021 ",2.5,66.47,"1x0s_oligo1","DGalpb1-6DManpa1-2DGlcpb1-C37O3","GAL(3_B_)-MAN(2_B_)-GLC(1_B_)-L2P(270_A_)",107.533,"","",""
"1XLU","X-RAY STRUCTURE OF DI-ISOPROPYL-PHOSPHORO-FLUORIDATE (DFP) INHIBITED BUTYRYLCHOLINESTERASE AFTER AGING","10.1021/BI048238D ",2.2,45.8,"1xlu_oligo2","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(241_A_)",82.4255,"","",""
"1XLV","ETHYLPHOSPHORYLATED BUTYRYLCHOLINESTERASE (AGED) OBTAINED BY REACTION WITH ECHOTHIOPHATE","10.1021/BI048238D ",2.25,48.28,"1xlv_oligo4","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(241_A_)",84.437,"","",""
"1XLW","DIETHYLPHOSPHORYLATED BUTYRYLCHOLINESTERASE (NONAGED) OBTAINED BY REACTION WITH ECHOTHIOPHATE","10.1021/BI048238D ",2.1,42.28,"1xlw_oligo1","LFucpb1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(106_A_)",64.4573,"","",""
"1XLW","DIETHYLPHOSPHORYLATED BUTYRYLCHOLINESTERASE (NONAGED) OBTAINED BY REACTION WITH ECHOTHIOPHATE","10.1021/BI048238D ",2.1,42.28,"1xlw_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(241_A_)",78.3858,"","",""
"1XLW","DIETHYLPHOSPHORYLATED BUTYRYLCHOLINESTERASE (NONAGED) OBTAINED BY REACTION WITH ECHOTHIOPHATE","10.1021/BI048238D ",2.1,42.28,"1xlw_oligo4","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(341_A_)",65.3379,"","",""
"2A0Z","THE MOLECULAR STRUCTURE OF TOLL-LIKE RECEPTOR 3 LIGAND BINDING DOMAIN","10.1073/PNAS.0505077102 ",2.4,45.4,"2a0z_oligo7","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(413_A_)",77.0195,"","",""
"2AC1","CRYSTAL STRUCTURE OF A CELL-WALL INVERTASE FROM ARABIDOPSIS THALIANA","10.1107/S0907444906044489 ",2.15,30.9,"2ac1_oligo1","DManpa1-2DManpa1-3[DManpb1-3DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAca1-ASN","MAN(7_B_)-MAN(6_B_)-[MAN(5_B_)-MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(299_A_)",58.7278,"","",""
"2AW2","CRYSTAL STRUCTURE OF THE HUMAN BTLA-HVEM COMPLEX","10.1074/JBC.M507629200 ",2.8,61.82,"2aw2_oligo2","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_D_)-NAG(1_D_)-ASN(72_Y_)",101.16,"","",""
"2AYL","2.0 ANGSTROM CRYSTAL STRUCTURE OF MANGANESE PROTOPORPHYRIN IX- RECONSTITUTED OVINE PROSTAGLANDIN H2 SYNTHASE-1 COMPLEXED WITH FLURBIPROFEN","10.1107/S0907444905036309 ",2,32.8,"2ayl_oligo2","DManpb1-6DManpb1-6DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_G_)-MAN(4_G_)-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(1144_B_)",58.3144,"","",""
"2AYL","2.0 ANGSTROM CRYSTAL STRUCTURE OF MANGANESE PROTOPORPHYRIN IX- RECONSTITUTED OVINE PROSTAGLANDIN H2 SYNTHASE-1 COMPLEXED WITH FLURBIPROFEN","10.1107/S0907444905036309 ",2,32.8,"2ayl_oligo5","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(410_A_)",63.5411,"","",""
"2AYL","2.0 ANGSTROM CRYSTAL STRUCTURE OF MANGANESE PROTOPORPHYRIN IX- RECONSTITUTED OVINE PROSTAGLANDIN H2 SYNTHASE-1 COMPLEXED WITH FLURBIPROFEN","10.1107/S0907444905036309 ",2,32.8,"2ayl_oligo3","DManpb1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_H_)-MAN(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(1410_B_)",56.6864,"","",""
"2AYL","2.0 ANGSTROM CRYSTAL STRUCTURE OF MANGANESE PROTOPORPHYRIN IX- RECONSTITUTED OVINE PROSTAGLANDIN H2 SYNTHASE-1 COMPLEXED WITH FLURBIPROFEN","10.1107/S0907444905036309 ",2,32.8,"2ayl_oligo1","DManpb1-6DManpa1-6DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(5_D_)-MAN(4_D_)-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(144_A_)",60.4125,"","",""
"2B65","CRYSTAL STRUCTURE OF THE COMPLEX OF C-LOBE OF BOVINE LACTOFERRIN WITH MALTOSE AT 1.5A RESOLUTION","",1.5,21.56,"2b65_oligo2","DManpb1-4[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(476_A_)",52.4458,"","",""
"2BAT","THE STRUCTURE OF THE COMPLEX BETWEEN INFLUENZA VIRUS NEURAMINIDASE AND SIALIC ACID, THE VIRAL RECEPTOR","10.1002/PROT.340140302 ",2,0,"2bat_oligo1","DGalpNAca1-4DGlcpNAcb1-4DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(7_B_)-[NGK(6_B_)-NAG(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(146_A_)",81.2249,"","",""
"2BF1","STRUCTURE OF AN UNLIGANDED AND FULLY-GLYCOSYLATED SIV GP120 ENVELOPE GLYCOPROTEIN","10.1038/NATURE03327 ",4,128.8,"2bf1_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(277_A_)",123.823,"","",""
"2BF1","STRUCTURE OF AN UNLIGANDED AND FULLY-GLYCOSYLATED SIV GP120 ENVELOPE GLYCOPROTEIN","10.1038/NATURE03327 ",4,128.8,"2bf1_oligo6","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(246_A_)",122.539,"","",""
"2BF1","STRUCTURE OF AN UNLIGANDED AND FULLY-GLYCOSYLATED SIV GP120 ENVELOPE GLYCOPROTEIN","10.1038/NATURE03327 ",4,128.8,"2bf1_oligo7","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(283_A_)",130.345,"","",""
"2BF1","STRUCTURE OF AN UNLIGANDED AND FULLY-GLYCOSYLATED SIV GP120 ENVELOPE GLYCOPROTEIN","10.1038/NATURE03327 ",4,128.8,"2bf1_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(243_A_)",115.522,"","",""
"2BF1","STRUCTURE OF AN UNLIGANDED AND FULLY-GLYCOSYLATED SIV GP120 ENVELOPE GLYCOPROTEIN","10.1038/NATURE03327 ",4,128.8,"2bf1_oligo8","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(294_A_)",158.442,"","",""
"2BF1","STRUCTURE OF AN UNLIGANDED AND FULLY-GLYCOSYLATED SIV GP120 ENVELOPE GLYCOPROTEIN","10.1038/NATURE03327 ",4,128.8,"2bf1_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(4_H_)-[BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(376_A_)",152.98,"","",""
"2BF1","STRUCTURE OF AN UNLIGANDED AND FULLY-GLYCOSYLATED SIV GP120 ENVELOPE GLYCOPROTEIN","10.1038/NATURE03327 ",4,128.8,"2bf1_oligo9","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(305_A_)",135.747,"","",""
"2BGN","HIV-1 TAT PROTEIN DERIVED N-TERMINAL NONAPEPTIDE TRP2-TAT(1-9) BOUND TO THE ACTIVE SITE OF DIPEPTIDYL PEPTIDASE IV (CD26)","10.1074/JBC.M413400200 ",3.15,64.8,"2bgn_oligo10","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_R_)-[NAG(2_R_)]-NAG(1_R_)-ASN(85_C_)",106.889,"","",""
"2BGN","HIV-1 TAT PROTEIN DERIVED N-TERMINAL NONAPEPTIDE TRP2-TAT(1-9) BOUND TO THE ACTIVE SITE OF DIPEPTIDYL PEPTIDASE IV (CD26)","10.1074/JBC.M413400200 ",3.15,64.8,"2bgn_oligo2","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(85_A_)",99.5109,"","",""
"2BGN","HIV-1 TAT PROTEIN DERIVED N-TERMINAL NONAPEPTIDE TRP2-TAT(1-9) BOUND TO THE ACTIVE SITE OF DIPEPTIDYL PEPTIDASE IV (CD26)","10.1074/JBC.M413400200 ",3.15,64.8,"2bgn_oligo15","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_a_)-NAG(1_a_)-ASN(85_D_)",105.256,"","",""
"2BGN","HIV-1 TAT PROTEIN DERIVED N-TERMINAL NONAPEPTIDE TRP2-TAT(1-9) BOUND TO THE ACTIVE SITE OF DIPEPTIDYL PEPTIDASE IV (CD26)","10.1074/JBC.M413400200 ",3.15,64.8,"2bgn_oligo6","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_N_)-NAG(1_N_)-ASN(85_B_)",85.4609,"","",""
"2BGR","CRYSTAL STRUCTURE OF HIV-1 TAT DERIVED NONAPEPTIDES TAT(1-9) BOUND TO THE ACTIVE SITE OF DIPEPTIDYL PEPTIDASE IV (CD26)","10.1074/JBC.M413400200 ",2,38.7,"2bgr_oligo6","LFucpb1-6DGlcpNAcb1-ASN","FUC(2_H_)-NAG(1_H_)-ASN(85_B_)",64.6991,"","",""
"2BGR","CRYSTAL STRUCTURE OF HIV-1 TAT DERIVED NONAPEPTIDES TAT(1-9) BOUND TO THE ACTIVE SITE OF DIPEPTIDYL PEPTIDASE IV (CD26)","10.1074/JBC.M413400200 ",2,38.7,"2bgr_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(85_A_)",64.8282,"","",""
"2BHW","PEA LIGHT-HARVESTING COMPLEX II AT 2.5 ANGSTROM RESOLUTION","10.1038/SJ.EMBOJ.7600585 ",2.5,"2.1496e+09","2bhw_oligo2","LAltpb1-6DGalpb1-C13O3","DGD(802_B_)-DGD(802_B_)",124.69,"","",""
"2BHW","PEA LIGHT-HARVESTING COMPLEX II AT 2.5 ANGSTROM RESOLUTION","10.1038/SJ.EMBOJ.7600585 ",2.5,"2.1496e+09","2bhw_oligo1","LAltpb1-6DGalpb1-C13O3","DGD(802_C_)-DGD(802_C_)",126.766,"","",""
"2BHW","PEA LIGHT-HARVESTING COMPLEX II AT 2.5 ANGSTROM RESOLUTION","10.1038/SJ.EMBOJ.7600585 ",2.5,"2.1496e+09","2bhw_oligo3","LAltpb1-6DGalpb1-C13O3","DGD(802_A_)-DGD(802_A_)",126.37,"","",""
"2C10","THE STRUCTURE OF A TRUNCATED, SOLUBLE VERSION OF SEMICARBAZIDE- SENSITIVE AMINE OXIDASE","10.1107/S0907444905028805 ",2.5,37.62,"2c10_oligo11","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(5_O_)-[MAN(4_O_)-BMA(3_O_)-NAG(2_O_)]-NAG(1_O_)-ASN(592_D_)",62.2315,"","",""
"2C10","THE STRUCTURE OF A TRUNCATED, SOLUBLE VERSION OF SEMICARBAZIDE- SENSITIVE AMINE OXIDASE","10.1107/S0907444905028805 ",2.5,37.62,"2c10_oligo7","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(592_A_)",52.55,"","",""
"2C10","THE STRUCTURE OF A TRUNCATED, SOLUBLE VERSION OF SEMICARBAZIDE- SENSITIVE AMINE OXIDASE","10.1107/S0907444905028805 ",2.5,37.62,"2c10_oligo3","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(5_I_)-[MAN(4_I_)-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(592_B_)",62.8775,"","",""
"2C10","THE STRUCTURE OF A TRUNCATED, SOLUBLE VERSION OF SEMICARBAZIDE- SENSITIVE AMINE OXIDASE","10.1107/S0907444905028805 ",2.5,37.62,"2c10_oligo8","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(3_L_)-[NAG(2_L_)]-NAG(1_L_)-ASN(592_C_)",55.2306,"","",""
"2C11","CRYSTAL STRUCTURE OF THE 2-HYDRAZINOPYRIDINE OF SEMICARBAZIDE- SENSITIVE AMINE OXIDASE","10.1107/S0907444905028805 ",2.9,60,"2c11_oligo5","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(5_H_)-[MAN(4_H_)-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(592_B_)",94.6956,"","",""
"2C11","CRYSTAL STRUCTURE OF THE 2-HYDRAZINOPYRIDINE OF SEMICARBAZIDE- SENSITIVE AMINE OXIDASE","10.1107/S0907444905028805 ",2.9,60,"2c11_oligo1","LFucpb1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(592_A_)",81.1368,"","",""
"2C11","CRYSTAL STRUCTURE OF THE 2-HYDRAZINOPYRIDINE OF SEMICARBAZIDE- SENSITIVE AMINE OXIDASE","10.1107/S0907444905028805 ",2.9,60,"2c11_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(592_C_)",86.7194,"","",""
"2C11","CRYSTAL STRUCTURE OF THE 2-HYDRAZINOPYRIDINE OF SEMICARBAZIDE- SENSITIVE AMINE OXIDASE","10.1107/S0907444905028805 ",2.9,60,"2c11_oligo8","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(5_L_)-[MAN(4_L_)-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(592_D_)",91.5107,"","",""
"2C9A","CRYSTAL STRUCTURE OF THE MAM-IG MODULE OF RECEPTOR PROTEIN TYROSINE PHOSPHATASE MU","10.1038/SJ.EMBOJ.7600974 ",2.7,47.97,"2c9a_oligo1","DGlcpNAca1-4[LFucpb1-6]DGlcpNAcx1-","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)",81.4216,"","",""
"2CH9","CRYSTAL STRUCTURE OF DIMERIC HUMAN CYSTATIN F","10.1074/JBC.M601033200 ",2.1,57.18,"2ch9_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(62_A_)",79.867,"","",""
"2D0G","CRYSTAL STRUCTURE OF THERMOACTINOMYCES VULGARIS R-47 ALPHA-AMYLASE 1 (TVAI) MUTANT D356N/E396Q COMPLEXED WITH P5, A PULLULAN MODEL OLIGOSACCHARIDE","10.1111/J.1742-4658.2005.05013.X ",2.6,0,"2d0g_oligo4","DGlcpa1-4DGlcpb1-4DGlcpb1-6DGlcpb1-4DGlcpb1-ROH","GLC(5_D_)-BGC(4_D_)-BGC(3_D_)-BGC(2_D_)-BGC(1_D_)",42.2571,"","",""
"2DOJ","CRYSTAL STRUCTURE OF THE COMPLEX OF C-TERMINAL LOBE OF BOVINE LACTOFERRIN WITH ADENOSINE AT 2.4 A RESOLUTION","",2.4,29.55,"2doj_oligo4","DManpb1-6DManpa1-4DGlcpNAca1-4DGlcpNAcb1-ASN","BMA(4_C_)-MAN(3_C_)-NDG(2_C_)-NAG(1_C_)-ASN(476_A_)",66.6218,"","",""
"2DP8","CARBOHYDRATE RECOGNITION BY LACTOFERRIN: CRYSTAL STRUCTURE OF THE COMPLEX OF C-TERMINAL LOBE OF BOVINE LACTOFERRIN WITH TRISACCHARIDE AT 2.5 A RESOLUTION","",2.5,37.17,"2dp8_oligo3","DManpb1-4[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(476_A_)",92.7018,"","",""
"2DQV","STRUCTURE OF THE C-TERMINAL LOBE OF BOVINE LACTOFERRIN IN COMPLEX WITH GALACTOSE AT 2.7 A RESOLUTION","",2.7,33.9,"2dqv_oligo1","DManpb1-4[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[BMA(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(476_A_)",90.7338,"","",""
"2DVB","CRYSTAL STRUCTURE OF PEANUT LECTIN GAL-BETA-1,6-GALNAC COMPLEX","10.1107/S0907444906035712 ",2.25,33.3,"2dvb_oligo1","DGalpb1-6DGalpNAca1-ROH","GAL(2_E_)-NGA(1_E_)",51.6732,"","",""
"2DWI","CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN C-TERMINAL HALF OF BOVINE LACTOFERRIN AND CELLOBIOSE AT 2.2 A RESOLUTION","",2.2,30.25,"2dwi_oligo4","DManpa1-4[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(476_A_)",67.6991,"","",""
"2DWJ","STRUCTURE OF THE COMPLEX OF C-TERMINAL LOBE OF BOVINE LACTOFERRIN WITH RAFFINOSE AT 2.3 A RESOLUTION","",2.3,39.2,"2dwj_oligo1","DGalpb1-6DGlcpa1-","GAL(3_B_)-GLC(2_B_)-FRU(1_B_)",78.3359,"","",""
"2DXR","CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN C-TERMINAL HALF OF BOVINE LACTOFERRIN AND SORBITOL AT 2.85 A RESOLUTION","",2.85,28.31,"2dxr_oligo3","DManpa1-4[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(476_A_)",65.1382,"","",""
"2DYX","STRUCTURE OF THE COMPLEX OF LACTOFERRIN C-LOBE WITH MELIBIOSE AT 2.0 A RESOLUTION","",2,34.84,"2dyx_oligo3","DGalpb1-6DGlcpa1-ROH","GAL(2_E_)-BGC(1_E_)",35.2082,"","",""
"2DYX","STRUCTURE OF THE COMPLEX OF LACTOFERRIN C-LOBE WITH MELIBIOSE AT 2.0 A RESOLUTION","",2,34.84,"2dyx_oligo4","DManpa1-4[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(476_A_)",67.2367,"","",""
"2E0S","CARBOHYDRATE RECOGNITION OF C-TERMINAL HALF OF LACTOFERRIN: CRYSTAL STRUCTURE OF THE COMPLEX OF C-LOBE WITH RHAMNOSE AT 2.15 A RESOLUTION","",2.15,27.09,"2e0s_oligo3","DManpa1-4[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(476_A_)",52.0555,"","",""
"2E1S","CRYSTAL STRUCTURE OF THE COMPLEX OF C-TERMINAL HALF OF BOVINE LACTOFERRIN AND ARABINOSE AT 2.7 A RESOLUTION","",2.7,19.16,"2e1s_oligo1","DManpa1-4[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(476_A_)",50.7555,"","",""
"2E3X","CRYSTAL STRUCTURE OF RUSSELL'S VIPER VENOM METALLOPROTEINASE","10.1016/J.FEBSLET.2007.11.062 ",2.91,0,"2e3x_oligo3","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_E_)-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(24_C_)",118.321,"","",""
"2ESC","CRYSTAL STRUCTURE OF A 40 KDA PROTECTIVE SIGNALLING PROTEIN FROM BOVINE (SPC-40) AT 2.1 A RESOLUTION","10.1107/S0907444906020427 ",2.1,36.15,"2esc_oligo1","DManpb1-4DManpb1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-MAN(4_B_)-[MAN(6_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(39_A_)",46.9409,"","",""
"2FA7","CRYSTAL STRUCTURE OF THE COMPLEX OF BOVINE LACTOFERRIN C-LOBE WITH A PENTASACCHARIDE AT 2.38 A RESOLUTION","",2.38,33.51,"2fa7_oligo3","DManpb1-4[DManpb1-6]DManpa1-4DGlcpNAca1-4DGlcpNAcb1-ASN","BMA(5_C_)-[BMA(4_C_)]-MAN(3_C_)-NDG(2_C_)-NAG(1_C_)-ASN(476_A_)",77.4207,"","",""
"2G8Z","CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF SIGNALLING PROTEIN FROM SHEEP (SPS-40) WITH TRIMER AND DESIGNED PEPTIDE AT 2.5A RESOLUTION","",2.5,36.2,"2g8z_oligo2","DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_B_)-[MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(39_A_)",49.6591,"","",""
"2G93","LIGAND RECOGNITION SITE IN C-LOBE OF LACTOFERRIN: CRYSTAL STRUCTURE OF THE COMPLEX OF C-LOBE OF BOVINE LACTOFERRIN WITH METHYL ALPHA-D- MANNOPYRANOSIDE AT 1.9 A RESOLUTION","",1.9,36.02,"2g93_oligo3","DManpb1-4[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_C_)-[BMA(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)",75.4602,"","",""
"2GJ7","CRYSTAL STRUCTURE OF A GE-GI/FC COMPLEX","10.1371/JOURNAL.PBIO.0040148 ",5,0,"2gj7_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",40.4411,"","",""
"2GJ7","CRYSTAL STRUCTURE OF A GE-GI/FC COMPLEX","10.1371/JOURNAL.PBIO.0040148 ",5,0,"2gj7_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",42.0837,"","",""
"2H26","HUMAN CD1B IN COMPLEX WITH ENDOGENOUS PHOSPHATIDYLCHOLINE AND SPACER","10.1038/SJ.EMBOJ.7601244 ",1.8,33.61,"2h26_oligo1","LFucpb1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(20_A_)",65.0236,"","",""
"2H26","HUMAN CD1B IN COMPLEX WITH ENDOGENOUS PHOSPHATIDYLCHOLINE AND SPACER","10.1038/SJ.EMBOJ.7601244 ",1.8,33.61,"2h26_oligo2","LFucpb1-6DGlcpNAcb1-ASN","FUC(2_D_)-NAG(1_D_)-ASN(57_A_)",47.1977,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo29","DManpb1-3[DManpb1-6]DManpx1-","MAN(11_U_)-[MAN(10_U_)]-BMA(9_U_)",129.08,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo18","DManpa1-2DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","MAN(9_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-MAN(3_Q_)-NAG(2_Q_)-NAG(1_Q_)",129.08,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo15","DManpb1-3DManpb1-6DManpb1-3DGlcpNAcb1-3DGlcpNAcb1-ASN","MAN(10_M_)-MAN(9_M_)-MAN(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(195_A_)",128.191,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo13","DManpb1-3[DManpb1-6]DManpx1-","MAN(7_J_)-[MAN(5_J_)]-MAN(4_J_)",129.08,"","",""
"2H6O","EPSTEIN BARR VIRUS MAJOR ENVELOPE GLYCOPROTEIN","10.1038/NSMB1161 ",3.5,0,"2h6o_oligo41","DManpb1-6DManpa1-6DManpx1-","MAN(8_d_)-MAN(6_d_)-MAN(3_d_)",129.08,"","",""
"2H9Y","CRYSTAL STRUCTURE OF MOUSE ACETYLCHOLINESTERASE COMPLEXED WITH M-(N,N, N-TRIMETHYLAMMONIO)TRIFLUOROACETOPHENONE","10.1074/JBC.M603018200 ",2.4,64.46,"2h9y_oligo1","LFucpb1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(350_A_)",102.844,"","",""
"2HG0","STRUCTURE OF THE WEST NILE VIRUS ENVELOPE GLYCOPROTEIN","10.1128/JVI.01125-06 ",3,91.81,"2hg0_oligo1","DGlcpNAca1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(3_B_)-[NDG(2_B_)]-NAG(1_B_)-ASN(154_A_)",115.079,"","",""
"2I69","CRYSTAL STRUCTURE OF THE WEST NILE VIRUS ENVELOPE GLYCOPROTEIN","10.1128/JVI.01735-06 ",3.11,117.6,"2i69_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(154_A_)",182.439,"","",""
"2I6S","COMPLEMENT COMPONENT C2A","10.1016/J.STR.2006.08.008 ",2.7,32.12,"2i6s_oligo2","DManpb1-3DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(313_A_)",61.7755,"","",""
"2I9B","CRYSTAL STRUCTURE OF ATF-UROKINASE RECEPTOR COMPLEX","10.1016/J.JMB.2006.08.063 ",2.8,67.3,"2i9b_oligo1","DManpb1-6DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(52_E_)",116.827,"","",""
"2I9B","CRYSTAL STRUCTURE OF ATF-UROKINASE RECEPTOR COMPLEX","10.1016/J.JMB.2006.08.063 ",2.8,67.3,"2i9b_oligo2","DManpb1-6DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(52_F_)",110.606,"","",""
"2IUF","THE STRUCTURES OF PENICILLIUM VITALE CATALASE: RESTING STATE, OXIDISED STATE (COMPOUND I) AND COMPLEX WITH AMINOTRIAZOLE","10.1021/JA063660Y ",1.71,11.94,"2iuf_oligo2","DGlcpNAcb1-6DGlcpNAcx1-","NAG(2_B_)-NAG(1_B_)",39.9955,"","",""
"2J6E","CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION","10.1016/J.JMB.2007.02.085 ",3,0,"2j6e_oligo1","DGalpb1-4DGlcpNAca1-2DManpa1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-BMA(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",54.9007,"","",""
"2J6E","CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION","10.1016/J.JMB.2007.02.085 ",3,0,"2j6e_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-BMA(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",116.527,"","",""
"2O26","STRUCTURE OF A CLASS III RTK SIGNALING ASSEMBLY","10.1038/SJ.EMBOJ.7601545 ",2.5,98,"2o26_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(296_Y_)",177.864,"","",""
"2O26","STRUCTURE OF A CLASS III RTK SIGNALING ASSEMBLY","10.1038/SJ.EMBOJ.7601545 ",2.5,98,"2o26_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(296_X_)",136.029,"","",""
"2O26","STRUCTURE OF A CLASS III RTK SIGNALING ASSEMBLY","10.1038/SJ.EMBOJ.7601545 ",2.5,98,"2o26_oligo5","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(296_U_)",145.155,"","",""
"2O26","STRUCTURE OF A CLASS III RTK SIGNALING ASSEMBLY","10.1038/SJ.EMBOJ.7601545 ",2.5,98,"2o26_oligo7","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(296_W_)",172.284,"","",""
"2OYE","INDOMETHACIN-(R)-ALPHA-ETHYL-ETHANOLAMIDE BOUND TO CYCLOOXYGENASE-1","10.1074/JBC.M701335200 ",2.85,62.96,"2oye_oligo4","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(144_P_)",76.5657,"","",""
"2QJE","CRYSTAL STRUCTURE OF THE COMPLEX OF BOVINE C-LOBE WITH AMYGDALIN AT 2.3A RESOLUTION","",2.3,37.3,"2qje_oligo2","LGlcpb1-6DManpa1-C8N1O1","Z8T(2_D_)-TVY(1_D_)",20,"","",""
"2QJR","DIPEPDYL PEPTIDASE IV IN COMPLEX WITH INHIBITOR PZF","10.1016/J.BMCL.2007.07.081 ",2.2,53.31,"2qjr_oligo6","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","LGU(803_A_)-[MAN(4_D_)]-LGU(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(229_A_)",83.0264,"","",""
"2QL1","STRUCTURAL CHARACTERIZATION OF A MUTATED, ADCC-ENHANCED HUMAN FC FRAGMENT","10.1016/J.MOLIMM.2007.10.042 ",2.53,36.25,"2ql1_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",74.3521,"","",""
"2QT6","CRYSTAL STRUCTURE DETERMINATION OF A BLUE LACCASE FROM LENTINUS TIGRINUS","10.1186/1472-6807-7-60 ",1.5,26.09,"2qt6_oligo2","DManpb1-3DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-BMA(4_D_)-[BMA(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(54_B_)",37.8806,"","",""
"2QT6","CRYSTAL STRUCTURE DETERMINATION OF A BLUE LACCASE FROM LENTINUS TIGRINUS","10.1186/1472-6807-7-60 ",1.5,26.09,"2qt6_oligo1","DManpb1-6DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-BMA(4_C_)-[BMA(6_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(54_A_)",33.07,"","",""
"2R71","CRYSTAL STRUCTURE OF THE COMPLEX OF BOVINE C-LOBE WITH INOSITOL AT 2.1A RESOLUTION","",2.07,33.84,"2r71_oligo3","DManpb1-4[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[BMA(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(476_A_)",62.22,"","",""
"2VDO","INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE, HHLGGAKQAGDV","10.1083/JCB.200801146 ",2.51,51.55,"2vdo_oligo2","DManpb1-3[DManpb1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)]-MAN(4_E_)-[MAN(7_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(371_B_)",91.3655,"","",""
"2VDO","INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE, HHLGGAKQAGDV","10.1083/JCB.200801146 ",2.51,51.55,"2vdo_oligo1","DManpb1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(320_B_)",108.462,"","",""
"2W52","2 BETA-GLUCANS (6-O-GLUCOSYL-LAMINARITRIOSE) IN BOTH DONOR AND ACCEPTOR SITES OF GH16 LAMINARINASE 16A FROM PHANEROCHAETE CHRYSOSPORIUM.","10.1111/J.1742-4658.2009.07099.X ",1.56,12.69,"2w52_oligo3","DGlcpb1-6DGlcpb1-3DGlcpb1-3DGlcpb1-ROH","BGC(4_C_)-BGC(3_C_)-BGC(2_C_)-BGC(1_C_)",19.1316,"","",""
"2WID","NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA1","10.1042/BJ20090091 ",2.3,37.65,"2wid_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(341_A_)",62.9646,"","",""
"2WID","NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA1","10.1042/BJ20090091 ",2.3,37.65,"2wid_oligo2","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_C_)-NAG(1_C_)-ASN(106_A_)",69.5291,"","",""
"2WID","NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA1","10.1042/BJ20090091 ",2.3,37.65,"2wid_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",82.7542,"","",""
"2WIF","AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA1","10.1042/BJ20090091 ",2.25,38.01,"2wif_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(341_A_)",62.1552,"","",""
"2WIF","AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA1","10.1042/BJ20090091 ",2.25,38.01,"2wif_oligo2","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_C_)-NAG(1_C_)-ASN(106_A_)",51.9941,"","",""
"2WIF","AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA1","10.1042/BJ20090091 ",2.25,38.01,"2wif_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",73.8133,"","",""
"2WIG","NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA4","10.1042/BJ20090091 ",2.15,35.28,"2wig_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",73.6345,"","",""
"2WIG","NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA4","10.1042/BJ20090091 ",2.15,35.28,"2wig_oligo2","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_C_)-NAG(1_C_)-ASN(106_A_)",70.3568,"","",""
"2WIG","NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA4","10.1042/BJ20090091 ",2.15,35.28,"2wig_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(341_A_)",61.633,"","",""
"2WII","COMPLEMENT C3B IN COMPLEX WITH FACTOR H DOMAINS 1-4","10.1038/NI.1755 ",2.7,68.2,"2wii_oligo1","DManpb1-6DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-BMA(4_D_)-[BMA(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(63_A_)",134.842,"","",""
"2WIJ","NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA5","10.1042/BJ20090091 ",2.1,35.89,"2wij_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(341_A_)",57.8576,"","",""
"2WIJ","NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA5","10.1042/BJ20090091 ",2.1,35.89,"2wij_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",66.5912,"","",""
"2WIJ","NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA5","10.1042/BJ20090091 ",2.1,35.89,"2wij_oligo2","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_C_)-NAG(1_C_)-ASN(106_A_)",64.3864,"","",""
"2WIK","NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA6","10.1042/BJ20090091 ",2.1,37.38,"2wik_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",74.8576,"","",""
"2WIK","NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA6","10.1042/BJ20090091 ",2.1,37.38,"2wik_oligo2","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_C_)-NAG(1_C_)-ASN(106_A_)",55.6486,"","",""
"2WIK","NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA6","10.1042/BJ20090091 ",2.1,37.38,"2wik_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(341_A_)",65.2103,"","",""
"2WIN","C3 CONVERTASE (C3BBB) STABILIZED BY SCIN","10.1038/NI.1756 ",3.9,158.8,"2win_oligo1","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","BMA(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(63_A_)",205.398,"","",""
"2WIN","C3 CONVERTASE (C3BBB) STABILIZED BY SCIN","10.1038/NI.1756 ",3.9,158.8,"2win_oligo7","DManpb1-6DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_W_)-BMA(4_W_)-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(63_G_)",225.702,"","",""
"2WIN","C3 CONVERTASE (C3BBB) STABILIZED BY SCIN","10.1038/NI.1756 ",3.9,158.8,"2win_oligo3","DManpb1-3DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_S_)-BMA(4_S_)-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(63_C_)",216.238,"","",""
"2WIN","C3 CONVERTASE (C3BBB) STABILIZED BY SCIN","10.1038/NI.1756 ",3.9,158.8,"2win_oligo6","DManpb1-3[DManpb1-6]DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","BMA(6_V_)-[BMA(5_V_)]-BMA(4_V_)-BMA(3_V_)-NAG(2_V_)-NAG(1_V_)-ASN(917_F_)",219.747,"","",""
"2WIN","C3 CONVERTASE (C3BBB) STABILIZED BY SCIN","10.1038/NI.1756 ",3.9,158.8,"2win_oligo2","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcp[2<R1>]b1-ASN","BMA(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(917_B_)",210.553,"","",""
"2WIN","C3 CONVERTASE (C3BBB) STABILIZED BY SCIN","10.1038/NI.1756 ",3.9,158.8,"2win_oligo5","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_U_)-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(63_E_)",217.541,"","",""
"2WIN","C3 CONVERTASE (C3BBB) STABILIZED BY SCIN","10.1038/NI.1756 ",3.9,158.8,"2win_oligo8","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_X_)-MAN(3_X_)-NAG(2_X_)-NAG(1_X_)-ASN(917_H_)",224.788,"","",""
"2WIN","C3 CONVERTASE (C3BBB) STABILIZED BY SCIN","10.1038/NI.1756 ",3.9,158.8,"2win_oligo12","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","MAN(5_b_)-[MAN(4_b_)]-MAN(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(260_K_)",223.247,"","",""
"2WIN","C3 CONVERTASE (C3BBB) STABILIZED BY SCIN","10.1038/NI.1756 ",3.9,158.8,"2win_oligo4","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_T_)-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(917_D_)",206.402,"","",""
"2WSL","AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN ANALOGUE TA4","10.1042/BJ20090091 ",2,27.9,"2wsl_oligo2","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(341_A_)",50.0891,"","",""
"2X8Y","CRYSTAL STRUCTURE OF ANCE","10.1016/J.JMB.2010.05.024 ",1.9,34.91,"2x8y_oligo1","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",55.2003,"","",""
"2X8Z","CRYSTAL STRUCTURE OF ANCE-CAPTOPRIL COMPLEX","10.1016/J.JMB.2010.05.024 ",1.98,30.9,"2x8z_oligo2","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",50.0815,"","",""
"2X90","CRYSTAL STRUCTURE OF ANCE-ENALAPRILAT COMPLEX","10.1016/J.JMB.2010.05.024 ",1.98,27.66,"2x90_oligo4","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",44.6505,"","",""
"2X91","CRYSTAL STRUCTURE OF ANCE-LISINOPRIL COMPLEX","10.1016/J.JMB.2010.05.024 ",1.98,29.73,"2x91_oligo4","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",53.837,"","",""
"2X92","CRYSTAL STRUCTURE OF ANCE-RAMIPRILAT COMPLEX","10.1016/J.JMB.2010.05.024 ",2.11,22.46,"2x92_oligo2","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",37.793,"","",""
"2X93","CRYSTAL STRUCTURE OF ANCE-TRANDOLAPRILAT COMPLEX","10.1016/J.JMB.2010.05.024 ",1.98,25.7,"2x93_oligo3","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",45.6244,"","",""
"2X94","CRYSTAL STRUCTURE OF ANCE-PERINDOPRILAT COMPLEX","10.1016/J.JMB.2010.05.024 ",1.88,29.53,"2x94_oligo2","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",46.5421,"","",""
"2X95","CRYSTAL STRUCTURE OF ANCE-LISINOPRIL-TRYPTOPHAN ANALOGUE, LISW-S COMPLEX","10.1016/J.JMB.2010.05.024 ",1.96,28.5,"2x95_oligo4","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",48.0124,"","",""
"2X96","CRYSTAL STRUCTURE OF ANCE-RXPA380 COMPLEX","10.1016/J.JMB.2010.05.024 ",1.85,29.84,"2x96_oligo2","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",50.0386,"","",""
"2X97","CRYSTAL STRUCTURE OF ANCE-RXP407 COMPLEX","10.1016/J.JMB.2010.05.024 ",1.85,28.46,"2x97_oligo1","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",44.8682,"","",""
"2XHM","CRYSTAL STRUCTURE OF ANCE-K26 COMPLEX","10.1016/J.BBRC.2010.06.113 ",1.96,32.74,"2xhm_oligo2","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",53.447,"","",""
"2XMB","G117H MUTANT OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH SULFATE","10.1042/BJ20101648 ",2.1,41.69,"2xmb_oligo2","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(341_A_)",68.2721,"","",""
"2XMB","G117H MUTANT OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH SULFATE","10.1042/BJ20101648 ",2.1,41.69,"2xmb_oligo1","LFucp[3<R1>]b1-6DGlcpNAcb1-ASN","FUL(2_C_)-NAG(1_C_)-ASN(106_A_)",51.2018,"","",""
"2XMB","G117H MUTANT OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH SULFATE","10.1042/BJ20101648 ",2.1,41.69,"2xmb_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",103.474,"","",""
"2XMC","G117H MUTANT OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH FLUORIDE ANION","10.1042/BJ20101648 ",2.4,46.08,"2xmc_oligo2","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",91.7185,"","",""
"2XMC","G117H MUTANT OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH FLUORIDE ANION","10.1042/BJ20101648 ",2.4,46.08,"2xmc_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(341_A_)",75.3036,"","",""
"2XMC","G117H MUTANT OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH FLUORIDE ANION","10.1042/BJ20101648 ",2.4,46.08,"2xmc_oligo1","LFucpb1-6DGlcpNAcb1-ASN","FUC(2_C_)-NAG(1_C_)-ASN(106_A_)",67.4395,"","",""
"2XMD","G117H MUTANT OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH ECHOTHIOPHATE","10.1042/BJ20101648 ",2.3,40.08,"2xmd_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(341_A_)",68.8597,"","",""
"2XMD","G117H MUTANT OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH ECHOTHIOPHATE","10.1042/BJ20101648 ",2.3,40.08,"2xmd_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(106_A_)",60.4712,"","",""
"2XMG","G117H MUTANT OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH VX","10.1042/BJ20101648 ",2.7,56.15,"2xmg_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(341_A_)",74.1945,"","",""
"2XMG","G117H MUTANT OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH VX","10.1042/BJ20101648 ",2.7,56.15,"2xmg_oligo2","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",93.7315,"","",""
"2XMG","G117H MUTANT OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH VX","10.1042/BJ20101648 ",2.7,56.15,"2xmg_oligo1","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_C_)-NAG(1_C_)-ASN(106_A_)",69.9091,"","",""
"2XQF","X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY RACEMIC VX","10.1074/JBC.M110.209569 ",2.1,37.05,"2xqf_oligo2","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(341_A_)",62.7436,"","",""
"2XQF","X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY RACEMIC VX","10.1074/JBC.M110.209569 ",2.1,37.05,"2xqf_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(241_A_)",82.1115,"","",""
"2XQG","X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY RACEMIC VR","10.1074/JBC.M110.209569 ",2.3,38.09,"2xqg_oligo2","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(341_A_)",64.4146,"","",""
"2XQG","X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY RACEMIC VR","10.1074/JBC.M110.209569 ",2.3,38.09,"2xqg_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(241_A_)",83.8727,"","",""
"2XQI","X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY RACEMIC CVX","10.1074/JBC.M110.209569 ",2.6,53.97,"2xqi_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(341_A_)",77.607,"","",""
"2XQI","X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY RACEMIC CVX","10.1074/JBC.M110.209569 ",2.6,53.97,"2xqi_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(241_A_)",103.638,"","",""
"2XQJ","X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY PURE ENANTIOMER VX-(R)","10.1074/JBC.M110.209569 ",2.4,39.7,"2xqj_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(241_A_)",87.8506,"","",""
"2XQJ","X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY PURE ENANTIOMER VX-(R)","10.1074/JBC.M110.209569 ",2.4,39.7,"2xqj_oligo2","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(341_A_)",68.2055,"","",""
"2XQR","CRYSTAL STRUCTURE OF PLANT CELL WALL INVERTASE IN COMPLEX WITH A SPECIFIC PROTEIN INHIBITOR","10.1073/PNAS.1004481107 ",2.58,31.26,"2xqr_oligo7","DManpa1-2DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAca1-ASN","BMA(6_M_)-[MAN(5_M_)-MAN(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(299_A_)",32.0432,"","",""
"2XQR","CRYSTAL STRUCTURE OF PLANT CELL WALL INVERTASE IN COMPLEX WITH A SPECIFIC PROTEIN INHIBITOR","10.1073/PNAS.1004481107 ",2.58,31.26,"2xqr_oligo9","DManpa1-2DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAca1-ASN","BMA(6_O_)-[MAN(5_O_)-MAN(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(299_C_)",36.2789,"","",""
"2XQR","CRYSTAL STRUCTURE OF PLANT CELL WALL INVERTASE IN COMPLEX WITH A SPECIFIC PROTEIN INHIBITOR","10.1073/PNAS.1004481107 ",2.58,31.26,"2xqr_oligo15","DManpa1-2DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAca1-ASN","BMA(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(299_I_)",32.8621,"","",""
"2XQR","CRYSTAL STRUCTURE OF PLANT CELL WALL INVERTASE IN COMPLEX WITH A SPECIFIC PROTEIN INHIBITOR","10.1073/PNAS.1004481107 ",2.58,31.26,"2xqr_oligo11","DManpa1-2DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAca1-ASN","BMA(6_Q_)-[MAN(5_Q_)-MAN(4_Q_)]-BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(299_E_)",42.0606,"","",""
"2XQR","CRYSTAL STRUCTURE OF PLANT CELL WALL INVERTASE IN COMPLEX WITH A SPECIFIC PROTEIN INHIBITOR","10.1073/PNAS.1004481107 ",2.58,31.26,"2xqr_oligo13","DManpa1-2DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAca1-ASN","BMA(6_S_)-[MAN(5_S_)-MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(299_G_)",34.5776,"","",""
"2XQR","CRYSTAL STRUCTURE OF PLANT CELL WALL INVERTASE IN COMPLEX WITH A SPECIFIC PROTEIN INHIBITOR","10.1073/PNAS.1004481107 ",2.58,31.26,"2xqr_oligo17","DManpa1-2DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAca1-4DGlcpNAca1-ASN","BMA(6_W_)-[MAN(5_W_)-MAN(4_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(299_K_)",35.6364,"","",""
"2YPG","HAEMAGGLUTININ OF 1968 HUMAN H3N2 VIRUS IN COMPLEX WITH HUMAN RECEPTOR ANALOGUE LSTC","10.1073/PNAS.1218841110 ",2.85,39.99,"2ypg_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(81_A_)",83.6939,"","",""
"2Z55","BACTERIORUBERIN IN THE TRIMERIC STRUCTURE OF ARCHAERHODOPSIN-2","10.1016/J.JMB.2007.11.039 ",2.5,42.78,"2z55_oligo4","DGalpb1-6DManpa1-2DGlcpa1-C43O3","GAL(3_H_)-MAN(2_H_)-GLC(1_H_)-L2P(280_E_)",108.897,"","",""
"2Z55","BACTERIORUBERIN IN THE TRIMERIC STRUCTURE OF ARCHAERHODOPSIN-2","10.1016/J.JMB.2007.11.039 ",2.5,42.78,"2z55_oligo2","DGalpb1-6DManpa1-2DGlcpa1-C43O3","GAL(3_F_)-MAN(2_F_)-GLC(1_F_)-L2P(280_B_)",106.962,"","",""
"2Z55","BACTERIORUBERIN IN THE TRIMERIC STRUCTURE OF ARCHAERHODOPSIN-2","10.1016/J.JMB.2007.11.039 ",2.5,42.78,"2z55_oligo1","DGalpb1-6DManpa1-2DGlcpa1-C43O3","GAL(3_C_)-MAN(2_C_)-GLC(1_C_)-L2P(280_A_)",109.437,"","",""
"2Z55","BACTERIORUBERIN IN THE TRIMERIC STRUCTURE OF ARCHAERHODOPSIN-2","10.1016/J.JMB.2007.11.039 ",2.5,42.78,"2z55_oligo3","DGalpb1-6DManpa1-2DGlcpa1-C43O3","GAL(3_G_)-MAN(2_G_)-GLC(1_G_)-L2P(280_D_)",107.053,"","",""
"2Z62","CRYSTAL STRUCTURE OF THE TV3 HYBRID OF HUMAN TLR4 AND HAGFISH VLRB.61","10.1016/J.CELL.2007.08.002 ",1.7,27.12,"2z62_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(35_A_)",39.1906,"","",""
"2Z62","CRYSTAL STRUCTURE OF THE TV3 HYBRID OF HUMAN TLR4 AND HAGFISH VLRB.61","10.1016/J.CELL.2007.08.002 ",1.7,27.12,"2z62_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(173_A_)",44.8816,"","",""
"2Z63","CRYSTAL STRUCTURE OF THE TV8 HYBRID OF HUMAN TLR4 AND HAGFISH VLRB.61","10.1016/J.CELL.2007.08.002 ",2,32.3,"2z63_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(309_A_)",63.1197,"","",""
"2Z64","CRYSTAL STRUCTURE OF MOUSE TLR4 AND MOUSE MD-2 COMPLEX","10.1016/J.CELL.2007.08.002 ",2.84,30.87,"2z64_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)",83.2409,"","",""
"2Z66","CRYSTAL STRUCTURE OF THE VT3 HYBRID OF HUMAN TLR4 AND HAGFISH VLRB.61","10.1016/J.CELL.2007.08.002 ",1.9,13.37,"2z66_oligo8","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_G_)-[BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(624_A_)",27.0145,"","",""
"2Z66","CRYSTAL STRUCTURE OF THE VT3 HYBRID OF HUMAN TLR4 AND HAGFISH VLRB.61","10.1016/J.CELL.2007.08.002 ",1.9,13.37,"2z66_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_S_)-[BMA(3_S_)-NAG(2_S_)]-NAG(1_S_)-ASN(624_D_)",26.9911,"","",""
"2Z66","CRYSTAL STRUCTURE OF THE VT3 HYBRID OF HUMAN TLR4 AND HAGFISH VLRB.61","10.1016/J.CELL.2007.08.002 ",1.9,13.37,"2z66_oligo12","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_K_)-[BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(624_B_)",26.9909,"","",""
"2Z66","CRYSTAL STRUCTURE OF THE VT3 HYBRID OF HUMAN TLR4 AND HAGFISH VLRB.61","10.1016/J.CELL.2007.08.002 ",1.9,13.37,"2z66_oligo16","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_O_)-[BMA(3_O_)-NAG(2_O_)]-NAG(1_O_)-ASN(624_C_)",26.9793,"","",""
"2ZFE","CRYSTAL STRUCTURE OF BACTERIORHODOPSIN-XENON COMPLEX","10.1016/J.JMB.2008.09.075 ",2.5,53.6,"2zfe_oligo1","DGalp[3S]b1-6DManpa1-2DGlcpa1-C25O3","SGA(3_B_)-MAN(2_B_)-GLC(1_B_)-L2P(270_A_)",98.7785,"","",""
"2ZMB","CRYSTAL STRUCTURE OF THE COMPLEX OF C-TERMINAL LOBE OF BOVINE LACTOFERRIN WITH PARECOXIB AT 2.9 A RESOLUTION","",2.9,46.9,"2zmb_oligo1","DManpa1-4[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BGC(5_B_)-[MAN(4_B_)]-BGC(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(476_A_)",77.5238,"","",""
"2ZZL","STRUCTURE OF BACTERIORHODOPSIN'S M INTERMEDIATE AT PH 7","10.1016/J.JMB.2009.08.047 ",2.03,41.47,"2zzl_oligo1","DGalp[3<R1>]b1-6DManpa1-2DGlcpa1-C25O3","SGA(3_B_)-MAN(2_B_)-GLC(1_B_)-L2P(270_A_)",52.4455,"","",""
"3AGV","CRYSTAL STRUCTURE OF A HUMAN IGG-APTAMER COMPLEX","10.1093/NAR/GKQ615 ",2.15,54.6,"3agv_oligo12","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ROH","FUL(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NDG(1_D_)",80.3653,"","",""
"3ALA","CRYSTAL STRUCTURE OF VASCULAR ADHESION PROTEIN-1 IN SPACE GROUP C2","10.1107/S1744309110041515 ",2.9,40.04,"3ala_oligo17","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_X_)-NAG(1_X_)-ASN(592_F_)",45.6882,"","",""
"3ALA","CRYSTAL STRUCTURE OF VASCULAR ADHESION PROTEIN-1 IN SPACE GROUP C2","10.1107/S1744309110041515 ",2.9,40.04,"3ala_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_L_)-[NAG(2_L_)]-NAG(1_L_)-ASN(592_B_)",45.9415,"","",""
"3ALA","CRYSTAL STRUCTURE OF VASCULAR ADHESION PROTEIN-1 IN SPACE GROUP C2","10.1107/S1744309110041515 ",2.9,40.04,"3ala_oligo11","LFucpb1-6DGlcpNAca1-ASN","FUL(2_R_)-NAG(1_R_)-ASN(592_D_)",60.1477,"","",""
"3ALA","CRYSTAL STRUCTURE OF VASCULAR ADHESION PROTEIN-1 IN SPACE GROUP C2","10.1107/S1744309110041515 ",2.9,40.04,"3ala_oligo14","LFucpb1-6DGlcpNAca1-ASN","FUL(2_U_)-NAG(1_U_)-ASN(592_E_)",63.1332,"","",""
"3ALA","CRYSTAL STRUCTURE OF VASCULAR ADHESION PROTEIN-1 IN SPACE GROUP C2","10.1107/S1744309110041515 ",2.9,40.04,"3ala_oligo6","LFucpb1-6DGlcpNAca1-ASN","FUL(2_J_)-NAG(1_J_)-ASN(592_A_)",46.1005,"","",""
"3AU1","CRYSTAL STRUCTURE OF MOUSE CD1D IN COMPLEX WITH GANGLIOSIDE GD3","10.1016/J.IMMUNI.2011.01.013 ",2.5,54.64,"3au1_oligo3","DManpa1-3[DManpb1-6]DGlcpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[BMA(5_D_)-[MAN(4_D_)]-GLC(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(165_A_)",33.8345,"","",""
"3C2S","STRUCTURAL CHARACTERIZATION OF A HUMAN FC FRAGMENT ENGINEERED FOR LACK OF EFFECTOR FUNCTIONS","10.1107/S0907444908007877 ",2.3,43.32,"3c2s_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(9_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-[NAG(8_B_)-MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(297_A_)",71.3893,"","",""
"3C5X","CRYSTAL STRUCTURE OF THE PRECURSOR MEMBRANE PROTEIN- ENVELOPE PROTEIN HETERODIMER FROM THE DENGUE 2 VIRUS AT LOW PH","10.1126/SCIENCE.1153263 ",2.2,0,"3c5x_oligo2","DManpa1-3[DManpb1-6]DAltpa1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_D_)-[BMA(4_D_)]-SHD(3_D_)-NAG(2_D_)-NAG(1_D_)",115.248,"","",""
"3CDZ","CRYSTAL STRUCTURE OF HUMAN FACTOR VIII","10.1016/J.STR.2008.03.001 ",3.98,199.2,"3cdz_oligo2","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcx1-","MAN(4_D_)-[MAN(3_D_)]-MAN(2_D_)-NAG(1_D_)",258.64,"","",""
"3CFW","L-SELECTIN LECTIN AND EGF DOMAINS","10.1074/JBC.M116.767186 ",2.2,34.9,"3cfw_oligo1","DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(66_A_)",38.8387,"","",""
"3CIG","CRYSTAL STRUCTURE OF MOUSE TLR3 ECTODOMAIN","10.1126/SCIENCE.1155406 ",2.66,64.69,"3cig_oligo6","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(275_A_)",73.5209,"","",""
"3CIG","CRYSTAL STRUCTURE OF MOUSE TLR3 ECTODOMAIN","10.1126/SCIENCE.1155406 ",2.66,64.69,"3cig_oligo5","DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(4_G_)-[BMA(3_G_)-NDG(2_G_)]-NAG(1_G_)-ASN(424_A_)",88.6734,"","",""
"3CIY","MOUSE TOLL-LIKE RECEPTOR 3 ECTODOMAIN COMPLEXED WITH DOUBLE-STRANDED RNA","10.1126/SCIENCE.1155406 ",3.41,154.3,"3ciy_oligo76","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_N_)-[NAG(2_N_)]-NAG(1_N_)-ASN(291_B_)",180.201,"","",""
"3DGV","CRYSTAL STRUCTURE OF THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI)","10.1074/JBC.M804003200 ",2.5,72.26,"3dgv_oligo2","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_E_)-NAG(1_E_)-ASN(63_A_)",96.0691,"","",""
"3DGV","CRYSTAL STRUCTURE OF THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI)","10.1074/JBC.M804003200 ",2.5,72.26,"3dgv_oligo4","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(22_A_)",99.44,"","",""
"3DJY","NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN","10.1021/JA804941Z ",2.1,39.79,"3djy_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",72.7954,"","",""
"3DJY","NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN","10.1021/JA804941Z ",2.1,39.79,"3djy_oligo2","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(341_A_)",62.4046,"","",""
"3DJY","NONAGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN","10.1021/JA804941Z ",2.1,39.79,"3djy_oligo3","LFucpb1-6DGlcpNAcx1-","FUL(2_C_)-NAG(1_C_)",61.007,"","",""
"3DKK","AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN","10.1021/JA804941Z ",2.31,39.71,"3dkk_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",80.7385,"","",""
"3DKK","AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN","10.1021/JA804941Z ",2.31,39.71,"3dkk_oligo2","LFucpb1-6DGlcpNAcx1-","FUL(2_C_)-NAG(1_C_)",55.0462,"","",""
"3DKK","AGED FORM OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY TABUN","10.1021/JA804941Z ",2.31,39.71,"3dkk_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(341_A_)",66.5755,"","",""
"3DNI","CRYSTALLOGRAPHIC REFINEMENT AND STRUCTURE OF DNASE I AT 2 ANGSTROMS RESOLUTION","10.1016/0022-2836(86)90280-9 ",2,0,"3dni_oligo1","DGalpa1-6DManpb1-3[DManpb1-6DAltpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(7_B_)-MAN(6_B_)-[GLA(5_B_)-BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(18_A_)",57.589,"","",""
"3DO3","HUMAN 1GG1 FC FRAGMENT, 2.5 ANGSTROM STRUCTURE","",2.5,0,"3do3_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",55.7868,"","",""
"3DO3","HUMAN 1GG1 FC FRAGMENT, 2.5 ANGSTROM STRUCTURE","",2.5,0,"3do3_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",74.4228,"","",""
"3E0G","STRUCTURE OF THE LEUKEMIA INHIBITORY FACTOR RECEPTOR (LIF-R) DOMAINS D1-D5","10.1016/J.MOLCEL.2008.08.011 ",3.1,94.34,"3e0g_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(4_B_)-[MAN(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(356_A_)",107.438,"","",""
"3F9P","CRYSTAL STRUCTURE OF MYELOPEROXIDASE FROM HUMAN LEUKOCYTES","10.1074/JBC.M109.002154 ",2.93,67.16,"3f9p_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[BMA(5_E_)-[BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(317_C_)",66.6189,"","",""
"3F9P","CRYSTAL STRUCTURE OF MYELOPEROXIDASE FROM HUMAN LEUKOCYTES","10.1074/JBC.M109.002154 ",2.93,67.16,"3f9p_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(317_D_)",65.6962,"","",""
"3FJT","CRYSTAL STRUCTURE OF A HUMAN FC FRAGMENT ENGINEERED FOR EXTENDED SERUM HALF-LIFE","10.1016/J.MOLIMM.2009.01.026 ",2.5,63.81,"3fjt_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",98.0298,"","",""
"3FJT","CRYSTAL STRUCTURE OF A HUMAN FC FRAGMENT ENGINEERED FOR EXTENDED SERUM HALF-LIFE","10.1016/J.MOLIMM.2009.01.026 ",2.5,63.81,"3fjt_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",107.811,"","",""
"3FRU","NEONATAL FC RECEPTOR, PH 6.5","10.1016/S0969-2126(98)00008-2 ",2.2,51.6,"3fru_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6DManpb1-4DGlcpNAca1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(7_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-BMA(3_G_)-NDG(2_G_)]-NAG(1_G_)-ASN(225_A_)",75.6945,"","",""
"3FUS","IMPROVED STRUCTURE OF THE UNLIGANDED SIMIAN IMMUNODEFICIENCY VIRUS GP120 CORE","10.1107/S0907444909003539 ",4,131.8,"3fus_oligo7","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(283_A_)",125.154,"","",""
"3FUS","IMPROVED STRUCTURE OF THE UNLIGANDED SIMIAN IMMUNODEFICIENCY VIRUS GP120 CORE","10.1107/S0907444909003539 ",4,131.8,"3fus_oligo3","DManpa1-3DManpb1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_H_)-[MAN(5_H_)-BMA(4_H_)-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(376_A_)",160.923,"","",""
"3FUS","IMPROVED STRUCTURE OF THE UNLIGANDED SIMIAN IMMUNODEFICIENCY VIRUS GP120 CORE","10.1107/S0907444909003539 ",4,131.8,"3fus_oligo6","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(277_A_)",128.633,"","",""
"3FUS","IMPROVED STRUCTURE OF THE UNLIGANDED SIMIAN IMMUNODEFICIENCY VIRUS GP120 CORE","10.1107/S0907444909003539 ",4,131.8,"3fus_oligo10","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_K_)-[MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(243_A_)",122.215,"","",""
"3FUS","IMPROVED STRUCTURE OF THE UNLIGANDED SIMIAN IMMUNODEFICIENCY VIRUS GP120 CORE","10.1107/S0907444909003539 ",4,131.8,"3fus_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(305_A_)",133.942,"","",""
"3FUS","IMPROVED STRUCTURE OF THE UNLIGANDED SIMIAN IMMUNODEFICIENCY VIRUS GP120 CORE","10.1107/S0907444909003539 ",4,131.8,"3fus_oligo8","DManpa1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_E_)-[MAN(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(294_A_)",152.816,"","",""
"3FUS","IMPROVED STRUCTURE OF THE UNLIGANDED SIMIAN IMMUNODEFICIENCY VIRUS GP120 CORE","10.1107/S0907444909003539 ",4,131.8,"3fus_oligo5","DManpb1-3DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(5_B_)-[BMA(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(246_A_)",130.215,"","",""
"3FXI","CRYSTAL STRUCTURE OF THE HUMAN TLR4-HUMAN MD-2-E.COLI LPS RA COMPLEX","10.1038/NATURE07830 ",3.1,82.2,"3fxi_oligo1","GMH1-7GMH1-3GMH1-5[DKdopa2-4]DKdopa2-6DGlcp[2<R1>,3<R2>,4P]b1-6DGlcp[2<R3>,3<R4>]a1-O4P1","GMH(6_E_)-GMH(5_E_)-GMH(4_E_)-[KDO(7_E_)]-KDO(3_E_)-PA1(2_E_)-PA1(1_E_)",105.977,"","",""
"3FXI","CRYSTAL STRUCTURE OF THE HUMAN TLR4-HUMAN MD-2-E.COLI LPS RA COMPLEX","10.1038/NATURE07830 ",3.1,82.2,"3fxi_oligo12","GMH1-7GMH1-3GMH1-5[DKdopa2-4]DKdopa2-6DGlcp[2<R1>,3<R2>,4P]b1-6DGlcp[2<R3>,3<R4>]a1-O4P1","GMH(6_H_)-GMH(5_H_)-GMH(4_H_)-[KDO(7_H_)]-KDO(3_H_)-GCS(2_H_)-PA1(1_H_)",106.153,"","",""
"3H32","CRYSTAL STRUCTURE OF D-DIMER FROM HUMAN FIBRIN COMPLEXED WITH GLY-HIS- ARG-PRO-TYR-AMIDE","10.1021/BI900647G ",3.6,0,"3h32_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAca1-2DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(8_G_)-[SIA(7_G_)-GAL(6_G_)-NAG(5_G_)-MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(364_B_)",110.818,"","",""
"3HDL","CRYSTAL STRUCTURE OF HIGHLY GLYCOSYLATED PEROXIDASE FROM ROYAL PALM TREE","10.1016/J.JSB.2009.10.009 ",1.85,0,"3hdl_oligo1","DManpa1-2[DManpa1-3][DXylfb1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-3]DGlcpNAcb1-ASN","XYZ(6_B_)-[MAN(5_B_)]-[MAN(4_B_)]-MAN(3_B_)-NAG(2_B_)-[FUC(7_B_)]-NAG(1_B_)-ASN(8_A_)",72.6727,"","",""
"3IB0","STRUCTURAL BASIS OF THE PREVENTION OF NSAID-INDUCED DAMAGE OF THE GASTROINTESTINAL TRACT BY C-TERMINAL HALF (C-LOBE) OF BOVINE COLOSTRUM PROTEIN LACTOFERRIN: BINDING AND STRUCTURAL STUDIES OF C- LOBE COMPLEX WITH DICLOFENAC","10.1016/J.BPJ.2009.09.030 ",1.4,23.61,"3ib0_oligo2","DManpb1-4[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(476_A_)",53.0767,"","",""
"3IYW","WEST NILE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF MAB CR4354 (FITTED COORDINATES OF ENVELOPE PROTEINS AND FAB FRAGMENTS OF ONE ICOSAHEDRAL ASU)","10.1073/PNAS.1011036107 ",13.7,0,"3iyw_oligo4","DGlcpNAca1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(3_E_)-[NDG(2_E_)]-NDG(1_E_)-ASN(154_B_)",115.079,"","",""
"3IYW","WEST NILE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF MAB CR4354 (FITTED COORDINATES OF ENVELOPE PROTEINS AND FAB FRAGMENTS OF ONE ICOSAHEDRAL ASU)","10.1073/PNAS.1011036107 ",13.7,0,"3iyw_oligo5","DGlcpNAca1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(3_F_)-[NDG(2_F_)]-NDG(1_F_)-ASN(154_C_)",115.079,"","",""
"3IYW","WEST NILE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF MAB CR4354 (FITTED COORDINATES OF ENVELOPE PROTEINS AND FAB FRAGMENTS OF ONE ICOSAHEDRAL ASU)","10.1073/PNAS.1011036107 ",13.7,0,"3iyw_oligo3","DGlcpNAca1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(3_D_)-[NDG(2_D_)]-NDG(1_D_)-ASN(154_A_)",115.079,"","",""
"3J2Q","MODEL OF MEMBRANE-BOUND FACTOR VIII ORGANIZED IN 2D CRYSTALS","10.1002/BIP.22199 ",15,0,"3j2q_oligo2","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcx1-","BMA(4_D_)-[MAN(3_D_)]-BMA(2_D_)-NAG(1_D_)",258.64,"","",""
"3JWO","STRUCTURE OF HIV-1 GP120 WITH GP41-INTERACTIVE REGION: LAYERED ARCHITECTURE AND BASIS OF CONFORMATIONAL MOBILITY","10.1073/PNAS.0911004107 ",3.51,141.6,"3jwo_oligo1","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_B_)-NAG(1_B_)-ASN(289_A_)",164.173,"","",""
"3K24","CRYSTAL STRUCTURE OF MATURE APO-CATHEPSIN L C25A MUTANT IN COMPLEX WITH GLN-LEU-ALA PEPTIDE","10.1038/NCOMMS1204 ",2.5,34.81,"3k24_oligo1","DGlcpNAca1-6DManpb1-6[DManpa1-2]DManpa1-4DGlcpNAca1-4DGlcpNAcb1-ASN","NDG(5_E_)-BMA(4_E_)-[MAN(6_E_)]-MAN(3_E_)-NDG(2_E_)-NAG(1_E_)-ASN(108_B_)",99.7732,"","",""
"3K7N","STRUCTURES OF TWO ELAPID SNAKE VENOM METALLOPROTEASES WITH DISTINCT ACTIVITIES HIGHLIGHT THE DISULFIDE PATTERNS IN THE D DOMAIN OF ADAMALYSIN FAMILY PROTEINS","10.1016/J.JSB.2009.11.009 ",2.3,0,"3k7n_oligo2","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(490_A_)",115.52,"","",""
"3KK6","CRYSTAL STRUCTURE OF CYCLOOXYGENASE-1 IN COMPLEX WITH CELECOXIB","10.1073/PNAS.0909765106 ",2.75,70.52,"3kk6_oligo5","DManpb1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(4_F_)-MAN(3_F_)-NAG(2_F_)-NAG(1_F_)",130.793,"","",""
"3LTF","CRYSTAL STRUCTURE OF THE DROSOPHILA EPIDERMAL GROWTH FACTOR RECEPTOR ECTODOMAIN IN COMPLEX WITH SPITZ","10.1016/J.CELL.2010.07.015 ",3.2,80.2,"3ltf_oligo1","DManpb1-4DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_E_)-[MAN(5_E_)-MAN(4_E_)]-MAN(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(470_A_)",84.5435,"","",""
"3MW2","CRYSTAL STRUCTURE OF BETA-NEUREXIN 1 WITH THE SPLICE INSERT 4","10.1016/J.NEURON.2010.06.001 ",2.69,35.84,"3mw2_oligo2","DGlcpNAcb1-4[DManpb1-6]DGlcpNAcb1-ASN","BMA(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(184_A_)",49.0579,"","",""
"3MW2","CRYSTAL STRUCTURE OF BETA-NEUREXIN 1 WITH THE SPLICE INSERT 4","10.1016/J.NEURON.2010.06.001 ",2.69,35.84,"3mw2_oligo1","DGlcpNAcb1-4[DManpb1-6]DGlcpNAcb1-ASN","BMA(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(184_B_)",49.6894,"","",""
"3MW3","CRYSTAL STRUCTURE OF BETA-NEUREXIN 2 WITH THE SPLICE INSERT 4","10.1016/J.NEURON.2010.06.001 ",2.33,34.77,"3mw3_oligo1","DGlcpNAcb1-4[DManpb1-6]DGlcpNAcx1-","BMA(3_B_)-[NAG(2_B_)]-NAG(1_B_)",44.989,"","",""
"3MW4","CRYSTAL STRUCTURE OF BETA-NEUREXIN 3 WITHOUT THE SPLICE INSERT 4","10.1016/J.NEURON.2010.06.001 ",2,30.56,"3mw4_oligo1","DGlcpNAcb1-4[DManpb1-6]DGlcpNAcb1-ASN","BMA(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(182_A_)",41.5673,"","",""
"3MW4","CRYSTAL STRUCTURE OF BETA-NEUREXIN 3 WITHOUT THE SPLICE INSERT 4","10.1016/J.NEURON.2010.06.001 ",2,30.56,"3mw4_oligo2","DGlcpNAcb1-4[DManpb1-6]DGlcpNAcb1-ASN","BMA(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(182_B_)",42.4048,"","",""
"3MW4","CRYSTAL STRUCTURE OF BETA-NEUREXIN 3 WITHOUT THE SPLICE INSERT 4","10.1016/J.NEURON.2010.06.001 ",2,30.56,"3mw4_oligo3","DGlcpNAcb1-4[DManpb1-6]DGlcpNAcb1-ASN","BMA(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(182_C_)",54.063,"","",""
"3N8V","CRYSTAL STRUCTURE OF UNOCCUPIED CYCLOOXYGENASE-1","10.1021/BI1003298 ",3.05,68.31,"3n8v_oligo2","DManpb1-6DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","BMA(4_H_)-BMA(3_H_)-NDG(2_H_)-NAG(1_H_)-ASN(144_B_)",57.5445,"","",""
"3N8X","CRYSTAL STRUCTURE OF CYCLOOXYGENASE-1 IN COMPLEX WITH NIMESULIDE","10.1021/BI1003298 ",2.75,56,"3n8x_oligo7","DManpb1-6DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-BMA(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(144_A_)",73.8171,"","",""
"3N8Y","STRUCTURE OF ASPIRIN ACETYLATED CYCLOOXYGENASE-1 IN COMPLEX WITH DICLOFENAC","10.1021/BI1003298 ",2.6,47.01,"3n8y_oligo7","DManpb1-6DManpb1-4DGlcpNAca1-4DGlcpNAcx1-","BMA(4_G_)-BMA(3_G_)-NDG(2_G_)-NAG(1_G_)",74.1731,"","",""
"3N8Y","STRUCTURE OF ASPIRIN ACETYLATED CYCLOOXYGENASE-1 IN COMPLEX WITH DICLOFENAC","10.1021/BI1003298 ",2.6,47.01,"3n8y_oligo6","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(4_F_)-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)",88.169,"","",""
"3N8Y","STRUCTURE OF ASPIRIN ACETYLATED CYCLOOXYGENASE-1 IN COMPLEX WITH DICLOFENAC","10.1021/BI1003298 ",2.6,47.01,"3n8y_oligo9","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(410_A_)",73.4098,"","",""
"3P0Y","ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAIN III OF EGFR EXTRACELLULAR REGION","10.1016/J.CCR.2011.09.003 ",1.8,24.63,"3p0y_oligo2","DGlcpNAcb1-3[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(389_A_)",46.2791,"","",""
"3QNF","CRYSTAL STRUCTURE OF THE OPEN STATE OF HUMAN ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1 ERAP1","10.1073/PNAS.1101262108 ",3,34.25,"3qnf_oligo1","DManpb1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(4_D_)-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(70_A_)",52.5209,"","",""
"3QUM","CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY","10.1016/J.JMB.2011.10.007 ",3.2,73.27,"3qum_oligo3","DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-6DManpa1-3[DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-6DManp[2<R1>]a1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(15_G_)-[SIA(14_G_)-GAL(13_G_)-NAG(12_G_)-MAN(8_G_)-[SIA(7_G_)-GAL(6_G_)-NAG(5_G_)-MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(61_Q_)",122.697,"","",""
"3QUM","CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY","10.1016/J.JMB.2011.10.007 ",3.2,73.27,"3qum_oligo2","DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-4DManpa1-3[DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-2[DNeup5Aca2-3DGalpb1-4DGlcpNAcb1-6]DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(15_E_)-[SIA(14_E_)-GAL(13_E_)-NAG(12_E_)-[SIA(11_E_)-GAL(10_E_)-NAG(9_E_)]-MAN(8_E_)-[SIA(7_E_)-GAL(6_E_)-NAG(5_E_)-MAN(4_E_)]-MAN(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(61_P_)",112.455,"","",""
"3QW9","CRYSTAL STRUCTURE OF BETAGLYCAN ZP-C DOMAIN","10.1073/PNAS.1010689108 ",2,39.45,"3qw9_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-[FUC(6_D_)]-NAG(1_D_)-ASN(14_B_)",58.0687,"","",""
"3R4L","HUMAN VERY LONG HALF LIFE PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1","10.3892/IJMM.2011.798 ",2.7,68.8,"3r4l_oligo1","DManpb1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAca1-ASN","FUC(5_B_)-[BMA(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(288_A_)",84.5155,"","",""
"3RTQ","STRUCTURE OF THE MOUSE CD1D-HS44-INKT TCR COMPLEX","10.4049/JIMMUNOL.1103049 ",2.8,42.7,"3rtq_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_F_)-[BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(165_A_)",62.5498,"","",""
"3RY6","COMPLEX OF FCGAMMARIIA (CD32) AND THE FC OF HUMAN IGG1","10.4049/JIMMUNOL.1101467 ",3.8,0,"3ry6_oligo2","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(12_E_)-[SIA(11_E_)-GAL(10_E_)-NAG(9_E_)-MAN(8_E_)-[SIA(7_E_)-GAL(6_E_)-NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",58.4448,"","",""
"3RY6","COMPLEX OF FCGAMMARIIA (CD32) AND THE FC OF HUMAN IGG1","10.4049/JIMMUNOL.1101467 ",3.8,0,"3ry6_oligo1","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(10_D_)-[NAG(9_D_)-MAN(8_D_)-[SIA(7_D_)-GAL(6_D_)-NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NDG(1_D_)-ASN(297_A_)",60.0921,"","",""
"3RY6","COMPLEX OF FCGAMMARIIA (CD32) AND THE FC OF HUMAN IGG1","10.4049/JIMMUNOL.1101467 ",3.8,0,"3ry6_oligo3","DManpb1-3[DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(6_F_)-[MAN(5_F_)-[BMA(4_F_)]-MAN(3_F_)-NAG(2_F_)]-NDG(1_F_)-ASN(145_C_)",65.053,"","",""
"3RZC","STRUCTURE OF THE SELF-ANTIGEN IGB3 BOUND TO MOUSE CD1D AND IN COMPLEX WITH THE INKT TCR","10.4049/JIMMUNOL.1101636 ",2.8,46.53,"3rzc_oligo2","DManpa1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_G_)-[MAN(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(165_A_)",61.3448,"","",""
"3S6C","STRUCTURE OF HUMAN CD1E","10.1073/PNAS.1105627108 ",2.9,87.65,"3s6c_oligo1","LFucpb1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(16_A_)",86.3418,"","",""
"3SDY","CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8020 BOUND TO THE INFLUENZA A H3 HEMAGGLUTININ","10.1126/SCIENCE.1204839 ",2.85,0,"3sdy_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_D_)-[MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(81_A_)",132.243,"","",""
"3SGJ","UNIQUE CARBOHYDRATE-CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING BETWEEN FCGIII AND ANTIBODIES LACKING CORE FUCOSE","10.1073/PNAS.1108455108 ",2.2,41.35,"3sgj_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(162_C_)",77.6204,"","",""
"3SGJ","UNIQUE CARBOHYDRATE-CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING BETWEEN FCGIII AND ANTIBODIES LACKING CORE FUCOSE","10.1073/PNAS.1108455108 ",2.2,41.35,"3sgj_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",49.3643,"","",""
"3SGK","UNIQUE CARBOHYDRATE/CARBOHYDRATE INTERACTIONS ARE REQUIRED FOR HIGH AFFINITY BINDING OF FCGIII AND ANTIBODIES LACKING CORE FUCOSE","10.1073/PNAS.1108455108 ",2.4,63.58,"3sgk_oligo1","DManpa1-2DManpb1-3[DManpb1-3[DManpb1-6]DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(8_F_)-[MAN(7_F_)]-MAN(6_F_)-[MAN(5_F_)-MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(162_C_)",56.5764,"","",""
"3TGX","IL-21:IL21R COMPLEX","10.1074/JBC.M111.311084 ",2.8,0,"3tgx_oligo8","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(7_S_)-[NAG(2_S_)]-NAG(1_S_)-ASN(54_E_)",77.9076,"","",""
"3TGX","IL-21:IL21R COMPLEX","10.1074/JBC.M111.311084 ",2.8,0,"3tgx_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(7_Q_)-[NAG(2_Q_)]-NAG(1_Q_)",76.6354,"","",""
"3TGX","IL-21:IL21R COMPLEX","10.1074/JBC.M111.311084 ",2.8,0,"3tgx_oligo5","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(7_T_)-[NAG(2_T_)]-NAG(1_T_)",76.6354,"","",""
"3TGX","IL-21:IL21R COMPLEX","10.1074/JBC.M111.311084 ",2.8,0,"3tgx_oligo9","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(7_U_)-[NAG(2_U_)]-NAG(1_U_)",76.6354,"","",""
"3TGX","IL-21:IL21R COMPLEX","10.1074/JBC.M111.311084 ",2.8,0,"3tgx_oligo7","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(7_R_)-[NAG(2_R_)]-NAG(1_R_)",76.6354,"","",""
"3TGX","IL-21:IL21R COMPLEX","10.1074/JBC.M111.311084 ",2.8,0,"3tgx_oligo15","DManpa1-6DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(6_X_)-[MAN(5_X_)-MAN(4_X_)-BMA(3_X_)-NAG(2_X_)]-NAG(1_X_)",108.188,"","",""
"3UYV","CRYSTAL STRUCTURE OF A GLYCOSYLATED ICE-BINDING PROTEIN (LEIBP) FROM ARCTIC YEAST","10.1074/JBC.M111.331835 ",2.43,23.6,"3uyv_oligo1","DManpb1-6DManpb1-4DGlcpNAca1-4DGlcpNAcb1-ASN","MAN(4_B_)-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(185_A_)",49.7052,"","",""
"3VHZ","CRYSTAL STRUCTURE OF THE TRANS ISOMER OF THE L93A MUTANT OF BACTERIORHODOPSIN","10.1002/PROT.24124 ",2.3,47.29,"3vhz_oligo2","DGalp[3<R1>]b1-6DManpa1-2DGlcpa1-C25O3","SGA(3_B_)-MAN(2_B_)-GLC(1_B_)-L2P(270_A_)",93.2833,"","",""
"3VI0","CRYSTAL STRUCTURE OF THE O INTERMEDIATE OF THE L93A MUTANT OF BACTERIORHODOPSIN","10.1002/PROT.24124 ",2.3,39.58,"3vi0_oligo1","DGalp[3S]b1-6DManpa1-2DGlcpa1-C25O3","SGA(3_B_)-MAN(2_B_)-GLC(1_B_)-L2P(303_A_)",79.7203,"","",""
"3W2T","CRYSTAL STRUCTURE OF HUMAN DEPIPTIDYL PEPTIDASE IV (DPP-4) IN COMPLEX WITH VILDAGLIPTIN","10.1016/J.BBRC.2013.03.010 ",2.36,32.87,"3w2t_oligo7","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_G_)-NAG(1_G_)-ASN(85_B_)",61.4618,"","",""
"3W2T","CRYSTAL STRUCTURE OF HUMAN DEPIPTIDYL PEPTIDASE IV (DPP-4) IN COMPLEX WITH VILDAGLIPTIN","10.1016/J.BBRC.2013.03.010 ",2.36,32.87,"3w2t_oligo3","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_C_)-NAG(1_C_)-ASN(85_A_)",66.36,"","",""
"3WJJ","CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(P238D), IN COMPLEX WITH FCGRIIB","10.1093/PROTEIN/GZT022 ",2.6,63.49,"3wjj_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",81.7589,"","",""
"3WJJ","CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(P238D), IN COMPLEX WITH FCGRIIB","10.1093/PROTEIN/GZT022 ",2.6,63.49,"3wjj_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",80.7042,"","",""
"3WJL","CRYSTAL STRUCTURE OF IIB SELECTIVE FC VARIANT, FC(V12), IN COMPLEX WITH FCGRIIB","10.1093/PROTEIN/GZT022 ",2.86,65.55,"3wjl_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[NAG(8_E_)-MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",64.4536,"","",""
"3WJM","CRYSTAL STRUCTURE OF BOMBYX MORI SP2/SP3 HETEROHEXAMER","10.1002/PRO.2457 ",2.8,53.4,"3wjm_oligo1","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(211_A_)",57.6647,"","",""
"3WLN","CRYSTAL STRUCTURE OF BARLEY BETA-D-GLUCAN GLUCOHYDROLASE ISOENZYME EXO1 IN COMPLEX WITH OCTYL-S-GLUCOSIDE","10.1038/S41467-019-09691-Z ",2,32.21,"3wln_oligo2","DGlcpNAcb1-2DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_C_)-BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(498_A_)",81.3987,"","",""
"3WN5","CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA","10.1016/J.MOLIMM.2013.11.017 ",2.78,54.66,"3wn5_oligo6","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_L_)-[GAL(6_L_)-NAG(5_L_)-MAN(4_L_)-[NAG(8_L_)-MAN(7_L_)]-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(297_E_)",70.6244,"","",""
"3WN5","CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA","10.1016/J.MOLIMM.2013.11.017 ",2.78,54.66,"3wn5_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_K_)-[NAG(7_K_)-MAN(6_K_)-[NAG(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(297_D_)",57.258,"","",""
"3WN5","CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA","10.1016/J.MOLIMM.2013.11.017 ",2.78,54.66,"3wn5_oligo3","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_H_)-[GAL(6_H_)-NAG(5_H_)-MAN(4_H_)-[NAG(8_H_)-MAN(7_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",67.0639,"","",""
"3WN5","CRYSTAL STRUCTURE OF ASYMMETRICALLY ENGINEERED FC VARIANT IN COMPLEX WITH FCGRIIIA","10.1016/J.MOLIMM.2013.11.017 ",2.78,54.66,"3wn5_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_G_)-[GAL(6_G_)-NAG(5_G_)-MAN(4_G_)-[NAG(8_G_)-MAN(7_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",54.1912,"","",""
"3ZQZ","CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH A SELENIUM ANALOGUE OF CAPTOPRIL","10.1111/J.1742-4658.2011.08276.X ",2.35,57,"3zqz_oligo1","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",90.8656,"","",""
"4AA1","CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH ANGIOTENSIN-II","10.1111/FEBS.12038 ",1.99,35.55,"4aa1_oligo1","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",53.5591,"","",""
"4AA2","CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH BRADYKININ POTENTIATING PEPTIDE B","10.1111/FEBS.12038 ",1.99,37.56,"4aa2_oligo1","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",57.2048,"","",""
"4AQD","CRYSTAL STRUCTURE OF FULLY GLYCOSYLATED HUMAN BUTYRYLCHOLINESTERASE","10.1111/J.1742-4658.2012.08672.X ",2.5,0,"4aqd_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(241_B_)",99.4121,"","",""
"4AQD","CRYSTAL STRUCTURE OF FULLY GLYCOSYLATED HUMAN BUTYRYLCHOLINESTERASE","10.1111/J.1742-4658.2012.08672.X ",2.5,0,"4aqd_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(57_A_)",97.5282,"","",""
"4AQD","CRYSTAL STRUCTURE OF FULLY GLYCOSYLATED HUMAN BUTYRYLCHOLINESTERASE","10.1111/J.1742-4658.2012.08672.X ",2.5,0,"4aqd_oligo2","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(486_A_)",106.643,"","",""
"4AQD","CRYSTAL STRUCTURE OF FULLY GLYCOSYLATED HUMAN BUTYRYLCHOLINESTERASE","10.1111/J.1742-4658.2012.08672.X ",2.5,0,"4aqd_oligo9","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(455_B_)",106.886,"","",""
"4AQD","CRYSTAL STRUCTURE OF FULLY GLYCOSYLATED HUMAN BUTYRYLCHOLINESTERASE","10.1111/J.1742-4658.2012.08672.X ",2.5,0,"4aqd_oligo6","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(241_A_)",131.496,"","",""
"4AQD","CRYSTAL STRUCTURE OF FULLY GLYCOSYLATED HUMAN BUTYRYLCHOLINESTERASE","10.1111/J.1742-4658.2012.08672.X ",2.5,0,"4aqd_oligo8","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(256_B_)",109.134,"","",""
"4AQS","LAMININ BETA1 LN-LE1-4 STRUCTURE","10.1371/JOURNAL.PONE.0042473 ",3.11,90.8,"4aqs_oligo1","DManpa1-3DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(5_B_)-[MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(356_A_)",133.035,"","",""
"4ARN","CRYSTAL STRUCTURE OF THE N-TERMINAL DOMAIN OF DROSOPHILA TOLL RECEPTOR","10.1016/J.STR.2012.11.003 ",2.41,66.68,"4arn_oligo3","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_G_)-[BMA(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-[FUC(6_G_)]-NAG(1_G_)-ASN(140_C_)",97.6677,"","",""
"4ASQ","CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH BRADYKININ","10.1111/FEBS.12038 ",1.99,29.32,"4asq_oligo1","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",44.4294,"","",""
"4ASR","CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH THR6-BRADYKININ","10.1111/FEBS.12038 ",1.9,26.7,"4asr_oligo1","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",40.9314,"","",""
"4AXB","CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 2-PAM","10.1016/J.CBI.2012.08.005 ",2.4,38.71,"4axb_oligo2","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(341_A_)",67.3415,"","",""
"4AXB","CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH 2-PAM","10.1016/J.CBI.2012.08.005 ",2.4,38.71,"4axb_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(241_A_)",86.9397,"","",""
"4B0O","CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH BENZYL PYRIDINIUM-4-METHYLTRICHLOROACETIMIDATE","10.1016/J.CBI.2012.08.005 ",2.35,0,"4b0o_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(241_A_)",121.435,"","",""
"4B0O","CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH BENZYL PYRIDINIUM-4-METHYLTRICHLOROACETIMIDATE","10.1016/J.CBI.2012.08.005 ",2.35,0,"4b0o_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(341_A_)",77.5521,"","",""
"4B0P","CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH METHYL 2-(PENTAFLUOROBENZYLOXYIMINO)PYRIDINIUM","10.1016/J.CBI.2012.08.005 ",2.5,0,"4b0p_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(341_A_)",73.083,"","",""
"4B0P","CRYSTAL STRUCTURE OF SOMAN-AGED HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH METHYL 2-(PENTAFLUOROBENZYLOXYIMINO)PYRIDINIUM","10.1016/J.CBI.2012.08.005 ",2.5,0,"4b0p_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(241_A_)",105.908,"","",""
"4BBZ","STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY CBDP (2-MIN SOAK): CRESYL-PHOSPHOSERINE ADDUCT","10.1021/TX3004505 ",2.7,0,"4bbz_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(241_A_)",98.8497,"","",""
"4BBZ","STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY CBDP (2-MIN SOAK): CRESYL-PHOSPHOSERINE ADDUCT","10.1021/TX3004505 ",2.7,0,"4bbz_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(341_A_)",54.2609,"","",""
"4BBZ","STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE INHIBITED BY CBDP (2-MIN SOAK): CRESYL-PHOSPHOSERINE ADDUCT","10.1021/TX3004505 ",2.7,0,"4bbz_oligo2","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_B_)-NAG(1_B_)-ASN(57_A_)",95.4254,"","",""
"4BDS","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH TACRINE","10.1042/BJ20130013 ",2.1,40.4,"4bds_oligo2","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(341_A_)",71.1924,"","",""
"4BDS","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH TACRINE","10.1042/BJ20130013 ",2.1,40.4,"4bds_oligo4","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(241_A_)",80.807,"","",""
"4BDT","HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH HUPRINE W AND FASCICULIN 2","10.1042/BJ20130013 ",3.1,48.2,"4bdt_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",94.6724,"","",""
"4BDV","CRYSTAL STRUCTURE OF A TRUNCATED B-DOMAIN HUMAN FACTOR VIII","10.1515/HSZ-2012-0298 ",3.98,160.4,"4bdv_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-[BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(2118_B_)",232.889,"","",""
"4BH3","HAEMAGGLUTININ FROM A TRANSMISSIBLE MUTANT H5 INFLUENZA VIRUS IN COMPLEX WITH HUMAN RECEPTOR ANALOGUE 6'-SLN","10.1038/NATURE12144 ",2,38.24,"4bh3_oligo2","DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(165_A_)",47.2706,"","",""
"4BH4","HAEMAGGLUTININ FROM A TRANSMISSIBLE MUTANT H5 INFLUENZA VIRUS IN COMPLEX WITH AVIAN RECEPTOR ANALOGUE 3'-SLN","10.1038/NATURE12144 ",1.9,38.74,"4bh4_oligo2","DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_C_)-[MAN(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(165_A_)",45.6453,"","",""
"4BM7","CRYSTAL STRUCTURE OF IGG FC F241A MUTANT WITH NATIVE GLYCOSYLATION","10.1021/JA4014375 ",1.95,45.81,"4bm7_oligo1","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",73.9148,"","",""
"4BTW","CRYSTAL STRUCTURE OF HUMAN VASCULAR ADHESION PROTEIN-1 IN COMPLEX WITH PYRIDAZINONE INHIBITORS","10.1021/JM401372D ",2.8,0,"4btw_oligo2","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)",111.674,"","",""
"4BV4","STRUCTURE AND ALLOSTERY IN TOLL-SPATZLE RECOGNITION","10.1073/PNAS.1317002110 ",2.35,59.74,"4bv4_oligo1","DManpa1-2DManpa1-3[DManpa1-3[DManpb1-6]DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(8_A_)-[MAN(7_A_)]-BMA(6_A_)-[MAN(5_A_)-MAN(4_A_)]-BMA(3_A_)-NAG(2_A_)-NAG(1_A_)-ASN(346_R_)",68.4011,"","",""
"4BXS","CRYSTAL STRUCTURE OF THE PROTHROMBINASE COMPLEX FROM THE VENOM OF PSEUDONAJA TEXTILIS","10.1182/BLOOD-2013-06-511733 ",3.32,117.5,"4bxs_oligo1","LFucpb1-6DGlcpNAcb1-ASN","FUC(2_B_)-NAG(1_B_)-ASN(376_V_)",224.413,"","",""
"4CA7","DROSOPHILA ANGIOTENSIN CONVERTING ENZYME (ANCE) IN COMPLEX WITH A PHOSPHINIC TRIPEPTIDE FI","10.1111/FEBS.12660 ",1.82,28.86,"4ca7_oligo1","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",52.1352,"","",""
"4CA8","DROSOPHILA ANGIOTENSIN CONVERTING ENZYME (ANCE) IN COMPLEX WITH A PHOSPHINIC TRIPEPTIDE FII","10.1111/FEBS.12660 ",1.99,30,"4ca8_oligo2","DManpb1-6DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_B_)-[BMA(5_B_)-MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(196_A_)",56.2638,"","",""
"4CDH","CRYSTALLOGRAPHIC STRUCTURE OF THE HUMAN IGG1 ALPHA 2-6 SIALILATED FC- FRAGMENT","10.1016/J.STR.2014.09.001 ",2.3,43.12,"4cdh_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(10_C_)-[GAL(9_C_)-NAG(8_C_)-MAN(7_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(78_A_)",55.2306,"","",""
"4CU4","FHUA FROM E. COLI IN COMPLEX WITH THE LASSO PEPTIDE MICROCIN J25 (MCCJ25)","10.1038/NCHEMBIO.1499 ",2.3,56.71,"4cu4_oligo1","GMH1-3GMH1-5[DKdopa2-4]DKdopa2-6DGlcp[2<R1>,3<R2>,4P]b1-6DGlcp[2<R3>,3<R4>]a1-O7P2","GMH(5_C_)-GMH(4_C_)-[KDO(6_C_)]-KDO(3_C_)-GCS(2_C_)-PA1(1_C_)-DPO(2000_A_)",76.6514,"","",""
"4CYV","STRUCTURE OF THE A_MALLARD_SWEDEN_51_2002 H10 AVIAN HAEMMAGLUTININ","10.1038/NATURE13443 ",2.3,57.08,"4cyv_oligo5","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_K_)-[MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(82_F_)",96.4684,"","",""
"4CYW","STRUCTURE OF THE A_MALLARD_SWEDEN_51_2002 H10 AVIAN HAEMMAGLUTININ IN COMPLEX WITH HUMAN RECEPTOR ANALOG 6-SLN","10.1038/NATURE13443 ",2.6,60.89,"4cyw_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_J_)-[BMA(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(82_D_)",89.8085,"","",""
"4DKE","CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB1.1","10.1016/J.STR.2012.02.010 ",3,67.84,"4dke_oligo1","DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(76_A_)",100.573,"","",""
"4DKE","CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB1.1","10.1016/J.STR.2012.02.010 ",3,67.84,"4dke_oligo2","DManpb1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_D_)-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(76_B_)",106.069,"","",""
"4DKF","CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2","10.1016/J.STR.2012.02.010 ",2.61,63.75,"4dkf_oligo1","DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(76_A_)",83.5982,"","",""
"4DKF","CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2","10.1016/J.STR.2012.02.010 ",2.61,63.75,"4dkf_oligo2","DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-[MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(76_B_)",96.8184,"","",""
"4DUW","E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) IN COMPLEX WITH ALLOLACTOSE","10.1074/JBC.M113.455436 ",2.2,37,"4duw_oligo1","DGalpb1-6DGlcpb1-ROH","GAL(2_E_)-BGC(1_E_)",55.8186,"","",""
"4DUW","E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) IN COMPLEX WITH ALLOLACTOSE","10.1074/JBC.M113.455436 ",2.2,37,"4duw_oligo4","DGalpb1-6DGlcpb1-ROH","GAL(2_H_)-BGC(1_H_)",51.1918,"","",""
"4DUW","E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) IN COMPLEX WITH ALLOLACTOSE","10.1074/JBC.M113.455436 ",2.2,37,"4duw_oligo2","DGalpb1-6DGlcpb1-ROH","GAL(2_F_)-BGC(1_F_)",46.4468,"","",""
"4DUW","E. COLI (LACZ) BETA-GALACTOSIDASE (G974A) IN COMPLEX WITH ALLOLACTOSE","10.1074/JBC.M113.455436 ",2.2,37,"4duw_oligo3","DGalpb1-6DGlcpb1-ROH","GAL(2_G_)-BGC(1_G_)",47.8818,"","",""
"4DVK","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 STRAIN NCP-7","10.1016/J.STR.2012.03.018 ",2.21,42.29,"4dvk_oligo3","DManpb1-6DManpb1-3[DManpa1-4DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-MAN(6_E_)-[BMA(5_E_)-BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(4_B_)",54.4716,"","",""
"4DVL","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 2'-3'-CYCLO-UMP","10.1016/J.STR.2012.03.018 ",2.75,62.41,"4dvl_oligo6","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4_A_)",64.992,"","",""
"4DVN","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 2'-UMP","10.1016/J.STR.2012.03.018 ",2.38,33.59,"4dvn_oligo6","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4_A_)",43.696,"","",""
"4DW3","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 5'-CMP","10.1016/J.STR.2012.03.018 ",2.35,38.96,"4dw3_oligo6","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4_A_)",45.8547,"","",""
"4DW3","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 5'-CMP","10.1016/J.STR.2012.03.018 ",2.35,38.96,"4dw3_oligo7","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(13_A_)",49.4885,"","",""
"4DW3","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 5'-CMP","10.1016/J.STR.2012.03.018 ",2.35,38.96,"4dw3_oligo3","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(4_B_)",44.0882,"","",""
"4DW4","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 5'-UMP","10.1016/J.STR.2012.03.018 ",2.23,28.63,"4dw4_oligo8","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(13_A_)",35.8104,"","",""
"4DW4","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 5'-UMP","10.1016/J.STR.2012.03.018 ",2.23,28.63,"4dw4_oligo5","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4_A_)",39.7051,"","",""
"4DW4","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH 5'-UMP","10.1016/J.STR.2012.03.018 ",2.23,28.63,"4dw4_oligo11","DManpa1-2DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(4_B_)",37.4459,"","",""
"4DW5","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH A NON-CLEAVABLE CPU DINUCLEOTIDE","10.1016/J.STR.2012.03.018 ",2.21,49.18,"4dw5_oligo8","DManpb1-6DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(6_C_)-[BMA(5_C_)-BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4_A_)",53.6144,"","",""
"4DW5","CRYSTAL STRUCTURE OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH A NON-CLEAVABLE CPU DINUCLEOTIDE","10.1016/J.STR.2012.03.018 ",2.21,49.18,"4dw5_oligo3","DManpb1-6DManpb1-3[DManpb1-3DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(7_F_)-MAN(6_F_)-[BMA(5_F_)-BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(4_B_)",56.4982,"","",""
"4DW7","CRYSTAL STRUCTURE OF AN ACTIVE-SITE MUTANT OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH A CPU DINUCLEOTIDE","10.1016/J.STR.2012.03.018 ",3.08,79.18,"4dw7_oligo5","DManpb1-6DManpb1-3[DManpa1-4DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_E_)-MAN(6_E_)-[BMA(5_E_)-BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(4_B_)",112.431,"","",""
"4DW7","CRYSTAL STRUCTURE OF AN ACTIVE-SITE MUTANT OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH A CPU DINUCLEOTIDE","10.1016/J.STR.2012.03.018 ",3.08,79.18,"4dw7_oligo6","DManpb1-6DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4_A_)",86.0696,"","",""
"4DWA","CRYSTAL STRUCTURE OF AN ACTIVE-SITE MUTANT OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH A CPUPC TRINUCLEOTIDE","10.1016/J.STR.2012.03.018 ",3.01,47.86,"4dwa_oligo4","DManpb1-6DManpb1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_G_)-[BMA(5_G_)-BMA(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(4_B_)",66.3174,"","",""
"4DWA","CRYSTAL STRUCTURE OF AN ACTIVE-SITE MUTANT OF THE GLYCOPROTEIN ERNS FROM THE PESTIVIRUS BVDV-1 IN COMPLEX WITH A CPUPC TRINUCLEOTIDE","10.1016/J.STR.2012.03.018 ",3.01,47.86,"4dwa_oligo12","DManpb1-6DManpb1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-BMA(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(4_A_)",56.0309,"","",""
"4EBZ","CRYSTAL STRUCTURE OF THE ECTODOMAIN OF A RECEPTOR LIKE KINASE","10.1126/SCIENCE.1218867 ",1.79,0,"4ebz_oligo1","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(102_A_)",57.1115,"","",""
"4EE3","CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4-GALACTOSYLTRANSFERASE-1 (M340H-B4GAL-T1) IN COMPLEX WITH PENTASACCHARIDE","10.1074/JBC.M112.373514 ",2.3,32.05,"4ee3_oligo4","DGalp[4H]b1-3DGlcpNAcb1-3[DGlcpNAcb1-6]DGalpb1-4DGlcpb1-ROH","NAG(5_E_)-GAL(4_E_)-NAG(3_E_)]-GAL(2_E_)-BGC(1_E_)",56.5583,"","",""
"4EE3","CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4-GALACTOSYLTRANSFERASE-1 (M340H-B4GAL-T1) IN COMPLEX WITH PENTASACCHARIDE","10.1074/JBC.M112.373514 ",2.3,32.05,"4ee3_oligo1","DGalpb1-3DGlcpNAcb1-3[DGlcpNAcb1-6]DGalpb1-4DGlcpb1-ROH","NAG(5_D_)-[GAL(4_D_)-NAG(3_D_)]-GAL(2_D_)-BGC(1_D_)",62.1015,"","",""
"4EE3","CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4-GALACTOSYLTRANSFERASE-1 (M340H-B4GAL-T1) IN COMPLEX WITH PENTASACCHARIDE","10.1074/JBC.M112.373514 ",2.3,32.05,"4ee3_oligo5","DGalpb1-3DGlcpNAcb1-3[DGlcpNAcb1-6]DGalpb1-4DGlcpb1-ROH","NAG(5_F_)-[GAL(4_F_)-NAG(3_F_)]-GAL(2_F_)-BGC(1_F_)",73.6733,"","",""
"4EE4","CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4-GALACTOSYLTRANSFERASE-1 (M340H-B4GAL-T1) IN COMPLEX WITH TETRASACCHARIDE FROM LACTO-N- NEOHEXOSE","10.1074/JBC.M112.373514 ",1.95,36.78,"4ee4_oligo2","DGlcpNAcb1-3[DGlcpNAcb1-6]DGalpb1-4DGlcpb1-ROH","NAG(4_E_)-[NAG(3_E_)]-GAL(2_E_)-BGC(1_E_)",38.8709,"","",""
"4EE4","CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4-GALACTOSYLTRANSFERASE-1 (M340H-B4GAL-T1) IN COMPLEX WITH TETRASACCHARIDE FROM LACTO-N- NEOHEXOSE","10.1074/JBC.M112.373514 ",1.95,36.78,"4ee4_oligo3","DGlcpNAcb1-3[DGlcpNAcb1-6]DGalpb1-4DGlcpb1-ROH","NAG(4_F_)-[NAG(3_F_)]-GAL(2_F_)-BGC(1_F_)",56.3814,"","",""
"4EE4","CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4-GALACTOSYLTRANSFERASE-1 (M340H-B4GAL-T1) IN COMPLEX WITH TETRASACCHARIDE FROM LACTO-N- NEOHEXOSE","10.1074/JBC.M112.373514 ",1.95,36.78,"4ee4_oligo1","DGlcpNAcb1-3[DGlcpNAcb1-6]DGalpb1-4DGlcpb1-ROH","NAG(4_D_)-[NAG(3_D_)]-GAL(2_D_)-BGC(1_D_)",42.7411,"","",""
"4EEA","CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4-GALACTOSYLTRANSFERASE-1 (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,6-GAL-BETA1,4-GLC-BETA","10.1074/JBC.M112.373514 ",2,36.23,"4eea_oligo4","DGlcpNAcb1-6DGalpb1-4DGlcpb1-ROH","NAG(3_E_)-GAL(2_E_)-BGC(1_E_)",41.5397,"","",""
"4EEA","CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4-GALACTOSYLTRANSFERASE-1 (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,6-GAL-BETA1,4-GLC-BETA","10.1074/JBC.M112.373514 ",2,36.23,"4eea_oligo5","DGlcpNAcb1-6DGalpb1-4DGlcpb1-ROH","NAG(3_F_)-GAL(2_F_)-BGC(1_F_)",75.8845,"","",""
"4EEA","CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4-GALACTOSYLTRANSFERASE-1 (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,6-GAL-BETA1,4-GLC-BETA","10.1074/JBC.M112.373514 ",2,36.23,"4eea_oligo1","DGlcpNAcb1-6DGalpb1-4DGlcpb1-ROH","NAG(3_D_)-GAL(2_D_)-BGC(1_D_)",46.4621,"","",""
"4EEG","CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4-GALACTOSYLTRANSFERASE-1 (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,6-GAL-BETA","10.1074/JBC.M112.373514 ",2.2,38.75,"4eeg_oligo5","DGlcpNAcb1-6DGalpb1-ROH","NAG(2_E_)-GAL(1_E_)",58.2268,"","",""
"4EEG","CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4-GALACTOSYLTRANSFERASE-1 (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,6-GAL-BETA","10.1074/JBC.M112.373514 ",2.2,38.75,"4eeg_oligo6","DGlcpNAcb1-6DGalpb1-ROH","NAG(2_F_)-GAL(1_F_)",74.1259,"","",""
"4EEG","CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4-GALACTOSYLTRANSFERASE-1 (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,6-GAL-BETA","10.1074/JBC.M112.373514 ",2.2,38.75,"4eeg_oligo4","DGlcpNAcb1-6DGalpb1-ROH","NAG(2_D_)-GAL(1_D_)",65.2695,"","",""
"4EEM","CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4-GALACTOSYLTRANSFERASE-1 (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,6-MAN-ALPHA-METHYL","10.1074/JBC.M112.373514 ",2.2,35.45,"4eem_oligo6","DGlcpNAcb1-6DManpa1-OME","NAG(2_F_)-MMA(1_F_)",66.1259,"","",""
"4EEM","CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4-GALACTOSYLTRANSFERASE-1 (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,6-MAN-ALPHA-METHYL","10.1074/JBC.M112.373514 ",2.2,35.45,"4eem_oligo4","DGlcpNAcb1-6DManpa1-OME","NAG(2_D_)-MMA(1_D_)",51.6368,"","",""
"4EEM","CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4-GALACTOSYLTRANSFERASE-1 (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,6-MAN-ALPHA-METHYL","10.1074/JBC.M112.373514 ",2.2,35.45,"4eem_oligo5","DGlcpNAcb1-6DManpa1-OME","NAG(2_E_)-MMA(1_E_)",47.2377,"","",""
"4EEO","CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4-GALACTOSYLTRANSFERASE-1 (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,6-GLCNAC-ALPHA-BENZYL","10.1074/JBC.M112.373514 ",2.3,0,"4eeo_oligo5","DGlcpNAcb1-6DGlcpNAca1-C7O1","NAG(2_E_)-BBV(1_E_)",42.2159,"","",""
"4EEO","CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4-GALACTOSYLTRANSFERASE-1 (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,6-GLCNAC-ALPHA-BENZYL","10.1074/JBC.M112.373514 ",2.3,0,"4eeo_oligo4","DGlcpNAcb1-6DGlcpNAca1-C7O1","NAG(2_D_)-BBV(1_D_)",43.4736,"","",""
"4EEO","CRYSTAL STRUCTURE OF HUMAN M340H-BETA-1,4-GALACTOSYLTRANSFERASE-1 (M340H-B4GAL-T1) IN COMPLEX WITH GLCNAC-BETA1,6-GLCNAC-ALPHA-BENZYL","10.1074/JBC.M112.373514 ",2.3,0,"4eeo_oligo6","DGlcpNAcb1-6DGlcpNAca1-C7O1","NAG(2_F_)-BBV(1_F_)",68.2768,"","",""
"4EXN","CRYSTAL STRUCTURE OF MOUSE INTERLEUKIN-34","10.1016/J.BBAPAP.2012.04.012 ",2.7,91.52,"4exn_oligo7","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_K_)-[BMA(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(76_F_)",126.989,"","",""
"4EXN","CRYSTAL STRUCTURE OF MOUSE INTERLEUKIN-34","10.1016/J.BBAPAP.2012.04.012 ",2.7,91.52,"4exn_oligo5","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_I_)-[MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(76_E_)",137.419,"","",""
"4EXN","CRYSTAL STRUCTURE OF MOUSE INTERLEUKIN-34","10.1016/J.BBAPAP.2012.04.012 ",2.7,91.52,"4exn_oligo2","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(76_B_)",125.708,"","",""
"4GEZ","STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009","10.1073/PNAS.1212579109 ",2.5,0,"4gez_oligo4","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_P_)-[NAG(2_P_)]-NAG(1_P_)-ASN(260_F_)",75.8658,"","",""
"4GEZ","STRUCTURE OF A NEURAMINIDASE-LIKE PROTEIN FROM A/BAT/GUATEMALA/164/2009","10.1073/PNAS.1212579109 ",2.5,0,"4gez_oligo2","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_N_)-[NAG(2_N_)]-NAG(1_N_)-ASN(260_B_)",80.67,"","",""
"4GPN","THE CRYSTAL STRUCTURE OF 6-P-BETA-D-GLUCOSIDASE (E375Q MUTANT) FROM STREPTOCOCCUS MUTANS UA150 IN COMPLEX WITH GENTIOBIOSE 6-PHOSPHATE.","10.1107/S0907444912049608 ",2.29,0,"4gpn_oligo2","DGlcp[6P]b1-6DGlcpb1-ROH","BG6(2_D_)-BGC(1_D_)",84.8627,"","",""
"4GPN","THE CRYSTAL STRUCTURE OF 6-P-BETA-D-GLUCOSIDASE (E375Q MUTANT) FROM STREPTOCOCCUS MUTANS UA150 IN COMPLEX WITH GENTIOBIOSE 6-PHOSPHATE.","10.1107/S0907444912049608 ",2.29,0,"4gpn_oligo1","DGlcp[6P]b1-6DGlcpb1-ROH","BG6(2_C_)-BGC(1_C_)",85.1554,"","",""
"4GZT","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE","10.1128/JVI.01426-12 ",2.19,33.6,"4gzt_oligo6","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_E_)-[BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(200_A_)",44.2975,"","",""
"4GZT","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE","10.1128/JVI.01426-12 ",2.19,33.6,"4gzt_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[BMA(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(200_B_)",43.2925,"","",""
"4GZT","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE","10.1128/JVI.01426-12 ",2.19,33.6,"4gzt_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_H_)-[BMA(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(200_C_)",42.7575,"","",""
"4GZT","N2 NEURAMINIDASE D151G MUTANT OF A/TANZANIA/205/2010 H3N2 IN COMPLEX WITH OSELTAMIVIR CARBOXYLATE","10.1128/JVI.01426-12 ",2.19,33.6,"4gzt_oligo5","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_J_)-[BMA(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(200_D_)",44.9751,"","",""
"4HJ1","CRYSTAL STRUCTURE OF GLYCOPROTEIN C FROM RIFT VALLEY FEVER VIRUS (GLYCOSYLATED)","10.1073/PNAS.1217780110 ",1.9,57,"4hj1_oligo8","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[BMA(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(1035_C_)",97.1602,"","",""
"4HJ1","CRYSTAL STRUCTURE OF GLYCOPROTEIN C FROM RIFT VALLEY FEVER VIRUS (GLYCOSYLATED)","10.1073/PNAS.1217780110 ",1.9,57,"4hj1_oligo6","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(1035_A_)",71.3325,"","",""
"4HJ1","CRYSTAL STRUCTURE OF GLYCOPROTEIN C FROM RIFT VALLEY FEVER VIRUS (GLYCOSYLATED)","10.1073/PNAS.1217780110 ",1.9,57,"4hj1_oligo9","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_H_)-[BMA(4_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(1035_D_)",62.8318,"","",""
"4IRS","STRUCTURE OF THE MOUSE CD1D-PYRC-ALPHA-GALCER-INKT TCR COMPLEX","10.4049/JIMMUNOL.1203134 ",2.8,36.98,"4irs_oligo4","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(165_A_)",44.9476,"","",""
"4J4P","THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS","10.1038/NSMB.2795 ",2.91,104.7,"4j4p_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_E_)-[BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(394_A_)",103.719,"","",""
"4J4P","THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS","10.1038/NSMB.2795 ",2.91,104.7,"4j4p_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(394_B_)",114.223,"","",""
"4JZJ","CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX","10.1016/J.CELREP.2014.06.038 ",2.8,50.31,"4jzj_oligo3","LFucpa1-3[LFucpb1-6]DGlcpNAcx1-","FUL(3_G_)-[FUC(2_G_)]-NAG(1_G_)",111.065,"","",""
"4JZJ","CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX","10.1016/J.CELREP.2014.06.038 ",2.8,50.31,"4jzj_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6][LFucpb1-3]DGlcpNAcx1-","FUL(7_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-[FUL(6_E_)]-NAG(1_E_)",83.4233,"","",""
"4K3X","CRYSTAL STRUCTURE OF A SUBTYPE H18 HEMAGGLUTININ HOMOLOGUE FROM A/FLAT-FACED BAT/PERU/033/2010 (H18N11)","10.1371/JOURNAL.PPAT.1003657 ",2.15,0,"4k3x_oligo3","LFucpb1-3[DGlcpNAcb1-4][LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_I_)-[NAG(3_I_)]-[FUL(2_I_)]-NAG(1_I_)-ASN(264_A_)",87.8548,"","",""
"4K3X","CRYSTAL STRUCTURE OF A SUBTYPE H18 HEMAGGLUTININ HOMOLOGUE FROM A/FLAT-FACED BAT/PERU/033/2010 (H18N11)","10.1371/JOURNAL.PPAT.1003657 ",2.15,0,"4k3x_oligo6","DManpb1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(5_L_)-[BMA(4_L_)-BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(264_C_)",81.5867,"","",""
"4KJG","STRUCTURE OF RAT INTESTINAL ALKALINE PHOSPHATASE EXPRESSED IN INSECT CELL","10.1016/J.JSB.2013.09.017 ",2.38,23.43,"4kjg_oligo1","DGlcpNAcb1-6DGlcpNAcb1-4DGlcpNAcb1-4DGlcpNAcx1-","NAG(4_C_)-NAG(3_C_)-NAG(2_C_)-NAG(1_C_)",45.5591,"","",""
"4KJG","STRUCTURE OF RAT INTESTINAL ALKALINE PHOSPHATASE EXPRESSED IN INSECT CELL","10.1016/J.JSB.2013.09.017 ",2.38,23.43,"4kjg_oligo2","DGlcpNAcb1-4[DGlcpNAcb1-6]DGlcpNAcx1-","NAG(3_D_)-[NAG(2_D_)]-NAG(1_D_)",58.1952,"","",""
"4KU1","ROLE OF THE HINGE AND C-GAMMA-2/C-GAMMA-3 INTERFACE IN IMMUNOGLOBIN G1 FC DOMAIN MOTIONS: IMPLICATIONS FOR FC ENGINEERING","10.1016/J.JMB.2014.01.011 ",1.9,31.64,"4ku1_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-3[DGalpb1-4DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(10_C_)-[GAL(9_C_)-NAG(8_C_)-MAN(7_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)",63.871,"","",""
"4KU1","ROLE OF THE HINGE AND C-GAMMA-2/C-GAMMA-3 INTERFACE IN IMMUNOGLOBIN G1 FC DOMAIN MOTIONS: IMPLICATIONS FOR FC ENGINEERING","10.1016/J.JMB.2014.01.011 ",1.9,31.64,"4ku1_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",40.4316,"","",""
"4MC5","CRYSTAL STRUCTURE OF A SUBTYPE H18 HEMAGGLUTININ HOMOLOGUE FROM A/FLAT-FACED BAT/PERU/033/2010 (H18N11)","10.1371/JOURNAL.PPAT.1003657 ",2.24,0,"4mc5_oligo6","LFucpa1-3[DGlcpNAcb1-4][LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_I_)-[NAG(3_I_)]-[FUC(2_I_)]-NAG(1_I_)-ASN(240_C_)",104.851,"","",""
"4MC5","CRYSTAL STRUCTURE OF A SUBTYPE H18 HEMAGGLUTININ HOMOLOGUE FROM A/FLAT-FACED BAT/PERU/033/2010 (H18N11)","10.1371/JOURNAL.PPAT.1003657 ",2.24,0,"4mc5_oligo2","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUL(7_E_)-[MAN(5_E_)-[MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-[FUC(6_E_)]-NAG(1_E_)-ASN(240_A_)",67.153,"","",""
"4MC5","CRYSTAL STRUCTURE OF A SUBTYPE H18 HEMAGGLUTININ HOMOLOGUE FROM A/FLAT-FACED BAT/PERU/033/2010 (H18N11)","10.1371/JOURNAL.PPAT.1003657 ",2.24,0,"4mc5_oligo4","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUL(7_G_)-[MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-[FUC(6_G_)]-NAG(1_G_)-ASN(240_B_)",73.7017,"","",""
"4MMX","INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO THE TENTH DOMAIN OF FIBRONECTIN","10.1038/NSMB.2797 ",3.32,0,"4mmx_oligo2","DManpa1-4DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-BMA(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(266_A_)",95.9556,"","",""
"4MMY","INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO THE TENTH DOMAIN OF FIBRONECTIN WITH THE IAKGDWND MOTIF","10.1038/NSMB.2797 ",3.18,0,"4mmy_oligo3","DManpa1-4DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-BMA(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(266_A_)",133.258,"","",""
"4MMZ","INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO AN ANTAGONISTIC TENTH DOMAIN OF FIBRONECTIN","10.1038/NSMB.2797 ",3.1,0,"4mmz_oligo2","DManpa1-4DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-BMA(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(266_A_)",123.124,"","",""
"4MZA","CRYSTAL STRUCTURE OF HPIV3 HEMAGGLUTININ-NEURAMINIDASE","10.1128/MBIO.00803-13 ",1.65,31.02,"4mza_oligo4","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_F_)-NAG(1_F_)-ASN(523_B_)",74.8805,"","",""
"4MZE","CRYSTAL STRUCTURE OF HPIV3 HEMAGGLUTININ-NEURAMINIDASE, H552Q/Q559R MUTANT","10.1128/MBIO.00803-13 ",1.8,29.87,"4mze_oligo2","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_D_)-NAG(1_D_)-ASN(523_A_)",73.5709,"","",""
"4N0U","TERNARY COMPLEX BETWEEN NEONATAL FC RECEPTOR, SERUM ALBUMIN AND FC","10.1074/JBC.M113.537563 ",3.8,143.8,"4n0u_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_E_)",124.464,"","",""
"4NZD","INTERLEUKIN 21 RECEPTOR","",2.75,0,"4nzd_oligo3","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(5_F_)-[MAN(4_F_)-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(54_C_)",68.4449,"","",""
"4NZD","INTERLEUKIN 21 RECEPTOR","",2.75,0,"4nzd_oligo2","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(5_E_)-[MAN(4_E_)-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(54_B_)",58.7867,"","",""
"4NZD","INTERLEUKIN 21 RECEPTOR","",2.75,0,"4nzd_oligo1","DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(5_D_)-[MAN(4_D_)-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(54_A_)",72.1351,"","",""
"4NZL","EXTRACELLULAR PROTEINS OF STAPHYLOCOCCUS AUREUS INHIBIT THE NEUTROPHIL SERINE PROTEASES","10.1073/PNAS.1407616111 ",1.85,0,"4nzl_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_C_)-[BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(124_A_)",61.2968,"","",""
"4NZL","EXTRACELLULAR PROTEINS OF STAPHYLOCOCCUS AUREUS INHIBIT THE NEUTROPHIL SERINE PROTEASES","10.1073/PNAS.1407616111 ",1.85,0,"4nzl_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(173_A_)",43.9461,"","",""
"4ODT","FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15 IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE","10.1074/JBC.M115.657874 ",1.95,40.78,"4odt_oligo1","DGlcpN[4P]b1-6DGlcpNa1-O4P1","Z9M(2_A_)-GP1(1_A_)",37.6636,"","",""
"4ODV","FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY A6 IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE","10.1074/JBC.M115.657874 ",2.15,48.67,"4odv_oligo1","DGlcpN[4P]b1-6DGlcpNa1-O4P1","Z9M(2_A_)-GP1(1_A_)",44.1168,"","",""
"4P5M","STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTOIMMUNITY","10.1016/J.CELL.2014.04.048 ",1.7,24.32,"4p5m_oligo2","DGlcpNAcb1-3[DGlcpNAcb1-4][DGlcpNAcb1-6]DGlcpNAcb1-ASN","NAG(4_J_)-[NAG(3_J_)]-[NAG(2_J_)]-NAG(1_J_)-ASN(19_B_)",47.7914,"","",""
"4P7R","STRUCTURE OF ESCHERICHIA COLI PGAB C-TERMINAL DOMAIN IN COMPLEX WITH A POLY-BETA-1,6-N-ACETYL-D-GLUCOSAMINE (PNAG) HEXAMER","10.1073/PNAS.1406388111 ",1.8,32.29,"4p7r_oligo1","DGlcpNAcb1-6DGlcpNAcb1-6DGlcpNAcb1-6DGlcpNAcb1-ROH","NAG(4_B_)-NAG(3_B_)-NAG(2_B_)-NAG(1_B_)",71.1961,"","",""
"4RGA","PHAGE 1358 RECEPTOR BINDING PROTEIN IN COMPLEX WITH THE TRISACCHARIDE GLCNAC-GALF-GLCOME","10.1111/MMI.12978 ",2.1,47.57,"4rga_oligo2","DGlcpNAcb1-2DGalfb1-6DGlcpa1-OME","NAG(3_D_)-GZL(2_D_)-GYP(1_D_)",61.1312,"","",""
"4RGA","PHAGE 1358 RECEPTOR BINDING PROTEIN IN COMPLEX WITH THE TRISACCHARIDE GLCNAC-GALF-GLCOME","10.1111/MMI.12978 ",2.1,47.57,"4rga_oligo1","DGlcpNAcb1-2DGalfb1-6DGlcpa1-OME","NAG(3_C_)-GZL(2_C_)-GYP(1_C_)",58.1023,"","",""
"4TPK","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N-((1-(2,3-DIHYDRO-1H- INDEN-2-YL)PIPERIDIN-3-YL)METHYL)-N-(2-METHOXYETHYL)-2-NAPHTHAMIDE","10.1021/JM501195E ",2.7,0,"4tpk_oligo10","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_J_)-NAG(1_J_)-ASN(241_B_)",101.368,"","",""
"4TPK","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N-((1-(2,3-DIHYDRO-1H- INDEN-2-YL)PIPERIDIN-3-YL)METHYL)-N-(2-METHOXYETHYL)-2-NAPHTHAMIDE","10.1021/JM501195E ",2.7,0,"4tpk_oligo5","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_C_)-NAG(1_C_)-ASN(57_A_)",103.545,"","",""
"4UNW","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",2.6,64.83,"4unw_oligo11","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_Q_)-NAG(1_Q_)-ASN(154_D_)",102.536,"","",""
"4UNW","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",2.6,64.83,"4unw_oligo4","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_K_)-NAG(1_K_)-ASN(154_B_)",92.81,"","",""
"4UNX","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",3.2,109.7,"4unx_oligo9","LFucpb1-6DGlcpNAcx1-","FUC(2_O_)-NAG(1_O_)",90.1148,"","",""
"4UNX","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",3.2,109.7,"4unx_oligo13","LFucpb1-6DGlcpNAcx1-","FUC(2_S_)-NAG(1_S_)",103.087,"","",""
"4UNX","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",3.2,109.7,"4unx_oligo3","LFucpb1-6DGlcpNAcx1-","FUC(2_K_)-NAG(1_K_)",98.3476,"","",""
"4UNY","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4-3SLN","10.1073/PNAS.1406606111 ",2.9,67.81,"4uny_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_N_)-[MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(22_C_)",93.4209,"","",""
"4UNY","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4-3SLN","10.1073/PNAS.1406606111 ",2.9,67.81,"4uny_oligo11","LFucpb1-6DGlcpNAcb1-ASN","FUC(2_Q_)-NAG(1_Q_)-ASN(154_D_)",112.363,"","",""
"4UNZ","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4-SIALYL LEWIS X","10.1073/PNAS.1406606111 ",2.9,73.96,"4unz_oligo7","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(154_B_)",105.759,"","",""
"4UNZ","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4-SIALYL LEWIS X","10.1073/PNAS.1406606111 ",2.9,73.96,"4unz_oligo11","LFucpb1-6DGlcpNAcb1-ASN","FUC(2_Q_)-NAG(1_Q_)-ASN(154_D_)",107.6,"","",""
"4UNZ","STRUCTURE OF THE A_EQUINE_NEWMARKET_2_93 H3 HAEMAGGLUTININ IN COMPLEX WITH 6SO4-SIALYL LEWIS X","10.1073/PNAS.1406606111 ",2.9,73.96,"4unz_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_N_)-[MAN(5_N_)-[MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(22_C_)",105.096,"","",""
"4UO0","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",1.9,33.21,"4uo0_oligo15","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_U_)-[NAG(2_U_)]-NAG(1_U_)-ASN(154_D_)",69.8567,"","",""
"4UO0","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",1.9,33.21,"4uo0_oligo13","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_S_)-[MAN(5_S_)-[MAN(4_S_)]-BMA(3_S_)-NAG(2_S_)]-NAG(1_S_)-ASN(22_C_)",52.1642,"","",""
"4UO0","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",1.9,33.21,"4uo0_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(4_K_)-[BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(8_A_)",65.6032,"","",""
"4UO0","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",1.9,33.21,"4uo0_oligo20","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_Z_)-[NAG(2_Z_)]-NAG(1_Z_)-ASN(8_E_)",70.4382,"","",""
"4UO0","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",1.9,33.21,"4uo0_oligo22","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_b_)-[NAG(2_b_)]-NAG(1_b_)-ASN(154_F_)",75.5973,"","",""
"4UO0","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ","10.1073/PNAS.1406606111 ",1.9,33.21,"4uo0_oligo6","LFucpb1-6DGlcpNAcb1-ASN","FUC(2_N_)-NAG(1_N_)-ASN(154_B_)",67.6795,"","",""
"4UO1","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",3,81.45,"4uo1_oligo9","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_R_)-[NAG(2_R_)]-NAG(1_R_)-ASN(8_E_)",118.438,"","",""
"4UO1","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",3,81.45,"4uo1_oligo11","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(4_J_)-[BMA(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(8_A_)",115.223,"","",""
"4UO1","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",3,81.45,"4uo1_oligo4","LFucpb1-6DGlcpNAcb1-ASN","FUC(2_M_)-NAG(1_M_)-ASN(154_B_)",102.677,"","",""
"4UO1","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ IN COMPLEX WITH 3SLN","10.1073/PNAS.1406606111 ",3,81.45,"4uo1_oligo15","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_U_)-[NAG(2_U_)]-NAG(1_U_)-ASN(154_F_)",104.828,"","",""
"4UO2","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ IN COMPLEX WITH SIALYL LEWIS X","10.1073/PNAS.1406606111 ",2.7,59.14,"4uo2_oligo11","LFucpb1-6DGlcpNAcb1-ASN","FUC(2_L_)-NAG(1_L_)-ASN(154_B_)",96.2464,"","",""
"4UO2","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ IN COMPLEX WITH SIALYL LEWIS X","10.1073/PNAS.1406606111 ",2.7,59.14,"4uo2_oligo22","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_b_)-[NAG(2_b_)]-NAG(1_b_)-ASN(154_F_)",102.38,"","",""
"4UO2","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ IN COMPLEX WITH SIALYL LEWIS X","10.1073/PNAS.1406606111 ",2.7,59.14,"4uo2_oligo7","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_T_)-[NAG(2_T_)]-NAG(1_T_)-ASN(154_D_)",96.9179,"","",""
"4UO2","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ IN COMPLEX WITH SIALYL LEWIS X","10.1073/PNAS.1406606111 ",2.7,59.14,"4uo2_oligo14","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(4_I_)-[BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(8_A_)",106.773,"","",""
"4UO3","STRUCTURE OF THE A_EQUINE_RICHMOND_07 H3 HAEMAGGLUTININ MUTANT SER30THR","10.1073/PNAS.1406606111 ",2.87,57.05,"4uo3_oligo9","LFucpb1-6DGlcpNAcb1-ASN","FUC(2_O_)-NAG(1_O_)-ASN(154_F_)",79.2568,"","",""
"4UTC","CRYSTAL STRUCTURE OF DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN","10.1038/NATURE14130 ",3.08,85.62,"4utc_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_E_)-[BMA(5_E_)-[BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(153_B_)",88.3062,"","",""
"4X4K","STRUCTURE OF LACCASE FROM BOTRYTIS ACLADA WITH FULL COPPER CONTENT","10.1107/S2053230X1502052X ",2.3,39.24,"4x4k_oligo1","DManpb1-2DManpb1-6DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_C_)-MAN(5_C_)-MAN(4_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(194_A_)",70.1142,"","",""
"4X4M","STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING","10.1073/PNAS.1418812112 ",3.49,0,"4x4m_oligo4","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_I_)-[GAL(6_I_)-NAG(5_I_)-MAN(4_I_)-[NAG(8_I_)-MAN(7_I_)]-BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(297_C_)",145.232,"","",""
"4X4M","STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING","10.1073/PNAS.1418812112 ",3.49,0,"4x4m_oligo3","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_G_)-[NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_A_)",122.935,"","",""
"4X4M","STRUCTURE OF FCGAMMARI IN COMPLEX WITH FC REVEALS THE IMPORTANCE OF GLYCAN RECOGNITION FOR HIGH AFFINITY IGG BINDING","10.1073/PNAS.1418812112 ",3.49,0,"4x4m_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_H_)-[NAG(7_H_)-MAN(6_H_)-[NAG(5_H_)-MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(297_B_)",152.959,"","",""
"4XII","X-RAY STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N-((1- (2,3-DIHYDRO-1H-INDEN-2-YL)PIPERIDIN-3-YL)METHYL)-8-HYDROXY-N-(2- METHOXYETHYL)-5-NITROQUINOLINE-7-CARBOXAMIDE","10.1016/J.BMC.2015.06.010 ",2.7,0,"4xii_oligo16","LFucpb1-6DGlcpNAcx1-","FUL(1006_B_)-NAG(1005_B_)",109.618,"","",""
"4Y16","CRYSTAL STRUCTURE OF THE MCD1D/NC-AGC/INKTCR TERNARY COMPLEX","10.1074/JBC.M115.654814 ",2.6,41.19,"4y16_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(165_A_)",51.1855,"","",""
"4ZNE","IGG1 FC-FCGAMMARI ECD COMPLEX","10.1107/S1399004715018015 ",2.42,34.24,"4zne_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_G_)-[NAG(7_G_)-MAN(6_G_)-[NAG(5_G_)-MAN(4_G_)]-MAN(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(297_J_)",72.298,"","",""
"4ZNE","IGG1 FC-FCGAMMARI ECD COMPLEX","10.1107/S1399004715018015 ",2.42,34.24,"4zne_oligo5","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_F_)-[NAG(7_F_)-MAN(6_F_)-[NAG(5_F_)-MAN(4_F_)]-MAN(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(297_E_)",63.5537,"","",""
"4ZO7","CRYSTAL STRUCTURE OF MUTANT (D270A) BETA-GLUCOSIDASE FROM LISTERIA INNOCUA IN COMPLEX WITH GENTIOBIOSE","10.1371/JOURNAL.PONE.0148870 ",2,17.44,"4zo7_oligo4","DGlcpb1-6DGlcpa1-ROH","BGC(2_C_)-GLC(1_C_)",26.4127,"","",""
"5A63","CRYO-EM STRUCTURE OF THE HUMAN GAMMA-SECRETASE COMPLEX AT 3.4 ANGSTROM RESOLUTION.","10.1038/NATURE14892 ",3.4,"1.35632e-19","5a63_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(55_A_)",390.712,"","",""
"5A7E","CRYSTALLOGRAPHIC STRUCTURAL DETERMINATION OF A TRIGONAL LACCASE FROM CORIOLOPSIS GALLICA (CGL) TO 1.5 A RESOLUTION","",1.5,0,"5a7e_oligo1","DGlcpb1-6DGlcp[2<R1>]b1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(432_A_)",42.6045,"","",""
"5AB0","CRYSTAL STRUCTURE OF AMINOPEPTIDASE ERAP2 WITH LIGAND","10.1074/JBC.M115.685909 ",2.5,56.3,"5ab0_oligo6","DManpb1-4[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_I_)-[BMA(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(85_C_)",64.6682,"","",""
"5AB2","CRYSTAL STRUCTURE OF AMINOPEPTIDASE ERAP2 WITH LIGAND","10.1074/JBC.M115.685909 ",2.73,82.4,"5ab2_oligo8","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_L_)-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(85_B_)",85.775,"","",""
"5AM8","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AMYLOID-BETA 4-10","10.1111/FEBS.13647 ",1.9,25.01,"5am8_oligo8","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_L_)-[BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(416_C_)",41.2568,"","",""
"5AM9","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AMYLOID-BETA 10-16","10.1111/FEBS.13647 ",1.8,27.35,"5am9_oligo1","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_E_)-NAG(1_E_)-ASN(480_A_)",56.7555,"","",""
"5AMA","CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N-DOMAIN IN COMPLEX WITH AMYLOID-BETA 1-16","10.1111/FEBS.13647 ",1.8,23.81,"5ama_oligo8","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_L_)-[BMA(3_L_)-NAG(2_L_)]-NAG(1_L_)-ASN(416_C_)",38.0898,"","",""
"5D6D","CRYSTAL STRUCTURE OF GASDALIE IGG1 FC IN COMPLEX WITH FCGRIIIA","10.1016/J.JSB.2016.02.001 ",3.13,0,"5d6d_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",49.7178,"","",""
"5DQ9","STRUCTURE OF S55-3 FAB IN COMPLEX WITH LIPID A","",1.95,38.84,"5dq9_oligo1","DGlcpNAc[4P]b1-6DGlcpNAca1-O4P1","GN4(2_E_)-GN1(1_E_)",20,"","",""
"5DQ9","STRUCTURE OF S55-3 FAB IN COMPLEX WITH LIPID A","",1.95,38.84,"5dq9_oligo2","DGlcpNAcb1-6DGlcpNAca1-O1P1","GN4(2_F_)-GN1(1_F_)",20,"","",""
"5DQ9","STRUCTURE OF S55-3 FAB IN COMPLEX WITH LIPID A","",1.95,38.84,"5dq9_oligo3","DGlcpNAc[4P]b1-6DGlcpNAca1-O4P1","GN4(2_G_)-GN1(1_G_)",20,"","",""
"5DQD","STRUCTURE OF S55-5 FAB IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE","",1.94,23.08,"5dqd_oligo1","DGlcpNAc[4P]b1-6DGlcpNAca1-O2P1","GN4(2_A_)-GN1(1_A_)",20,"","",""
"5DYS","CRYSTAL STRUCTURE OF T94I RHODOPSIN MUTANT","10.15252/EMBR.201642671 ",2.3,66.09,"5dys_oligo3","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[MAN(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(15_A_)",81.56,"","",""
"5DYT","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- ((1-BENZYLPIPERIDIN-3-YL)METHYL)-N-METHYLNAPHTHALENE-2-SULFONAMIDE","10.1038/SREP39495 ",2.55,0,"5dyt_oligo4","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(486_A_)",121.533,"","",""
"5DYT","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- ((1-BENZYLPIPERIDIN-3-YL)METHYL)-N-METHYLNAPHTHALENE-2-SULFONAMIDE","10.1038/SREP39495 ",2.55,0,"5dyt_oligo5","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(606_B_)-[NAG(2_H_)]-NAG(1_H_)-ASN(241_B_)",103.676,"","",""
"5DYW","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- ((1-BENZYLPIPERIDIN-3-YL)METHYL)-N-(2-METHOXYETHYL)NAPHTHALENE-2- SULFONAMIDE","10.1038/SREP39495 ",2.5,0,"5dyw_oligo11","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(455_B_)",98.5836,"","",""
"5DYW","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- ((1-BENZYLPIPERIDIN-3-YL)METHYL)-N-(2-METHOXYETHYL)NAPHTHALENE-2- SULFONAMIDE","10.1038/SREP39495 ",2.5,0,"5dyw_oligo8","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(486_A_)",97.5636,"","",""
"5DYW","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- ((1-BENZYLPIPERIDIN-3-YL)METHYL)-N-(2-METHOXYETHYL)NAPHTHALENE-2- SULFONAMIDE","10.1038/SREP39495 ",2.5,0,"5dyw_oligo10","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(256_B_)",106.144,"","",""
"5DYW","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- ((1-BENZYLPIPERIDIN-3-YL)METHYL)-N-(2-METHOXYETHYL)NAPHTHALENE-2- SULFONAMIDE","10.1038/SREP39495 ",2.5,0,"5dyw_oligo9","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(241_B_)",73.5733,"","",""
"5DYY","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- ((1-BENZYLPIPERIDIN-3-YL)METHYL)NAPHTHALENE-2-SULFONAMIDE","10.1038/SREP39495 ",2.65,0,"5dyy_oligo13","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(3_G_)-[NAG(2_G_)]-NAG(1_G_)",113.294,"","",""
"5DYY","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- ((1-BENZYLPIPERIDIN-3-YL)METHYL)NAPHTHALENE-2-SULFONAMIDE","10.1038/SREP39495 ",2.65,0,"5dyy_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(241_B_)",91.4415,"","",""
"5DYY","CRYSTAL STRUCTURE OF HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH N- ((1-BENZYLPIPERIDIN-3-YL)METHYL)NAPHTHALENE-2-SULFONAMIDE","10.1038/SREP39495 ",2.65,0,"5dyy_oligo15","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_E_)-NAG(1_E_)-ASN(241_A_)",101.074,"","",""
"5E6V","RE-REFINEMENT OF THE CRYSTAL STRUCTURE OF THE PLEXIN-SEMAPHORIN- INTEGRIN DOMAIN/HYBRID DOMAIN/I-EGF1 SEGMENT FROM THE HUMAN INTEGRIN B2 SUBUNIT","10.1073/PNAS.1601379113 ",1.8,0,"5e6v_oligo2","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(28_A_)",59.6882,"","",""
"5EGE","STRUCTURE OF ENPP6, A CHOLINE-SPECIFIC GLYCEROPHOSPHODIESTER- PHOSPHODIESTERASE","10.1038/SREP20995 ",2,22.3,"5ege_oligo7","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(341_D_)",51.9718,"","",""
"5EGE","STRUCTURE OF ENPP6, A CHOLINE-SPECIFIC GLYCEROPHOSPHODIESTER- PHOSPHODIESTERASE","10.1038/SREP20995 ",2,22.3,"5ege_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(341_A_)",40.8912,"","",""
"5EGE","STRUCTURE OF ENPP6, A CHOLINE-SPECIFIC GLYCEROPHOSPHODIESTER- PHOSPHODIESTERASE","10.1038/SREP20995 ",2,22.3,"5ege_oligo5","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(341_C_)",52.6079,"","",""
"5EGE","STRUCTURE OF ENPP6, A CHOLINE-SPECIFIC GLYCEROPHOSPHODIESTER- PHOSPHODIESTERASE","10.1038/SREP20995 ",2,22.3,"5ege_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(341_B_)",38.8012,"","",""
"5EGH","STRUCTURE OF ENPP6, A CHOLINE-SPECIFIC GLYCEROPHOSPHODIESTER- PHOSPHODIESTERASE IN COMPLEX WITH PHOSPHOCHOLINE","10.1038/SREP20995 ",1.8,32.9,"5egh_oligo2","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(341_A_)",59.0376,"","",""
"5EGH","STRUCTURE OF ENPP6, A CHOLINE-SPECIFIC GLYCEROPHOSPHODIESTER- PHOSPHODIESTERASE IN COMPLEX WITH PHOSPHOCHOLINE","10.1038/SREP20995 ",1.8,32.9,"5egh_oligo4","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(341_B_)",69.667,"","",""
"5FK8","STRUCTURE OF D80A-FRUCTOFURANOSIDASE FROM XANTHOPHYLLOMYCES DENDRORHOUS COMPLEXED WITH NEO-ERLOSE","10.1074/JBC.M115.708495 ",1.88,27.76,"5fk8_oligo34","DManpa1-3DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_H_)-MAN(4_H_)-[MAN(6_H_)]-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(58_B_)",47.6364,"","",""
"5FVN","X-RAY CRYSTAL STRUCTURE OF ENTEROBACTER CLOACAE OMPE36 PORIN.","10.1073/PNAS.1602382113 ",1.45,18.21,"5fvn_oligo15","GMH1-5[DKdopa2-4]DKdopa2-6DGlcp[2<R1>,3<R2>,4P]b1-6DGlcp[2<R3>,3<R4>]a1-O4P1","GMH(5_N_)-[KDO(4_N_)]-KDO(3_N_)-Z9M(2_N_)-GP1(1_N_)",24.0577,"","",""
"5FVN","X-RAY CRYSTAL STRUCTURE OF ENTEROBACTER CLOACAE OMPE36 PORIN.","10.1073/PNAS.1602382113 ",1.45,18.21,"5fvn_oligo13","DKdopa2-6DGlcp[2<R1>,3<R2>,4P]b1-6DGlcp[2<R3>,3<R4>]a1-O4P1","KDO(3_L_)-Z9M(2_L_)-GP1(1_L_)",26.4457,"","",""
"5FVN","X-RAY CRYSTAL STRUCTURE OF ENTEROBACTER CLOACAE OMPE36 PORIN.","10.1073/PNAS.1602382113 ",1.45,18.21,"5fvn_oligo2","GMH1-5DKdopa2-6DGlcp[2<R1>,3<R2>,4P]b1-6DGlcp[2<R3>,3<R4>]a1-O4P1","GMH(5_I_)-KDO(3_I_)-Z9M(2_I_)-GP1(1_I_)",27.391,"","",""
"5FVN","X-RAY CRYSTAL STRUCTURE OF ENTEROBACTER CLOACAE OMPE36 PORIN.","10.1073/PNAS.1602382113 ",1.45,18.21,"5fvn_oligo14","DKdopa2-6DGlcp[2<R1>,3<R2>,4P]b1-6DGlcp[2<R3>,3<R4>]a1-O4P1","KDO(3_M_)-Z9M(2_M_)-GP1(1_M_)",25.3571,"","",""
"5FVN","X-RAY CRYSTAL STRUCTURE OF ENTEROBACTER CLOACAE OMPE36 PORIN.","10.1073/PNAS.1602382113 ",1.45,18.21,"5fvn_oligo11","DKdopa2-6DGlcp[2<R1>,3<R2>,4P]b1-6DGlcp[2<R3>,3<R4>]a1-O4P1","KDO(3_G_)-Z9M(2_G_)-GP1(1_G_)",26.7514,"","",""
"5FVN","X-RAY CRYSTAL STRUCTURE OF ENTEROBACTER CLOACAE OMPE36 PORIN.","10.1073/PNAS.1602382113 ",1.45,18.21,"5fvn_oligo12","KKdo2-6DGlcp[2<R1>,3<R2>,4P]b1-6DGlcp[2<R3>,3<R4>]a1-O4P1","KDO(3_K_)-Z9M(2_K_)-GP1(1_K_)",39.6585,"","",""
"5FVN","X-RAY CRYSTAL STRUCTURE OF ENTEROBACTER CLOACAE OMPE36 PORIN.","10.1073/PNAS.1602382113 ",1.45,18.21,"5fvn_oligo3","DKdopa2-4DKdopa2-6DGlcp[2<R1>,3<R2>,4P]b1-6DGlcp[2<R3>,3<R4>]a1-O4P1","KDO(4_J_)-KDO(3_J_)-Z9M(2_J_)-GP1(1_J_)",19.7538,"","",""
"5FVN","X-RAY CRYSTAL STRUCTURE OF ENTEROBACTER CLOACAE OMPE36 PORIN.","10.1073/PNAS.1602382113 ",1.45,18.21,"5fvn_oligo1","GMH1-5DKdopa2-6DGlcp[2<R1>,3<R2>,4P]b1-6DGlcp[2<R3>,3<R4>]a1-O4P1","GMH(5_H_)-KDO(3_H_)-Z9M(2_H_)-GP1(1_H_)",27.5366,"","",""
"5FVN","X-RAY CRYSTAL STRUCTURE OF ENTEROBACTER CLOACAE OMPE36 PORIN.","10.1073/PNAS.1602382113 ",1.45,18.21,"5fvn_oligo8","DKdopa2-6DGlcp[2<R1>,3<R2>,4P]b1-6DGlcp[2<R3>,3<R4>]a1-O4P1","KDO(3_O_)-Z9M(2_O_)-GP1(1_O_)",19.9806,"","",""
"5HUK","THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/NORTHERN PINTAIL/WASHINGTON/40964/2014 INFLUENZA VIRUS","10.1128/JVI.00180-16 ",2.45,46,"5huk_oligo3","DManpa1-2DManpa1-3[DManpa1-3DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_G_)-MAN(6_G_)-[MAN(5_G_)-MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(200_A_)",60.9379,"","",""
"5HUK","THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/NORTHERN PINTAIL/WASHINGTON/40964/2014 INFLUENZA VIRUS","10.1128/JVI.00180-16 ",2.45,46,"5huk_oligo7","DManpa1-2DManpa1-3[DManpa1-3DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_K_)-MAN(6_K_)-[MAN(5_K_)-MAN(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(200_C_)",70.9693,"","",""
"5HUK","THE CRYSTAL STRUCTURE OF NEURAMINIDASE FROM A/NORTHERN PINTAIL/WASHINGTON/40964/2014 INFLUENZA VIRUS","10.1128/JVI.00180-16 ",2.45,46,"5huk_oligo5","DManpa1-2DManpa1-3[DManpa1-3DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_I_)-MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(200_B_)",88.1809,"","",""
"5HVW","MONOMERIC IGG4 FC","10.1371/JOURNAL.PONE.0160345 ",1.95,66.13,"5hvw_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(9_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-[NAG(8_B_)-MAN(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(297_A_)",103.175,"","",""
"5HY9","GLYCOSYLATED, DISULFIDE-LINKED KNOB-INTO-HOLE FC FRAGMENT","10.1093/PROTEIN/GZX041 ",2.7,92.03,"5hy9_oligo1","DGalpb1-4DGlcpNAcb1-2DManpb1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_C_)-[GAL(6_C_)-NAG(5_C_)-BMA(4_C_)-[NAG(8_C_)-BMA(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",47.8242,"","",""
"5HYE","GLYCOSYLATED KNOB-KNOB FC FRAGMENT (P212121)","10.1093/PROTEIN/GZX041 ",1.89,62.68,"5hye_oligo1","DGalpb1-4DGlcpNAcb1-2DManpb1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_D_)-[GAL(6_D_)-NAG(5_D_)-BMA(4_D_)-[NAG(8_D_)-BMA(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_C_)",109.557,"","",""
"5HYF","GLYCOSYLATED KNOB-KNOB FC FRAGMENT (P6122)","10.1093/PROTEIN/GZX041 ",1.8,39.51,"5hyf_oligo1","DGalpb1-4DGlcpNAcb1-2DManpb1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_B_)-[GAL(6_B_)-NAG(5_B_)-BMA(4_B_)-[NAG(8_B_)-BMA(7_B_)]-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(297_A_)",54.3523,"","",""
"5IHR","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH ALLOLACTOSE","10.1111/FEBS.14083 ",2.4,21.7,"5ihr_oligo4","DGalpb1-6DGlcpa1-ROH","GAL(2_E_)-GLC(1_E_)",56.1705,"","",""
"5IW6","ANTI-CD20 MONOCLONAL ANTIBODY FC FRAGMENT","",2.34,58.38,"5iw6_oligo2","DGalpb1-4DGlcpNAcb1-2DManpb1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_D_)-NAG(5_D_)-BMA(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(320_B_)",98.8407,"","",""
"5IW6","ANTI-CD20 MONOCLONAL ANTIBODY FC FRAGMENT","",2.34,58.38,"5iw6_oligo1","DGalpb1-4DGlcpNAcb1-2DManpb1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","GAL(6_C_)-NAG(5_C_)-BMA(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(320_A_)",85.8538,"","",""
"5JDU","CRYSTAL STRUCTURE FOR HUMAN THROMBIN MUTANT D189A","10.1021/ACS.BIOCHEM.6B00385 ",1.7,27.94,"5jdu_oligo2","DGlcpNAcb1-6DGlcpNAcb1-ASN","NAG(2_F_)-NAG(1_F_)-ASN(60_D_)",37.9568,"","",""
"5JDU","CRYSTAL STRUCTURE FOR HUMAN THROMBIN MUTANT D189A","10.1021/ACS.BIOCHEM.6B00385 ",1.7,27.94,"5jdu_oligo1","DGlcpNAcb1-6DGlcpNAcb1-ASN","NAG(2_E_)-NAG(1_E_)-ASN(60_B_)",47.8895,"","",""
"5JOP","CRYSTAL STRUCTURE OF ANTI-GLYCAN ANTIBODY FAB14.22 IN COMPLEX WITH STREPTOCOCCUS PNEUMONIAE SEROTYPE 14 TETRASACCHARIDE AT 1.75 A","10.1172/JCI91192 ",1.75,0,"5jop_oligo2","DGalpb1-4DGlcpb1-6[DGalpb1-4]DGlcpNAcb1-ROH","GAL(3_B_)-BGC(2_B_)-[GAL(4_B_)]-NAG(1_B_)",23.367,"","",""
"5JOP","CRYSTAL STRUCTURE OF ANTI-GLYCAN ANTIBODY FAB14.22 IN COMPLEX WITH STREPTOCOCCUS PNEUMONIAE SEROTYPE 14 TETRASACCHARIDE AT 1.75 A","10.1172/JCI91192 ",1.75,0,"5jop_oligo1","DGalpb1-4DGlcpb1-6[DGalpb1-4]DGlcpNAcb1-ROH","GAL(3_A_)-BGC(2_A_)-[GAL(4_A_)]-NAG(1_A_)",32.1834,"","",""
"5JSD","CRYSTAL STRUCTURE OF PHIAB6 TAILSPIKE IN COMPLEX WITH FIVE-REPEATED OLIGOSACCHARIDES OF ACINETOBACTER BAUMANNII SURFACE POLYSACCHARIDE","10.1038/SREP42711 ",1.48,16.89,"5jsd_oligo5","DGalpb1-3DGalpNAcb1-3[6PZ2-6DGlcpb1-6]DGalpb1-3DGalpNAcb1-3[DGlcpb1-6]DGalpb1-ROH","BGC(8_G_)-[6PZ(7_G_)-BGC(6_G_)-[GAL(5_G_)-1GN(4_G_)]-GAL(3_G_)-1GN(2_G_)]-GAL(1_G_)",28.32,"","",""
"5JSD","CRYSTAL STRUCTURE OF PHIAB6 TAILSPIKE IN COMPLEX WITH FIVE-REPEATED OLIGOSACCHARIDES OF ACINETOBACTER BAUMANNII SURFACE POLYSACCHARIDE","10.1038/SREP42711 ",1.48,16.89,"5jsd_oligo1","DGlcpb1-6DGalpb1-3DGalpNAcb1-3[DGlcpb1-6]DGalpb1-3DGalpNAcb1-ROH","BGC(6_F_)-[BGC(5_F_)-GAL(4_F_)-1GN(3_F_)]-GAL(2_F_)-1GN(1_F_)",35.0727,"","",""
"5JSD","CRYSTAL STRUCTURE OF PHIAB6 TAILSPIKE IN COMPLEX WITH FIVE-REPEATED OLIGOSACCHARIDES OF ACINETOBACTER BAUMANNII SURFACE POLYSACCHARIDE","10.1038/SREP42711 ",1.48,16.89,"5jsd_oligo6","DGalpb1-3DGalpNAcb1-3[6PZ2-6DGlcpb1-6]DGalpb1-3DGalpNAcb1-3[DGlcpb1-6]DGalpb1-ROH","BGC(8_H_)-[6PZ(7_H_)-BGC(6_H_)-[GAL(5_H_)-1GN(4_H_)]-GAL(3_H_)-1GN(2_H_)]-GAL(1_H_)",28.1861,"","",""
"5JSD","CRYSTAL STRUCTURE OF PHIAB6 TAILSPIKE IN COMPLEX WITH FIVE-REPEATED OLIGOSACCHARIDES OF ACINETOBACTER BAUMANNII SURFACE POLYSACCHARIDE","10.1038/SREP42711 ",1.48,16.89,"5jsd_oligo3","DGlcpb1-6DGalpb1-3DGalpNAcb1-3[DGlcpb1-6]DGalpb1-3DGalpNAcb1-ROH","BGC(6_E_)-[BGC(5_E_)-GAL(4_E_)-1GN(3_E_)]-GAL(2_E_)-1GN(1_E_)",34.4485,"","",""
"5JSD","CRYSTAL STRUCTURE OF PHIAB6 TAILSPIKE IN COMPLEX WITH FIVE-REPEATED OLIGOSACCHARIDES OF ACINETOBACTER BAUMANNII SURFACE POLYSACCHARIDE","10.1038/SREP42711 ",1.48,16.89,"5jsd_oligo4","DGalpb1-3DGalpNAcb1-3[6PZ2-6DGlcpb1-6]DGalpb1-3DGalpNAcb1-3[DGlcpb1-6]DGalpb1-ROH","BGC(8_D_)-[6PZ(7_D_)-BGC(6_D_)-[GAL(5_D_)-1GN(4_D_)]-GAL(3_D_)-1GN(2_D_)]-GAL(1_D_)",28.0623,"","",""
"5JSD","CRYSTAL STRUCTURE OF PHIAB6 TAILSPIKE IN COMPLEX WITH FIVE-REPEATED OLIGOSACCHARIDES OF ACINETOBACTER BAUMANNII SURFACE POLYSACCHARIDE","10.1038/SREP42711 ",1.48,16.89,"5jsd_oligo2","DGlcpb1-6DGalpb1-3DGalpNAcb1-3[DGlcpb1-6]DGalpb1-3DGalpNAcb1-ROH","BGC(6_I_)-[BGC(5_I_)-GAL(4_I_)-1GN(3_I_)]-GAL(2_I_)-1GN(1_I_)",34.9621,"","",""
"5JSE","CRYSTAL STRUCTURE OF PHIAB6 TAILSPIKE IN COMPLEX WITH THREE-REPEATED OLIGOSACCHARIDES OF ACINETOBACTER BAUMANNII SURFACE POLYSACCHARIDE","10.1038/SREP42711 ",1.89,22.22,"5jse_oligo2","DGalpb1-3DGalpNAcb1-3[6PZ2-6DGlcpb1-6]DGalpb1-3DGalpNAcb1-3[DGlcpb1-6]DGalpb1-ROH","BGC(8_E_)-[6PZ(7_E_)-BGC(6_E_)-[GAL(5_E_)-1GN(4_E_)]-GAL(3_E_)-1GN(2_E_)]-GAL(1_E_)",49.378,"","",""
"5JSE","CRYSTAL STRUCTURE OF PHIAB6 TAILSPIKE IN COMPLEX WITH THREE-REPEATED OLIGOSACCHARIDES OF ACINETOBACTER BAUMANNII SURFACE POLYSACCHARIDE","10.1038/SREP42711 ",1.89,22.22,"5jse_oligo1","DGalpb1-3DGalpNAcb1-3[6PZ2-6DGlcpb1-6]DGalpb1-3DGalpNAcb1-3[DGlcpb1-6]DGalpb1-ROH","BGC(8_D_)-[6PZ(7_D_)-BGC(6_D_)-[GAL(5_D_)-1GN(4_D_)]-GAL(3_D_)-1GN(2_D_)]-GAL(1_D_)",49.7548,"","",""
"5JSE","CRYSTAL STRUCTURE OF PHIAB6 TAILSPIKE IN COMPLEX WITH THREE-REPEATED OLIGOSACCHARIDES OF ACINETOBACTER BAUMANNII SURFACE POLYSACCHARIDE","10.1038/SREP42711 ",1.89,22.22,"5jse_oligo3","DGalpb1-3DGalpNAcb1-3[6PZ2-6DGlcpb1-6]DGalpb1-3DGalpNAcb1-3[DGlcpb1-6]DGalpb1-ROH","BGC(8_F_)-[6PZ(7_F_)-BGC(6_F_)-[GAL(5_F_)-1GN(4_F_)]-GAL(3_F_)-1GN(2_F_)]-GAL(1_F_)",49.1276,"","",""
"5JUV","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH 6-B-GALACTOPYRANOSYL GALACTOSE","10.1111/FEBS.14083 ",2.27,23.5,"5juv_oligo4","DGalpb1-6DGalpb1-ROH","GAL(2_E_)-GAL(1_E_)",45.2923,"","",""
"5KVM","EXTRACELLULAR REGION OF MOUSE GPR56/ADGRG1 IN COMPLEX WITH FN3 MONOBODY","10.1016/J.NEURON.2016.08.022 ",2.45,0,"5kvm_oligo3","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_D_)-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(148_A_)",110.34,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo13","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_K_)-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(128_B_)",116.407,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo12","DManpb1-3DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_W_)-BMA(4_W_)-[BMA(6_W_)]-BMA(3_W_)-NAG(2_W_)-NAG(1_W_)-ASN(625_C_)",119.506,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo21","DManpb1-3[DManpb1-6]DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","BMA(6_Y_)-[BMA(5_Y_)]-BMA(4_Y_)-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(735_C_)",137.27,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo7","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_R_)-BMA(3_R_)-NAG(2_R_)-NAG(1_R_)-ASN(128_C_)",132.479,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo14","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_L_)-[BMA(4_L_)]-BMA(3_L_)-NAG(2_L_)-NAG(1_L_)-ASN(234_B_)",88.8476,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo2","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(128_A_)",92.6091,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo8","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_S_)-[BMA(4_S_)]-BMA(3_S_)-NAG(2_S_)-NAG(1_S_)-ASN(234_C_)",85.7215,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo5","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAca1-ASN","BMA(4_J_)-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(681_A_)",116.223,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo6","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(234_A_)",85.4498,"","",""
"5LHD","STRUCTURE OF GLYCOSYLATED HUMAN AMINOPEPTIDASE N","10.1038/SREP46045 ",2.6,0,"5lhd_oligo23","DManpb1-3DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_a_)-BMA(4_a_)-[BMA(6_a_)]-BMA(3_a_)-NAG(2_a_)-NAG(1_a_)-ASN(234_D_)",93.4405,"","",""
"5LJX","STRUCTURE OF HANTAVIRUS ENVELOPE GLYCOPROTEIN GC IN POSTFUSION CONFORMATION IN PRESENCE OF 600 MM KCL","10.1371/JOURNAL.PPAT.1005813 ",1.4,0,"5ljx_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(280_A_)",50.5161,"","",""
"5LJZ","STRUCTURE OF HANTAVIRUS ENVELOPE GLYCOPROTEIN GC IN POSTFUSION CONFORMATION","10.1371/JOURNAL.PPAT.1005813 ",1.6,0,"5ljz_oligo2","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(280_A_)",50.6327,"","",""
"5LK0","STRUCTURE OF HANTAVIRUS ENVELOPE GLYCOPROTEIN GC IN POSTFUSION CONFORMATION IN PRESENCE OF 100 MM KCL","10.1371/JOURNAL.PPAT.1005813 ",1.8,0,"5lk0_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(280_A_)",60.8933,"","",""
"5LK1","STRUCTURE OF HANTAVIRUS ENVELOPE GLYCOPROTEIN GC IN POSTFUSION CONFORMATION IN PRESENCE OF 200 MM KCL","10.1371/JOURNAL.PPAT.1005813 ",1.7,0,"5lk1_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(280_A_)",58.2691,"","",""
"5LK2","STRUCTURE OF HANTAVIRUS ENVELOPE GLYCOPROTEIN GC IN POSTFUSION CONFORMATION IN PRESENCE OF 300 MM KCL","10.1371/JOURNAL.PPAT.1005813 ",1.6,0,"5lk2_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(280_A_)",49.8667,"","",""
"5LK3","STRUCTURE OF HANTAVIRUS ENVELOPE GLYCOPROTEIN GC IN POSTFUSION CONFORMATION IN PRESENCE OF 500 MM KCL","10.1371/JOURNAL.PPAT.1005813 ",1.5,0,"5lk3_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(280_A_)",58.0427,"","",""
"5LKR","HUMAN BUTYRYLCHOLINESTERASE COMPLEXED WITH N-PROPARGYLIPERIDINES","10.1016/J.BMC.2016.11.032 ",2.52,0,"5lkr_oligo10","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_J_)-NAG(1_J_)-ASN(241_B_)",100.366,"","",""
"5M3V","BEAT FC","10.1074/JBC.M117.782433 ",1.97,56.56,"5m3v_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",64.1388,"","",""
"5M3V","BEAT FC","10.1074/JBC.M117.782433 ",1.97,56.56,"5m3v_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",127.389,"","",""
"5M5E","CRYSTAL STRUCTURE OF A INTERLEUKIN-2 VARIANT IN COMPLEX WITH INTERLEUKIN-2 RECEPTOR","10.1080/2162402X.2016.1277306 ",2.3,54.88,"5m5e_oligo2","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_A_)-[NAG(2_A_)]-NAG(1_A_)-ASN(45_B_)",58.4897,"","",""
"5M63","CRYSTAL STRUCTURE OF GROUP B STREPTOCOCCUS TYPE III DP2 OLIGOSACCHARIDE BOUND TO FAB NVS-1-19-5","10.1073/PNAS.1701885114 ",2.74,69.42,"5m63_oligo1","DNeup5Aca2-3DGalpb1-4[DGalpb1-4DGlcpb1-6]DGlcpNAcb1-3DGalpb1-4DGlcpb1-","GAL(7_B_)-BGC(6_B_)-[SIA(5_B_)-GAL(4_B_)]-NAG(3_B_)-GAL(2_B_)-BGC(1_B_)-7GW(304_H_)",108.403,"","",""
"5M63","CRYSTAL STRUCTURE OF GROUP B STREPTOCOCCUS TYPE III DP2 OLIGOSACCHARIDE BOUND TO FAB NVS-1-19-5","10.1073/PNAS.1701885114 ",2.74,69.42,"5m63_oligo4","DNeup5Aca2-3DGalpb1-4[DGalpb1-4DGlcpb1-6]DGlcpNAcb1-3DGalpb1-4DGlcpb1-","GAL(7_D_)-BGC(6_D_)-[SIA(5_D_)-GAL(4_D_)]-NAG(3_D_)-GAL(2_D_)-BGC(1_D_)-7GW(302_M_)",89.9555,"","",""
"5MGD","STRUCTURE OF E298Q-BETA-GALACTOSIDASE FROM ASPERGILLUS NIGER IN COMPLEX WITH 6-GALACTOSYL-LACTOSE","10.1111/FEBS.14083 ",2.15,28.76,"5mgd_oligo4","DGalpb1-6DGalpb1-4DGlcpa1-ROH","GAL(3_E_)-GAL(2_E_)-GLC(1_E_)",20,"","",""
"5MWF","HUMAN JAGGED2 C2-EGF2","10.15252/EMBJ.201796632 ",2.8,0,"5mwf_oligo5","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(153_E_)",101.917,"","",""
"5NAN","CRYSTAL STRUCTURE OF HUMAN IL-17AF IN COMPLEX WITH HUMAN IL-17RA","10.1038/S41598-017-08360-9 ",3.3,169.1,"5nan_oligo1","DGlcpNAcb1-4[DGalpb1-6]DGlcpNAcb1-ASN","GAL(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(83_F_)",235.809,"","",""
"5NQ7","CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS, IZOFORM I","10.1016/J.IJBIOMAC.2017.10.024 ",2.75,52.63,"5nq7_oligo2","DManpa1-3[DManpb1-6]DManp[2H]b1-3DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(6_C_)-[MAN(5_C_)--BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(398_A_)",134.018,"","",""
"5NSC","FC DEKK HETERODIMER VARIANT","10.1074/JBC.M117.793497 ",2.3,0,"5nsc_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_E_)-[GAL(6_E_)-NAG(5_E_)-MAN(4_E_)-[MAN(7_E_)]-BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(297_B_)",41.9274,"","",""
"5NUR","STRUCTURAL BASIS FOR MAINTENANCE OF BACTERIAL OUTER MEMBRANE LIPID ASYMMETRY","10.1038/S41564-017-0046-X ",3.29,0,"5nur_oligo3","DKdopa2-4DKdopa2-6DGlcpN[4P]b1-6DAllpNa1-O4P1","KDO(4_G_)-KDO(3_G_)-Z9M(2_G_)-GP1(1_G_)",212.167,"","",""
"5NUR","STRUCTURAL BASIS FOR MAINTENANCE OF BACTERIAL OUTER MEMBRANE LIPID ASYMMETRY","10.1038/S41564-017-0046-X ",3.29,0,"5nur_oligo2","KKdoDGlcpN[4P]b1-6DAllpNa1-O4P1","GP1(1_I_)-Z9M(2_I_)-KDO(3_I_)",185.236,"","",""
"5NUR","STRUCTURAL BASIS FOR MAINTENANCE OF BACTERIAL OUTER MEMBRANE LIPID ASYMMETRY","10.1038/S41564-017-0046-X ",3.29,0,"5nur_oligo1","KKdoDKdopa2-6DGlcpN[4P]b1-6DAllpNa1-O4P1","GP1(1_H_)-Z9M(2_H_)-KDO(3_H_)-KDO(4_H_)",160.378,"","",""
"5O32","THE STRUCTURE OF COMPLEMENT COMPLEX","10.1038/NSMB.3427 ",4.21,108.2,"5o32_oligo3","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_M_)-[BMA(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(85_E_)",153.757,"","",""
"5O32","THE STRUCTURE OF COMPLEMENT COMPLEX","10.1038/NSMB.3427 ",4.21,108.2,"5o32_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_K_)-[BMA(4_K_)]-BMA(3_K_)-NAG(2_K_)-NAG(1_K_)-ASN(85_A_)",133.796,"","",""
"5TO3","CRYSTAL STRUCTURE OF THROMBIN MUTANT W215A/E217A FUSED TO EGF456 OF THROMBOMODULIN VIA A 31-RESIDUE LINKER AND BOUND TO PPACK","10.1038/SREP44596 ",2.34,47.7,"5to3_oligo1","DGlcpNAcb1-4DManpb1-4DManpb1-4DManpa1-4[DManpb1-6]DManpb1-4DGlcpNAcb1-ASN","BMA(7_C_)-[NAG(6_C_)-BMA(5_C_)-BMA(4_C_)-MAN(3_C_)]-BMA(2_C_)-NAG(1_C_)-ASN(364_B_)",75.9236,"","",""
"5TV4","3D CRYO-EM RECONSTRUCTION OF NUCLEOTIDE-FREE MSBA IN LIPID NANODISC","10.1038/NATURE23649 ",4.2,0,"5tv4_oligo1","GMH1-7GMH1-3GMH1-5[DKdopa2-4]DKdopa2-6DGlcp[2<R1>,3<R2>,4P]b1-6DGlcp[2<R3>,3<R4>]a1-O4P1","GMH(6_C_)-GMH(5_C_)-GMH(4_C_)-[KDO(7_C_)]-KDO(3_C_)-PA1(2_C_)-PA1(1_C_)",20,"","",""
"5TZN","STRUCTURE OF THE VIRAL IMMUNOEVASIN M12 (SMITH) BOUND TO THE NATURAL KILLER CELL RECEPTOR NKR-P1B (B6)","10.1016/J.CELL.2017.03.002 ",2.6,40.65,"5tzn_oligo5","DManpb1-6DManpb1-3DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(97_G_)",78.7393,"","",""
"5UWC","CYTOKINE-RECEPTOR COMPLEX","10.1038/S41467-017-02633-7 ",2.4,70.84,"5uwc_oligo4","LFucpb1-6DGlcpNAcx1-","FUL(3_A_)-NAG(1_A_)",117.518,"","",""
"5VH5","CRYSTAL STRUCTURE OF FC FRAGMENT OF ANTI-TNFA ANTIBODY INFLIXIMAB","10.1080/19420862.2017.1320463 ",1.75,39.71,"5vh5_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6DManp[3<R1>]b1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_B_)-[GAL(6_B_)-NAG(5_B_)-MAN(4_B_)-BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(300_A_)",57.0187,"","",""
"5VKI","CRYSTAL STRUCTURE OF P[19] ROTAVIRUS VP8* COMPLEXED WITH MUCIN CORE 2","10.1371/JOURNAL.PPAT.1006707 ",1.9,26.89,"5vki_oligo2","DGalpb1-3[DGlcpNAcb1-6]DGalpNAcb1-THR","NAG(3_D_)-[GAL(2_D_)]-NGA(1_D_)-THR(303_B_)",41.343,"","",""
"5VKI","CRYSTAL STRUCTURE OF P[19] ROTAVIRUS VP8* COMPLEXED WITH MUCIN CORE 2","10.1371/JOURNAL.PPAT.1006707 ",1.9,26.89,"5vki_oligo1","DGalpb1-3[DGlcpNAcb1-6]DGalpNAcb1-THR","NAG(3_C_)-[GAL(2_C_)]-NGA(1_C_)-THR(303_A_)",41.5703,"","",""
"5W7B","RABBIT ACYLOXYACYL HYDROLASE (AOAH), PROTEOLYTICALLY PROCESSED, S262A MUTANT, WITH LPS","10.1073/PNAS.1719834115 ",1.9,0,"5w7b_oligo3","DKdopa2-6DGlcp[2<R1>,4P]b1-6DGlcp[2<R2>,3<R3>]a1-O4P1","KDO(3_J_)-GCS(2_J_)-PA1(1_J_)-PO4(620_D_)",71.4153,"","",""
"5W7B","RABBIT ACYLOXYACYL HYDROLASE (AOAH), PROTEOLYTICALLY PROCESSED, S262A MUTANT, WITH LPS","10.1073/PNAS.1719834115 ",1.9,0,"5w7b_oligo7","DKdopa2-6DGlcp[2<R1>,4P]b1-6DGlcp[2<R2>,3<R3>]a1-O4P1","KDO(3_F_)-GCS(2_F_)-PA1(1_F_)-PO4(626_C_)",58.899,"","",""
"5WAV","FC ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY.","",2.6,58.2,"5wav_oligo2","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_D_)-[NAG(7_D_)-MAN(6_D_)-[NAG(5_D_)-MAN(4_D_)]-MAN(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",98.6161,"","",""
"5WAV","FC ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY.","",2.6,58.2,"5wav_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpa1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-MAN(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",63.6848,"","",""
"5X0M","STRUCTURE OF A EUKARYOTIC VOLTAGE-GATED SODIUM CHANNEL AT NEAR ATOMIC RESOLUTION","10.1126/SCIENCE.AAL4326 ",3.8,0,"5x0m_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(330_A_)",166.845,"","",""
"5XJY","CRYO-EM STRUCTURE OF HUMAN ABCA1","10.1016/J.CELL.2017.05.020 ",4.1,0,"5xjy_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(1504_A_)",60.3313,"","",""
"5XSY","STRUCTURE OF THE NAV1.4-BETA1 COMPLEX FROM ELECTRIC EEL","10.1016/J.CELL.2017.06.039 ",4,0,"5xsy_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(317_A_)",185.607,"","",""
"5Y56","FC MUTANT (K392D/K409D/D399K)","10.1074/JBC.M116.771188 ",2.65,0,"5y56_oligo2","DGalpb1-4DGlcpNAca1-2DManpa1-6[DGlcpNAcb1-2DManpb1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_C_)-[GAL(6_C_)-NDG(5_C_)-MAN(4_C_)-[NAG(8_C_)-BMA(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",121.516,"","",""
"5YMS","STRUCTURAL BASIS OF GLYCAN SPECIFICITY AND IDENTIFICATION OF A NOVEL GLYCAN BINDING CAVITY IN HUMAN P[19] ROTAVIRUS","10.1128/JVI.00538-18 ",2.1,31.9,"5yms_oligo2","DGalpb1-3[DGlcpNAcb1-6]DGalpNAca1-ROH","NAG(3_J_)-[GAL(2_J_)]-A2G(1_J_)",67.2421,"","",""
"5YMS","STRUCTURAL BASIS OF GLYCAN SPECIFICITY AND IDENTIFICATION OF A NOVEL GLYCAN BINDING CAVITY IN HUMAN P[19] ROTAVIRUS","10.1128/JVI.00538-18 ",2.1,31.9,"5yms_oligo1","DGalpb1-3[DGlcpNAcb1-6]DGalpNAca1-ROH","NAG(3_I_)-[GAL(2_I_)]-A2G(1_I_)",68.3485,"","",""
"6B3M","THE CRYSTAL STRUCTURE OF A BROADLY-REACTIVE HUMAN ANTI-HEMAGGLUTININ STALK ANTIBODY (70-1F02) IN COMPLEX WITH H5 HEMAGGLUTININ","10.1128/JVI.00949-18 ",3.92,60.36,"6b3m_oligo14","DManpa1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAca1-ASN","BMA(5_l_)-[MAN(4_l_)]-MAN(3_l_)-NAG(2_l_)-NAG(1_l_)-ASN(286_Q_)",72.0587,"","",""
"6BE4","CRYSTAL STRUCTURE OF A POLYSACCHARIDE-BINDING HUMAN FAB (F598) IN COMPLEX WITH NONA-N-ACETYL-D-GLUCOSAMINE (9NAC)","10.1074/JBC.RA117.001170 ",1.9,0,"6be4_oligo1","DGlcpNAcb1-6DGlcpNAcb1-6DGlcpNAcb1-6DGlcpNAcb1-6DGlcpNAcb1-ROH","NAG(5_A_)-NAG(4_A_)-NAG(3_A_)-NAG(2_A_)-NAG(1_A_)",26.9316,"","",""
"6BHQ","MOUSE IMMUNOGLOBULIN G 2C FC FRAGMENT WITH COMPLEX-TYPE GLYCAN","10.1371/JOURNAL.PONE.0192123 ",2.05,0,"6bhq_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(8_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",99.2546,"","",""
"6BHQ","MOUSE IMMUNOGLOBULIN G 2C FC FRAGMENT WITH COMPLEX-TYPE GLYCAN","10.1371/JOURNAL.PONE.0192123 ",2.05,0,"6bhq_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",59.9193,"","",""
"6BPP","E. COLI MSBA IN COMPLEX WITH LPS AND INHIBITOR G092","10.1038/S41586-018-0083-5 ",2.92,0,"6bpp_oligo1","DGlcpa1-3[DGlcpa1-6]DGlcpa1-3[GMH1-7]GMH1-3GMH1-5[DKdopa2-4]DKdopa2-6DGlcp[2<R1>,3<R2>,4P]b1-6DGlcp[2<R3>,3<R4>]a1-O4P1","GMH(9_C_)-[GLC(8_C_)-[GLC(7_C_)]-GLC(6_C_)]-GMH(5_C_)-GMH(4_C_)-[KDO(10_C_)]-KDO(3_C_)-GCS(2_C_)-PA1(1_C_)",142.913,"","",""
"6C26","THE CRYO-EM STRUCTURE OF A EUKARYOTIC OLIGOSACCHARYL TRANSFERASE COMPLEX","10.1038/NATURE25755 ",3.5,"1.35632e-19","6c26_oligo1","DManpb1-2DManpb1-2DManpb1-2[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(7_D_)-[BMA(6_D_)-BMA(5_D_)-BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(539_A_)",52.3196,"","",""
"6C5H","S25-5 FAB IN COMPLEX WITH CHLAMYDIACEAE-SPECIFIC LPS ANTIGEN","10.1021/ACS.BIOCHEM.8B00318 ",1.99,30.01,"6c5h_oligo1","DKdopa2-8DKdopa2-4DKdopa2-6DGlcpN[4P]b1-6DGlcpNa1-O4P1","KDO(5_B_)-KDO(4_B_)-KDO(3_B_)-Z9M(2_B_)-GP1(1_B_)",29.5294,"","",""
"6C5J","S25-23 FAB IN COMPLEX WITH CHLAMYDIACEAE LPS (CRYSTAL FORM 1)","10.1021/ACS.BIOCHEM.8B00318 ",2.29,53.07,"6c5j_oligo2","DKdopa2-8DKdopa2-4DKdopa2-6DGlcpN[4P]b1-6DGlcpNa1-O4P1","KDO(5_A_)-KDO(4_A_)-KDO(3_A_)-Z9M(2_A_)-GP1(1_A_)",60.7896,"","",""
"6C5K","S25-23 FAB IN COMPLEX WITH CHLAMYDIACEAE LPS (CRYSTAL FORM 2)","10.1021/ACS.BIOCHEM.8B00318 ",1.75,25.91,"6c5k_oligo6","DKdopa2-8DKdopa2-4DKdopa2-6DGlcpN[4P]b1-6DGlcpNa1-O4P1","KDO(5_F_)-KDO(4_F_)-KDO(3_F_)-Z9M(2_F_)-GP1(1_F_)",25.9317,"","",""
"6C5K","S25-23 FAB IN COMPLEX WITH CHLAMYDIACEAE LPS (CRYSTAL FORM 2)","10.1021/ACS.BIOCHEM.8B00318 ",1.75,25.91,"6c5k_oligo4","DKdopa2-8DKdopa2-4DKdopa2-6DGlcpN[4P]b1-6DGlcpNa1-O4P1","KDO(5_D_)-KDO(4_D_)-KDO(3_D_)-Z9M(2_D_)-GP1(1_D_)",33.9602,"","",""
"6DCQ","ECTODOMAIN OF FULL LENGTH, WILD TYPE HIV-1 GLYCOPROTEIN CLONE PC64M18C043 IN COMPLEX WITH PGT151 FAB","10.1016/J.CELREP.2018.05.046 ",3.1,"8.10669e+08","6dcq_oligo28","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_f_)-[GAL(8_f_)-NAG(7_f_)-[GAL(6_f_)-NAG(5_f_)]-MAN(4_f_)-[MAN(9_f_)]-BMA(3_f_)-NAG(2_f_)]-NAG(1_f_)-ASN(611_D_)",69.7595,"","",""
"6DCQ","ECTODOMAIN OF FULL LENGTH, WILD TYPE HIV-1 GLYCOPROTEIN CLONE PC64M18C043 IN COMPLEX WITH PGT151 FAB","10.1016/J.CELREP.2018.05.046 ",3.1,"8.10669e+08","6dcq_oligo27","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-6]DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(9_s_)-[GAL(8_s_)-NAG(7_s_)-[GAL(6_s_)-NAG(5_s_)]-MAN(4_s_)-BMA(3_s_)-NAG(2_s_)]-NAG(1_s_)-ASN(611_F_)",76.7788,"","",""
"6DFE","THE STRUCTURE OF A TERNARY COMPLEX OF E. COLI WAAC","10.1016/J.STR.2018.07.001 ",2.31,46.93,"6dfe_oligo6","DKdopa2-4DKdopa2-6DGlcpNAc[4P]b1-6DGlcpNAca1-O4P1","KDO(4_C_)-KDO(3_C_)-GN4(2_C_)-GN1(1_C_)",75.8503,"","",""
"6DFE","THE STRUCTURE OF A TERNARY COMPLEX OF E. COLI WAAC","10.1016/J.STR.2018.07.001 ",2.31,46.93,"6dfe_oligo5","DKdopa2-4DKdopa2-6DGlcpNAc[4P]b1-6DGlcpNAca1-O4P1","KDO(4_D_)-KDO(3_D_)-GN4(2_D_)-GN1(1_D_)",80.5038,"","",""
"6EGT","STRUCTURE OF RVFV ENVELOPE PROTEIN GC IN POSTFUSION CONFORMATION IN COMPLEX WITH MES","10.1126/SCIENCE.AAL2712 ",2.5,0,"6egt_oligo3","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_D_)-NAG(1_D_)-ASN(1077_A_)",63.9286,"","",""
"6EGU","STRUCTURE OF RVFV ENVELOPE PROTEIN GC IN POSTFUSION CONFORMATION IN COMPLEX WITH 1,2-DIPROPIONYL-SN-GLYCERO-3-PHOSPHOCHOLINE","10.1126/SCIENCE.AAL2712 ",2.3,0,"6egu_oligo1","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_D_)-NAG(1_D_)-ASN(1077_A_)",63.5386,"","",""
"6EGU","STRUCTURE OF RVFV ENVELOPE PROTEIN GC IN POSTFUSION CONFORMATION IN COMPLEX WITH 1,2-DIPROPIONYL-SN-GLYCERO-3-PHOSPHOCHOLINE","10.1126/SCIENCE.AAL2712 ",2.3,0,"6egu_oligo2","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_E_)-NAG(1_E_)-ASN(1077_B_)",64.4873,"","",""
"6EP4","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH DECAMETHONIUM","10.3390/MOLECULES22122098 ",2.3,49.96,"6ep4_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(241_A_)",105.954,"","",""
"6EP4","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH DECAMETHONIUM","10.3390/MOLECULES22122098 ",2.3,49.96,"6ep4_oligo2","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(341_A_)",81.793,"","",""
"6EPK","CRYSTAL STRUCTURE OF THE PRECURSOR MEMBRANE PROTEIN-ENVELOPE PROTEIN HETERODIMER FROM THE YELLOW FEVER VIRUS","10.1128/MBIO.00706-23 ",2.7,0,"6epk_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_H_)-[MAN(5_H_)-[MAN(4_H_)]-BMA(3_H_)-NAG(2_H_)]-NAG(1_H_)-ASN(529_E_)",103.334,"","",""
"6EPK","CRYSTAL STRUCTURE OF THE PRECURSOR MEMBRANE PROTEIN-ENVELOPE PROTEIN HETERODIMER FROM THE YELLOW FEVER VIRUS","10.1128/MBIO.00706-23 ",2.7,0,"6epk_oligo3","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(6_F_)-[MAN(5_F_)-[MAN(4_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(529_B_)",96.4894,"","",""
"6EQP","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH ETHOPROPAZINE","10.3390/MOLECULES22122098 ",2.35,57.56,"6eqp_oligo2","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(341_A_)",86.9739,"","",""
"6EQP","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH ETHOPROPAZINE","10.3390/MOLECULES22122098 ",2.35,57.56,"6eqp_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(241_A_)",116.896,"","",""
"6EQQ","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH HUPRINE 19","10.3390/MOLECULES22122098 ",2.4,60.38,"6eqq_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_B_)-[NAG(2_B_)]-NAG(1_B_)-ASN(341_A_)",84.7976,"","",""
"6EQQ","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH HUPRINE 19","10.3390/MOLECULES22122098 ",2.4,60.38,"6eqq_oligo2","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_C_)-NAG(1_C_)-ASN(241_A_)",103.081,"","",""
"6ESY","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH THIOFLAVINE T","10.3390/MOLECULES22122098 ",2.8,0,"6esy_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(57_A_)",163.903,"","",""
"6ESY","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH THIOFLAVINE T","10.3390/MOLECULES22122098 ",2.8,0,"6esy_oligo6","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(241_B_)",125.083,"","",""
"6ESY","HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH THIOFLAVINE T","10.3390/MOLECULES22122098 ",2.8,0,"6esy_oligo2","LFucpb1-6DGlcpNAcb1-ASN","FUC(2_F_)-NAG(1_F_)-ASN(486_A_)",170.514,"","",""
"6EUF","THE GH43, BETA 1,3 GALACTOSIDASE, BT0265","10.1038/S41564-018-0258-8 ",2.2,36.98,"6euf_oligo2","[LArafa1-3][LArafa1-4]DGalpb1-6DGalpb1-ROH","RAM(4_F_)-BDP(3_F_)-[AHR(6_F_)]-[AHR(5_F_)]-GAL(2_F_)-GAL(1_F_)",54.6592,"","",""
"6EUF","THE GH43, BETA 1,3 GALACTOSIDASE, BT0265","10.1038/S41564-018-0258-8 ",2.2,36.98,"6euf_oligo4","LArafa1-3[LArafa1-4][DGlcpAb1-6]DGalpb1-6DGalpb1-ROH","BDP(5_H_)-[AHR(4_H_)]-[AHR(3_H_)]-GAL(2_H_)-GAL(1_H_)",56.3538,"","",""
"6EUF","THE GH43, BETA 1,3 GALACTOSIDASE, BT0265","10.1038/S41564-018-0258-8 ",2.2,36.98,"6euf_oligo1","LArafa1-3[LArafa1-4][DGlcpAb1-6]DGalpb1-6DGalpb1-ROH","BDP(5_E_)-[AHR(4_E_)]-[AHR(3_E_)]-GAL(2_E_)-GAL(1_E_)",53.2694,"","",""
"6EUF","THE GH43, BETA 1,3 GALACTOSIDASE, BT0265","10.1038/S41564-018-0258-8 ",2.2,36.98,"6euf_oligo3","[LArafa1-3][LArafa1-4]DGalpb1-6DGalpb1-ROH","RAM(4_G_)-BDP(3_G_)-[AHR(6_G_)]-[AHR(5_G_)]-GAL(2_G_)-GAL(1_G_)",61.368,"","",""
"6F02","CRYSTAL STRUCTURE OF HUMAN GLYCOSYLATED KALLISTATIN AT 3.0 ANGSTROM RESOLUTION","",3,86.63,"6f02_oligo4","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_F_)-NAG(1_F_)-ASN(108_C_)",142.724,"","",""
"6F02","CRYSTAL STRUCTURE OF HUMAN GLYCOSYLATED KALLISTATIN AT 3.0 ANGSTROM RESOLUTION","",3,86.63,"6f02_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_B_)-[BMA(3_B_)-NAG(2_B_)]-NAG(1_B_)-ASN(157_A_)",101.353,"","",""
"6F02","CRYSTAL STRUCTURE OF HUMAN GLYCOSYLATED KALLISTATIN AT 3.0 ANGSTROM RESOLUTION","",3,86.63,"6f02_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(108_A_)",120.008,"","",""
"6F02","CRYSTAL STRUCTURE OF HUMAN GLYCOSYLATED KALLISTATIN AT 3.0 ANGSTROM RESOLUTION","",3,86.63,"6f02_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_E_)-[BMA(3_E_)-NAG(2_E_)]-NAG(1_E_)-ASN(157_C_)",95.8091,"","",""
"6F25","CRYSTAL STRUCTURE OF HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH C35.","10.1016/J.NEUROPHARM.2019.05.025 ",3.05,80.71,"6f25_oligo5","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(350_B_)",135.626,"","",""
"6F25","CRYSTAL STRUCTURE OF HUMAN ACETYLCHOLINESTERASE IN COMPLEX WITH C35.","10.1016/J.NEUROPHARM.2019.05.025 ",3.05,80.71,"6f25_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_C_)-[NAG(2_C_)]-NAG(1_C_)-ASN(350_A_)",124.644,"","",""
"6F2Z","STRUCTURE OF A FC MUTANT","",2.3,53.42,"6f2z_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_A_)",60.2502,"","",""
"6F7Q","HUMAN BUTYRYLCHOLINESTERASE COMPLEXED WITH N-PROPARGYLIPERIDINES","10.1016/J.EJMECH.2018.07.033 ",2.6,0,"6f7q_oligo4","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(3_E_)-[NAG(2_E_)]-NAG(1_E_)",111.445,"","",""
"6F7Q","HUMAN BUTYRYLCHOLINESTERASE COMPLEXED WITH N-PROPARGYLIPERIDINES","10.1016/J.EJMECH.2018.07.033 ",2.6,0,"6f7q_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(241_A_)",123.798,"","",""
"6F7Q","HUMAN BUTYRYLCHOLINESTERASE COMPLEXED WITH N-PROPARGYLIPERIDINES","10.1016/J.EJMECH.2018.07.033 ",2.6,0,"6f7q_oligo10","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(241_B_)",121.032,"","",""
"6F7Q","HUMAN BUTYRYLCHOLINESTERASE COMPLEXED WITH N-PROPARGYLIPERIDINES","10.1016/J.EJMECH.2018.07.033 ",2.6,0,"6f7q_oligo6","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_C_)-NAG(1_C_)-ASN(57_A_)",93.405,"","",""
"6FJ3","HIGH RESOLUTION CRYSTAL STRUCTURE OF PARATHYROID HORMONE 1 RECEPTOR IN COMPLEX WITH A PEPTIDE AGONIST.","10.1038/S41594-018-0151-4 ",2.5,0,"6fj3_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUC(4_D_)-[BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)",103.195,"","",""
"6FJ3","HIGH RESOLUTION CRYSTAL STRUCTURE OF PARATHYROID HORMONE 1 RECEPTOR IN COMPLEX WITH A PEPTIDE AGONIST.","10.1038/S41594-018-0151-4 ",2.5,0,"6fj3_oligo1","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUC(6_C_)-[MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)",77.5261,"","",""
"6G1E","BEAT FC WITH IMPROVED HETERODIMERIZATION (Q3A-D84.4Q)","10.1074/JBC.RA119.012335 ",1.88,56.12,"6g1e_oligo2","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_C_)-[GAL(6_C_)-NAG(5_C_)-MAN(4_C_)-[NAG(8_C_)-MAN(7_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",71.6165,"","",""
"6G1E","BEAT FC WITH IMPROVED HETERODIMERIZATION (Q3A-D84.4Q)","10.1074/JBC.RA119.012335 ",1.88,56.12,"6g1e_oligo1","DGalpb1-4DGlcpNAcb1-2DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(9_D_)-[GAL(6_D_)-NAG(5_D_)-MAN(4_D_)-[NAG(8_D_)-MAN(7_D_)]-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(297_B_)",95.0465,"","",""
"6H0H","THE ABC TRANSPORTER ASSOCIATED BINDING PROTEIN FROM B. ANIMALIS SUBSP. LACTIS BL-04 IN COMPLEX WITH BETA-1,6-GALACTOBIOSE","10.1074/JBC.RA119.008843 ",1.39,0,"6h0h_oligo2","DGalpb1-6DGalpb1-ROH","GAL(2_D_)-GAL(1_D_)",7.70182,"","",""
"6H0H","THE ABC TRANSPORTER ASSOCIATED BINDING PROTEIN FROM B. ANIMALIS SUBSP. LACTIS BL-04 IN COMPLEX WITH BETA-1,6-GALACTOBIOSE","10.1074/JBC.RA119.008843 ",1.39,0,"6h0h_oligo1","DGalpb1-6DGalpb1-ROH","GAL(2_C_)-GAL(1_C_)",6.47364,"","",""
"6IAL","PORCINE E.COLI HEAT-LABILE ENTEROTOXIN B-PENTAMER IN COMPLEX WITH LACTO-N-NEOHEXAOSE","10.3390/IJMS20030703 ",1.45,18.48,"6ial_oligo2","DGalpb1-4DGlcpNAcb1-3[DGalpb1-4DGlcpNAcb1-6]DGalpb1-4DGlcpb1-ROH","GAL(6_L_)-NAG(5_L_)-[GAL(4_L_)-NAG(3_L_)]-GAL(2_L_)-BGC(1_L_)",22.3283,"","",""
"6IAL","PORCINE E.COLI HEAT-LABILE ENTEROTOXIN B-PENTAMER IN COMPLEX WITH LACTO-N-NEOHEXAOSE","10.3390/IJMS20030703 ",1.45,18.48,"6ial_oligo1","DGalpb1-4DGlcpNAcb1-3[DGalpb1-4DGlcpNAcb1-6]DGalpb1-4DGlcpb1-ROH","GAL(6_K_)-NAG(5_K_)-[GAL(4_K_)-NAG(3_K_)]-GAL(2_K_)-BGC(1_K_)",21.8977,"","",""
"6IDF","CRYO-EM STRUCTURE OF GAMMA SECRETASE IN COMPLEX WITH A NOTCH FRAGMENT","10.1038/S41586-018-0813-8 ",2.7,"1.35632e-19","6idf_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[BMA(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(55_A_)",70.3275,"","",""
"6IK8","CRYSTAL STRUCTURE OF TOMATO BETA-GALACTOSIDASE (TBG) 4 IN COMPLEX WITH BETA-1,6-GALACTOBIOSE","10.1007/S00425-020-03481-4 ",2.8,52.38,"6ik8_oligo2","DGalpb1-6DGalpb1-ROH","GAL(2_D_)-GAL(1_D_)",95.6668,"","",""
"6IK8","CRYSTAL STRUCTURE OF TOMATO BETA-GALACTOSIDASE (TBG) 4 IN COMPLEX WITH BETA-1,6-GALACTOBIOSE","10.1007/S00425-020-03481-4 ",2.8,52.38,"6ik8_oligo4","DGalpb1-6DGalpb1-ROH","GAL(2_F_)-GAL(1_F_)",98.4273,"","",""
"6IYC","RECOGNITION OF THE AMYLOID PRECURSOR PROTEIN BY HUMAN GAMMA-SECRETASE","10.1126/SCIENCE.AAW0930 ",2.6,"1.57771e-19","6iyc_oligo3","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[BMA(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(55_A_)",64.7514,"","",""
"6JYS","GII.13/21 NOROVIRUSES RECOGNIZE GLYCANS WITH A TERMINAL BETA-GALACTOSE VIA AN UNCONVENTIONAL GLYCAN BINDING SITE","10.1128/JVI.00723-19 ",1.7,18.97,"6jys_oligo1","DGalpb1-3[DGlcpNAcb1-6]DGalpNAca1-THR","NAG(3_F_)-[GAL(2_F_)]-A2G(1_F_)-THR(404_B_)",18.5264,"","",""
"6K2N","STRUCTURAL BASIS OF GLYCAN RECOGNITION IN GLOBALLY PREDOMINANT HUMAN P[8] ROTAVIRUS","10.1007/S12250-019-00164-7 ",1.8,24.85,"6k2n_oligo1","DGalpb1-3[DGlcpNAcb1-6]DGalpNAca1-ROH","NAG(3_H_)-[GAL(2_H_)]-A2G(1_H_)",57.2206,"","",""
"6K2N","STRUCTURAL BASIS OF GLYCAN RECOGNITION IN GLOBALLY PREDOMINANT HUMAN P[8] ROTAVIRUS","10.1007/S12250-019-00164-7 ",1.8,24.85,"6k2n_oligo2","DGalpb1-3[DGlcpNAcb1-6]DGalpNAca1-ROH","NAG(3_G_)-[GAL(2_G_)]-A2G(1_G_)",62.9949,"","",""
"6LQG","HUMAN GAMMA-SECRETASE IN COMPLEX WITH SMALL MOLECULE AVAGACESTAT","10.1016/J.CELL.2020.11.049 ",3.1,"1.08527e-19","6lqg_oligo5","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(55_A_)",73.1962,"","",""
"6LR4","MOLECULAR BASIS FOR INHIBITION OF HUMAN GAMMA-SECRETASE BY SMALL MOLECULE","10.1016/J.CELL.2020.11.049 ",3,"1.08527e-19","6lr4_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(55_A_)",84.3891,"","",""
"6MAR","HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 DELCT N332T IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY FAB PGT151","10.1038/S41467-018-06121-4 ",4.5,"1.08527e-19","6mar_oligo30","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_n_)-[GAL(8_n_)-NAG(7_n_)-[GAL(6_n_)-NAG(5_n_)]-MAN(4_n_)-[MAN(9_n_)]-BMA(3_n_)-NAG(2_n_)]-NAG(1_n_)-ASN(611_F_)",146.443,"","",""
"6MAR","HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 DELCT N332T IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY FAB PGT151","10.1038/S41467-018-06121-4 ",4.5,"1.08527e-19","6mar_oligo17","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-6]DManpa1-6[DGlcpNAcb1-2DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(11_T_)-[GAL(8_T_)-NAG(7_T_)-[GAL(6_T_)-NAG(5_T_)]-MAN(4_T_)-[NAG(10_T_)-MAN(9_T_)]-BMA(3_T_)-NAG(2_T_)]-NAG(1_T_)-ASN(611_B_)",188.354,"","",""
"6MK0","INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO ANTAGONIST TDI-4161","10.1021/ACSPTSCI.9B00041 ",3.01,56.99,"6mk0_oligo2","DManpa1-4DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-BMA(4_D_)-[MAN(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(266_A_)",56.2542,"","",""
"6MSL","INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO EETI-II 2.5D","10.1016/J.STR.2019.06.011 ",3.1,62.24,"6msl_oligo3","DManpa1-4DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-BMA(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(266_A_)",71.875,"","",""
"6MSU","INTEGRIN ALPHAVBETA3 IN COMPLEX WITH EETI-II 2.5F","10.1016/J.STR.2019.06.011 ",3.11,0,"6msu_oligo2","DManpa1-4DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_F_)-BMA(4_F_)-[MAN(6_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(266_A_)",68.6494,"","",""
"6N9T","STRUCTURE OF A PEPTIDE-BASED PHOTO-AFFINITY CROSS-LINKER WITH HERCEPTIN FC","10.1021/ACS.BIOCONJCHEM.8B00809 ",2.58,0,"6n9t_oligo2","DGlcpNAcb1-2DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(7_C_)-[NAG(5_C_)-MAN(4_C_)-[MAN(6_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_A_)",55.6258,"","",""
"6NAJ","INTEGRIN ALPHAVBETA3 ECTODOMAIN BOUND TO HR10 VARIANT OF THE 10TH DOMAIN OF FIBRONECTIN.","10.1038/S41467-019-13928-2 ",3.1,0,"6naj_oligo4","DManpa1-4DManpb1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_E_)-BMA(4_E_)-[MAN(6_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(266_A_)",68.6142,"","",""
"6NSC","CRYSTAL STRUCTURE OF THE A/BRISBANE/10/2007 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G186V/L194P MUTANT APO FORM","10.1016/J.CHOM.2019.04.013 ",2.25,64.91,"6nsc_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(63_A_)",106.8,"","",""
"6NSF","CRYSTAL STRUCTURE OF THE A/BRISBANE/10/2007 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G186V/L194P MUTANT IN COMPLEX WITH 3'-SLNLN","10.1016/J.CHOM.2019.04.013 ",2.1,51.46,"6nsf_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(63_A_)",87.9264,"","",""
"6NSG","CRYSTAL STRUCTURE OF THE A/BRISBANE/10/2007 (H3N2) INFLUENZA VIRUS HEMAGGLUTININ G186V/L194P MUTANT IN COMPLEX WITH 6'-SLNLN","10.1016/J.CHOM.2019.04.013 ",2.4,71.07,"6nsg_oligo1","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_D_)-[NAG(2_D_)]-NAG(1_D_)-ASN(63_A_)",113.726,"","",""
"6NT3","CRYO-EM STRUCTURE OF A HUMAN-COCKROACH HYBRID NAV CHANNEL.","",3.4,"1.15243e-41","6nt3_oligo8","DManpb1-3[DManpb1-6]DManpb1-3DGlcpNAcb1-3DGlcpNAcb1-ASN","BMA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(330_A_)",113.85,"","",""
"6NT4","CRYO-EM STRUCTURE OF A HUMAN-COCKROACH HYBRID NAV CHANNEL BOUND TO ALPHA-SCORPION TOXIN AAH2.","10.1126/SCIENCE.AAV8573 ",3.5,"1.15243e-41","6nt4_oligo1","DManpb1-3[DManpb1-6]DManpb1-3DGlcpNAcb1-3DGlcpNAcb1-ASN","BMA(5_D_)-[BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(330_A_)",95.5116,"","",""
"6OLP","FULL LENGTH HIV-1 ENV AMC011 IN COMPLEX WITH PGT151 FAB","10.1371/JOURNAL.PPAT.1007920 ",4.2,0,"6olp_oligo7","DGalpb1-4DGlcpNAcb1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_W_)-[GAL(6_W_)-NAG(5_W_)-MAN(4_W_)-[MAN(7_W_)]-BMA(3_W_)-NAG(2_W_)]-NAG(1_W_)-ASN(611_B_)",97.6494,"","",""
"6OLP","FULL LENGTH HIV-1 ENV AMC011 IN COMPLEX WITH PGT151 FAB","10.1371/JOURNAL.PPAT.1007920 ",4.2,0,"6olp_oligo22","DGalpb1-4DGlcpNAcb1-2[DGalpb1-4DGlcpNAcb1-6]DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(10_f_)-[GAL(8_f_)-NAG(7_f_)-[GAL(6_f_)-NAG(5_f_)]-MAN(4_f_)-[MAN(9_f_)]-BMA(3_f_)-NAG(2_f_)]-NAG(1_f_)-ASN(611_D_)",142.411,"","",""
"6OLP","FULL LENGTH HIV-1 ENV AMC011 IN COMPLEX WITH PGT151 FAB","10.1371/JOURNAL.PPAT.1007920 ",4.2,0,"6olp_oligo6","DGlcpNAcb1-6DGlcpNAcb1-ASN","NAG(2_K_)-NAG(1_K_)-ASN(241_A_)",249.457,"","",""
"6P3R","CRYSTAL STRUCTURE OF HUMAN FAB H5.31 IN COMPLEX WITH INFLUENZA A H5N1 VIETNAM HEMAGGLUTININ HEAD DOMAIN","",3,0,"6p3r_oligo3","DNeup5Aca2-6DGalpb1-4DGlcpNAca1-2DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_H_)-GAL(6_H_)-NDG(5_H_)-BMA(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(163_L_)",134.35,"","",""
"6P3S","CRYSTAL STRUCTURE OF HUMAN FAB H5.28 IN COMPLEX WITH INFLUENZA A H5N1 VIETNAM HEMAGGLUTININ HEAD DOMAIN","",4,0,"6p3s_oligo6","DNeup5Aca2-6DGalpb1-4DGlcpNAca1-2DManpb1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcx1-","SIA(7_d_)-GAL(6_d_)-NDG(5_d_)-BMA(4_d_)-MAN(3_d_)-NAG(2_d_)-NAG(1_d_)",127.216,"","",""
"6P3S","CRYSTAL STRUCTURE OF HUMAN FAB H5.28 IN COMPLEX WITH INFLUENZA A H5N1 VIETNAM HEMAGGLUTININ HEAD DOMAIN","",4,0,"6p3s_oligo5","DNeup5Aca2-6DGalpb1-4DGlcpNAca1-2DManpb1-6DManpx1-","SIA(5_c_)-GAL(4_c_)-NDG(3_c_)-BMA(2_c_)-BMA(1_c_)",126.251,"","",""
"6P3S","CRYSTAL STRUCTURE OF HUMAN FAB H5.28 IN COMPLEX WITH INFLUENZA A H5N1 VIETNAM HEMAGGLUTININ HEAD DOMAIN","",4,0,"6p3s_oligo7","DNeup5Aca2-6DGalpb1-4DGlcpNAca1-2DManpb1-6DManpx1-","SIA(5_e_)-GAL(4_e_)-NDG(3_e_)-BMA(2_e_)-MAN(1_e_)",129.585,"","",""
"6P3S","CRYSTAL STRUCTURE OF HUMAN FAB H5.28 IN COMPLEX WITH INFLUENZA A H5N1 VIETNAM HEMAGGLUTININ HEAD DOMAIN","",4,0,"6p3s_oligo2","DNeup5Aca2-6DGalpb1-4DGlcpNAcb1-2DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","SIA(7_Z_)-GAL(6_Z_)-NAG(5_Z_)-BMA(4_Z_)-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)-ASN(163_H_)",134.551,"","",""
"6P7Y","CRYSTAL STRUCTURE OF THE CEDAR HENIPAVIRUS ATTACHMENT G GLYCOPROTEIN GLOBULAR DOMAIN IN COMPLEX WITH THE RECEPTOR EPHRIN-B2","10.1073/PNAS.1911773116 ",2.84,65.29,"6p7y_oligo5","DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6][LFucpb1-3]DGlcpNAcb1-ASN","FUC(7_G_)-[MAN(5_G_)-[MAN(4_G_)]-BMA(3_G_)-NAG(2_G_)]-[FUC(6_G_)]-NAG(1_G_)-ASN(403_A_)",104.784,"","",""
"6P7Y","CRYSTAL STRUCTURE OF THE CEDAR HENIPAVIRUS ATTACHMENT G GLYCOPROTEIN GLOBULAR DOMAIN IN COMPLEX WITH THE RECEPTOR EPHRIN-B2","10.1073/PNAS.1911773116 ",2.84,65.29,"6p7y_oligo8","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_L_)-[NAG(2_L_)]-NAG(1_L_)-ASN(322_C_)",119.972,"","",""
"6P7Y","CRYSTAL STRUCTURE OF THE CEDAR HENIPAVIRUS ATTACHMENT G GLYCOPROTEIN GLOBULAR DOMAIN IN COMPLEX WITH THE RECEPTOR EPHRIN-B2","10.1073/PNAS.1911773116 ",2.84,65.29,"6p7y_oligo2","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(322_A_)",99.5073,"","",""
"6PD4","CRYSTAL STRUCTURE OF HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN","10.1371/JOURNAL.PONE.0048742 ",2.2,32.52,"6pd4_oligo6","DManpb1-6DManpa1-4DGlcpNAcb1-4[LFucpb1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(6_H_)-[BMA(4_H_)-BMA(3_H_)-NAG(2_H_)]-[FUC(5_H_)]-NAG(1_H_)-ASN(529_B_)",57.8429,"","",""
"6PD4","CRYSTAL STRUCTURE OF HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN","10.1371/JOURNAL.PONE.0048742 ",2.2,32.52,"6pd4_oligo2","LFucpa1-3[DGlcpNAcb1-4][LFucpb1-6]DGlcpNAcb1-ASN","FUC(4_E_)-[NAG(3_E_)]-[FUC(2_E_)]-NAG(1_E_)-ASN(529_A_)",51.6116,"","",""
"6QWN","PROTEIN PEPTIDE COMPLEX","10.1073/PNAS.2000100117 ",3.89,0,"6qwn_oligo3","DManpb1-4DGlcpNAcb1-6DGlcpNAcb1-ASN","BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(338_B_)",168.851,"","",""
"6RU5","HUMAN COMPLEMENT C3 IN COMPLEX WITH THE HC3NB1 NANOBODY","10.3389/FIMMU.2019.02007 ",3.9,0,"6ru5_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_D_)-[MAN(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(939_B_)",189.934,"","",""
"6RUA","STRUCTURE OF RECOMBINANT HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH A COUMARIN-BASED FLUORESCENT PROBE LINKED TO SULFONAMIDE TYPE INHIBITOR.","10.1080/14756366.2019.1710502 ",2.75,0,"6rua_oligo10","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcx1-","FUL(3_K_)-[NAG(2_K_)]-NAG(1_K_)",130.525,"","",""
"6RUA","STRUCTURE OF RECOMBINANT HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH A COUMARIN-BASED FLUORESCENT PROBE LINKED TO SULFONAMIDE TYPE INHIBITOR.","10.1080/14756366.2019.1710502 ",2.75,0,"6rua_oligo8","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_I_)-[NAG(2_I_)]-NAG(1_I_)-ASN(241_B_)",99.6724,"","",""
"6RUA","STRUCTURE OF RECOMBINANT HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH A COUMARIN-BASED FLUORESCENT PROBE LINKED TO SULFONAMIDE TYPE INHIBITOR.","10.1080/14756366.2019.1710502 ",2.75,0,"6rua_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_H_)-[NAG(2_H_)]-NAG(1_H_)-ASN(486_A_)",117.924,"","",""
"6RUA","STRUCTURE OF RECOMBINANT HUMAN BUTYRYLCHOLINESTERASE IN COMPLEX WITH A COUMARIN-BASED FLUORESCENT PROBE LINKED TO SULFONAMIDE TYPE INHIBITOR.","10.1080/14756366.2019.1710502 ",2.75,0,"6rua_oligo9","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(3_J_)-[NAG(2_J_)]-NAG(1_J_)-ASN(256_B_)",128.135,"","",""
"6RUR","STRUCTURE OF THE SCIN STABILIZED C3BBB CONVERTASE BOUND TO PROPERDIN","10.3389/FIMMU.2019.02007 ",6,0,"6rur_oligo6","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_K_)-[NAG(2_K_)]-NAG(1_K_)-ASN(428_Y_)",608.054,"","",""
"6RUR","STRUCTURE OF THE SCIN STABILIZED C3BBB CONVERTASE BOUND TO PROPERDIN","10.3389/FIMMU.2019.02007 ",6,0,"6rur_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(428_V_)",508.405,"","",""
"6RUS","STRUCTURE OF A FUNCTIONAL PROPERDIN MONOMER","10.3389/FIMMU.2019.02007 ",2.8,0,"6rus_oligo2","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_G_)-[NAG(2_G_)]-NAG(1_G_)-ASN(428_B_)",138.393,"","",""
"6RUV","STRUCTURE OF THE SCIN STABILIZED C3BBB CONVERTASE BOUND TO PROPERDIN AND A THE NON-INHIBITORY NANOBODY HFPNB1","10.3389/FIMMU.2019.02007 ",6.15,0,"6ruv_oligo7","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(3_M_)-[NAG(2_M_)]-NAG(1_M_)-ASN(428_Y_)",659.894,"","",""
"6RUV","STRUCTURE OF THE SCIN STABILIZED C3BBB CONVERTASE BOUND TO PROPERDIN AND A THE NON-INHIBITORY NANOBODY HFPNB1","10.3389/FIMMU.2019.02007 ",6.15,0,"6ruv_oligo3","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_E_)-[NAG(2_E_)]-NAG(1_E_)-ASN(428_V_)",694.445,"","",""
"6RV6","STRUCTURE OF PROPERDIN LACKING TSR3 BASED ON ANOMALOUS DATA","10.3389/FIMMU.2019.02007 ",3.51,0,"6rv6_oligo5","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(428_B_)",207.633,"","",""
"6SEJ","STRUCTURE OF A FUNCTIONAL MONOMERIC PROPERDIN LACKING TSR3","10.3389/FIMMU.2019.02007 ",3.5,0,"6sej_oligo5","DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUC(3_F_)-[NAG(2_F_)]-NAG(1_F_)-ASN(428_B_)",285.885,"","",""
"6UM5","CRYO-EM STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY DH270 UCA3 IN COMPLEX WITH CH848 10.17DT ENV","10.1126/SCIENCE.AAY7199 ",4.2,"5.37397e+08","6um5_oligo5","DManpa1-2DManpa1-3[DManpa1-6DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_U_)-BMA(6_U_)-[MAN(5_U_)-MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)-ASN(332_E_)",29.6255,"","",""
"6UM5","CRYO-EM STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY DH270 UCA3 IN COMPLEX WITH CH848 10.17DT ENV","10.1126/SCIENCE.AAY7199 ",4.2,"5.37397e+08","6um5_oligo9","DManpa1-2DManpa1-3[DManpa1-6DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_N_)-BMA(6_N_)-[MAN(5_N_)-MAN(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(332_A_)",29.6255,"","",""
"6UM5","CRYO-EM STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY DH270 UCA3 IN COMPLEX WITH CH848 10.17DT ENV","10.1126/SCIENCE.AAY7199 ",4.2,"5.37397e+08","6um5_oligo16","DManpa1-2DManpa1-3[DManpa1-6DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(7_b_)-BMA(6_b_)-[MAN(5_b_)-MAN(4_b_)]-BMA(3_b_)-NAG(2_b_)-NAG(1_b_)-ASN(332_I_)",29.6255,"","",""
"6UM6","CRYO-EM STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY DH270.6 IN COMPLEX WITH CH848 10.17DT ENV","10.1126/SCIENCE.AAY7199 ",4.3,"5.37397e+08","6um6_oligo1","DGlcpNAcb1-6DGlcpNAcx1-","NAG(2_N_)-NAG(1_N_)",30,"","",""
"6UM6","CRYO-EM STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY DH270.6 IN COMPLEX WITH CH848 10.17DT ENV","10.1126/SCIENCE.AAY7199 ",4.3,"5.37397e+08","6um6_oligo7","DGlcpNAcb1-6DGlcpNAcx1-","NAG(2_S_)-NAG(1_S_)",30,"","",""
"6UM6","CRYO-EM STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY DH270.6 IN COMPLEX WITH CH848 10.17DT ENV","10.1126/SCIENCE.AAY7199 ",4.3,"5.37397e+08","6um6_oligo12","DGlcpNAcb1-6DGlcpNAcx1-","NAG(2_X_)-NAG(1_X_)",30,"","",""
"6V06","CRYSTAL STRUCTURE OF BETA-2 GLYCOPROTEIN I PURIFIED FROM PLASMA (PB2GPI)","10.1074/JBC.RA120.013939 ",2.4,65.47,"6v06_oligo5","DGlcpNAcb1-2DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_E_)-BMA(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(164_A_)",199.785,"","",""
"6VPX","NANODISC OF FULL-LENGTH HIV-1 ENVELOPE GLYCOPROTEIN CLONE AMC011 IN COMPLEX WITH ONE PGT151 FAB AND THREE 10E8 FABS","10.1016/J.CELREP.2020.107583 ",5,0.00048876,"6vpx_oligo5","DGlcpNAcb1-6DGlcpNAcb1-ASN","NAG(2_S_)-NAG(1_S_)-ASN(241_A_)",249.457,"","",""
"6VPX","NANODISC OF FULL-LENGTH HIV-1 ENVELOPE GLYCOPROTEIN CLONE AMC011 IN COMPLEX WITH ONE PGT151 FAB AND THREE 10E8 FABS","10.1016/J.CELREP.2020.107583 ",5,0.00048876,"6vpx_oligo22","DGalpb1-4DGlcpNAcb1-6DManpa1-6[DManpa1-3]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_m_)-[GAL(6_m_)-NAG(5_m_)-MAN(4_m_)-[MAN(7_m_)]-BMA(3_m_)-NAG(2_m_)]-NAG(1_m_)-ASN(611_B_)",97.6494,"","",""
"6WLW","THE VO REGION OF HUMAN V-ATPASE IN STATE 1 (FOCUSED REFINEMENT)","10.1016/J.MOLCEL.2020.09.029 ",3,"1.08527e-19","6wlw_oligo1","DGlcpa1-2DGlcpa1-3DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpb1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-C25O7P2","MAN(11_r_)-MAN(10_r_)-[GLC(9_r_)-GLC(8_r_)-GLC(7_r_)-MAN(6_r_)-MAN(5_r_)-MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-WJP(905_R_)",65.1511,"","",""
"6WM2","HUMAN V-ATPASE IN STATE 1 WITH SIDK AND ADP","10.1016/J.MOLCEL.2020.09.029 ",3.1,"1.08527e-19","6wm2_oligo9","DGlcpa1-2DGlcpa1-3DGlcpa1-3DManpa1-2DManpa1-2DManpa1-3[DManpb1-6DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAca1-C25O7P2","MAN(11_r_)-MAN(10_r_)-[GLC(9_r_)-GLC(8_r_)-GLC(7_r_)-MAN(6_r_)-MAN(5_r_)-MAN(4_r_)]-BMA(3_r_)-NAG(2_r_)-NAG(1_r_)-WJP(907_R_)",83.4146,"","",""
"6WOL","NEXT GENERATION MONOMERIC IGG4 FC BOUND TO NEONATAL FC RECEPTOR","10.1038/S42003-021-02565-5 ",2.49,45.35,"6wol_oligo1","DGlcpNAcb1-2DManpa1-3[DGlcpNAcb1-2DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(8_C_)-[NAG(7_C_)-MAN(6_C_)-[NAG(5_C_)-MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)]-NAG(1_C_)-ASN(297_H_)",79.3048,"","",""
"6XLP","STRUCTURE OF THE ESSENTIAL INNER MEMBRANE LIPOPOLYSACCHARIDE-PBGA COMPLEX","10.1038/S41586-020-2597-X ",2,51.56,"6xlp_oligo1","DKdopa2-6DGlcp[2<R1>,4P]b1-6DGlcp[2<R2>,3<R3>]a1-O4P1","KDO(3_B_)-VJ4(1_B_)-VJ1(2_B_)",89.0532,"","",""
"6XP6","3C11-DQ2-GLIA-A2 COMPLEX","10.1126/SCIIMMUNOL.ABG4925 ",2.4,0,"6xp6_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6][LFucpa1-3]DGlcpNAcb1-ASN","FUC(7_L_)-[BMA(5_L_)-[BMA(4_L_)]-BMA(3_L_)-NAG(2_L_)]-[FUC(6_L_)]-NAG(1_L_)-ASN(19_B_)",85.7192,"","",""
"6XP6","3C11-DQ2-GLIA-A2 COMPLEX","10.1126/SCIIMMUNOL.ABG4925 ",2.4,0,"6xp6_oligo5","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_O_)-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(19_E_)",84.5577,"","",""
"6XPZ","HUMAN ANTIBODY S1V2-83 IN COMPLEX WITH THE INFLUENZA HEMAGGLUTININ HEAD DOMAIN OF A/MOSCOW/10/1999(H3N2)","10.1128/MBIO.01144-21 ",3.45,140,"6xpz_oligo4","DManpb1-4DGlcpNAcb1-6DGlcpNAcb1-ASN","BMA(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(63_D_)",156.772,"","",""
"6XPZ","HUMAN ANTIBODY S1V2-83 IN COMPLEX WITH THE INFLUENZA HEMAGGLUTININ HEAD DOMAIN OF A/MOSCOW/10/1999(H3N2)","10.1128/MBIO.01144-21 ",3.45,140,"6xpz_oligo2","DManpb1-4DGlcpNAcb1-6DGlcpNAcb1-ASN","BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(63_A_)",157.492,"","",""
"6XUT","CRYSTALLOGRAPHIC STRUCTURE OF OLIGOSACCHARIDE DEHYDROGENASE FROM PYCNOPORUS CINNABARINUS, LIGAND-FREE FORM","10.1186/S13068-021-02003-Y ",1.6,39.76,"6xut_oligo3","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(439_A_)",100.282,"","",""
"6Y3C","HUMAN COX-1 CRYSTAL STRUCTURE","10.1038/S41598-021-83438-Z ",3.36,90.9,"6y3c_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcp[2<R1>]b1-ASN","BMA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(144_A_)",121.356,"","",""
"6YCF","STRUCTURE THE BROMELAIN PROTEASE FROM ANANAS COMOSUS IN COMPLEX WITH THE E64 INHIBITOR","10.1038/S41598-020-76172-5 ",1.85,29.03,"6ycf_oligo1","DXylpb1-2[DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-3]DGlcpNAcb1-ASN","MAN(5_C_)-[XYS(4_C_)]-BMA(3_C_)-NAG(2_C_)-[FUC(6_C_)]-NAG(1_C_)-ASN(117_A_)",38.3723,"","",""
"6ZOW","SARS-COV-2 SPIKE IN PREFUSION STATE","10.1107/S2052252520012725 ",3,0,"6zow_oligo14","DManpb1-4DGlcpNAcb1-6DGlcpNAcb1-ASN","BMA(3_Q_)-NAG(2_Q_)-NAG(1_Q_)-ASN(801_C_)",64.3542,"","",""
"7AKK","STRUCTURE OF A COMPLEMENT FACTOR-RECEPTOR COMPLEX","10.1038/S41467-022-29580-2 ",3.4,112.4,"7akk_oligo2","DManpb1-6DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_J_)-MAN(3_J_)-NAG(2_J_)-NAG(1_J_)-ASN(63_C_)",126.509,"","",""
"7BLJ","STRUCTURE OF CBM BT3015C FROM BACTEROIDES THETAIOTAOMICRON IN COMPLEX WITH O-GALNAC CORE 2-THR","",1.76,14.1,"7blj_oligo1","DGalpb1-3[DGlcpNAcb1-6]DGalpNAca1-THR","NAG(3_B_)-[GAL(2_B_)]-A2G(1_B_)-THR(202_A_)",16.047,"","",""
"7C6G","CRYSTAL STRUCTURE OF BETA-GLYCOSIDES-BINDING PROTEIN (W177X) OF ABC TRANSPORTER IN AN OPEN-LIGANDED STATE BOUND TO GENTIOBIOSE","10.1016/J.JMB.2020.08.021 ",1.9,27.59,"7c6g_oligo2","DGlcpb1-6DGlcpb1-ROH","BGC(2_C_)-BGC(1_C_)",37.0641,"","",""
"7C6G","CRYSTAL STRUCTURE OF BETA-GLYCOSIDES-BINDING PROTEIN (W177X) OF ABC TRANSPORTER IN AN OPEN-LIGANDED STATE BOUND TO GENTIOBIOSE","10.1016/J.JMB.2020.08.021 ",1.9,27.59,"7c6g_oligo1","DGlcpb1-6DGlcpb1-ROH","BGC(2_D_)-BGC(1_D_)",35.0932,"","",""
"7C70","CRYSTAL STRUCTURE OF BETA-GLYCOSIDES-BINDING PROTEIN (W67A) OF ABC TRANSPORTER IN AN OPEN-LIGANDED STATE BOUND TO GENTIOBIOSE","10.1016/J.JMB.2020.08.021 ",1.63,16.09,"7c70_oligo2","DGlcpb1-6DGlcpb1-ROH","BGC(2_D_)-BGC(1_D_)",24.2141,"","",""
"7C70","CRYSTAL STRUCTURE OF BETA-GLYCOSIDES-BINDING PROTEIN (W67A) OF ABC TRANSPORTER IN AN OPEN-LIGANDED STATE BOUND TO GENTIOBIOSE","10.1016/J.JMB.2020.08.021 ",1.63,16.09,"7c70_oligo1","DGlcpb1-6DGlcpb1-ROH","BGC(2_C_)-BGC(1_C_)",38.1927,"","",""
"7C9I","HUMAN GAMMA-SECRETASE IN COMPLEX WITH SMALL MOLECULE L-685,458","10.1016/J.CELL.2020.11.049 ",3.1,"1.08527e-19","7c9i_oligo6","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(55_A_)",66.3371,"","",""
"7D8X","CRYOEM STRUCTURE OF HUMAN GAMMA-SECRETASE IN COMPLEX WITH E2012 AND L685458","10.1016/J.CELL.2020.11.049 ",2.6,"1.08527e-19","7d8x_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(55_A_)",51.2158,"","",""
"7DSI","CRYO-EM STRUCTURE OF DNF1 FROM SACCHAROMYCES CEREVISIAE IN YEAST LIPIDS WITH AMPPCP ( RESTING STATE )","10.1016/J.CELREP.2022.110518 ",3.21,"1.08527e-19","7dsi_oligo4","DGlcpNAcb1-6DGlcpNAcb1-ASN","NAG(2_E_)-NAG(1_E_)-ASN(256_B_)",71.7677,"","",""
"7E7I","CRYO-EM STRUCTURE OF HUMAN ABCA4 IN THE APO STATE","10.1038/S41467-021-24194-6 ",3.3,"1.15243e-41","7e7i_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_M_)-[BMA(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(1529_A_)",51.898,"","",""
"7E7I","CRYO-EM STRUCTURE OF HUMAN ABCA4 IN THE APO STATE","10.1038/S41467-021-24194-6 ",3.3,"1.15243e-41","7e7i_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-[BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(415_A_)",78.2338,"","",""
"7E7O","CRYO-EM STRUCTURE OF HUMAN ABCA4 IN NRPE-BOUND STATE","10.1038/S41467-021-24194-6 ",3.4,"1.15243e-41","7e7o_oligo1","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_E_)-[BMA(4_E_)]-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(415_A_)",86.0476,"","",""
"7E7O","CRYO-EM STRUCTURE OF HUMAN ABCA4 IN NRPE-BOUND STATE","10.1038/S41467-021-24194-6 ",3.4,"1.15243e-41","7e7o_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_N_)-[BMA(4_N_)]-BMA(3_N_)-NAG(2_N_)-NAG(1_N_)-ASN(1529_A_)",66.4942,"","",""
"7E7Q","CRYO-EM STRUCTURE OF HUMAN ABCA4 IN ATP-BOUND STATE","10.1038/S41467-021-24194-6 ",3.3,"1.15243e-41","7e7q_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_M_)-[BMA(4_M_)]-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(1529_A_)",83.9967,"","",""
"7E7Q","CRYO-EM STRUCTURE OF HUMAN ABCA4 IN ATP-BOUND STATE","10.1038/S41467-021-24194-6 ",3.3,"1.15243e-41","7e7q_oligo3","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-[BMA(4_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(415_A_)",100.188,"","",""
"7EEB","STRUCTURE OF THE CATSPERMASOME","10.1038/S41586-021-03742-6 ",2.9,"1.35632e-19","7eeb_oligo1","DManpb1-2DManpb1-3[DManpb1-3DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(7_O_)-BMA(6_O_)-[BMA(5_O_)-BMA(4_O_)]-BMA(3_O_)-NAG(2_O_)-NAG(1_O_)-ASN(90_E_)",79.3492,"","",""
"7EEB","STRUCTURE OF THE CATSPERMASOME","10.1038/S41586-021-03742-6 ",2.9,"1.35632e-19","7eeb_oligo11","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_Y_)-[BMA(4_Y_)]-BMA(3_Y_)-NAG(2_Y_)-NAG(1_Y_)-ASN(502_H_)",101.864,"","",""
"7EEB","STRUCTURE OF THE CATSPERMASOME","10.1038/S41586-021-03742-6 ",2.9,"1.35632e-19","7eeb_oligo12","DManpb1-3[DManpb1-6]DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(6_Z_)-[BMA(5_Z_)]-BMA(4_Z_)-[BMA(7_Z_)]-BMA(3_Z_)-NAG(2_Z_)-NAG(1_Z_)",71.1831,"","",""
"7EEB","STRUCTURE OF THE CATSPERMASOME","10.1038/S41586-021-03742-6 ",2.9,"1.35632e-19","7eeb_oligo15","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_c_)-[BMA(4_c_)]-BMA(3_c_)-NAG(2_c_)-NAG(1_c_)",123.991,"","",""
"7EEE","COMPLEX STRUCTURE OF GLYCOSIDE HYDROLASE FAMILY 12 BETA-1,3-1,4- GLUCANASE WITH GENTIOBIOSE","10.1016/J.JSB.2021.107774 ",1.66,24.89,"7eee_oligo1","DManpb1-6DManpb1-ROH","BMA(2_B_)-BMA(1_B_)",34.4332,"","",""
"7EY1","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.46,0,"7ey1_oligo1","DManpa1-2DManpb1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-ROH","MAN(5_E_)-BMA(4_E_)-[MAN(6_E_)]-MAN(3_E_)-[MAN(8_E_)-MAN(7_E_)]-BMA(2_E_)-NAG(1_E_)",50.9472,"","",""
"7EY1","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL WITH INTERMEDIATE SUBSTRATE XYLOSE","",2.46,0,"7ey1_oligo4","DManpa1-2DManpb1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-ROH","MAN(5_G_)-BMA(4_G_)-[MAN(6_G_)]-MAN(3_G_)-[MAN(8_G_)-MAN(7_G_)]-BMA(2_G_)-NAG(1_G_)",43.8794,"","",""
"7F7F","CRYO-EM STRUCTURE OF DNF1 FROM SACCHAROMYCES CEREVISIAE IN YEAST LIPIDS WITH BERYLLIUM FLUORIDE (RESTING STATE)","10.1016/J.CELREP.2022.110518 ",3.81,"1.08527e-19","7f7f_oligo3","DGlcpNAcb1-6DGlcpNAcb1-ASN","NAG(2_E_)-NAG(1_E_)-ASN(256_B_)",50.5559,"","",""
"7F95","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL WITH INTERMEDIATE SUBSTRATE XYLOSE FOR 2 MIN","",2.43,41.66,"7f95_oligo12","DManpa1-2DManpb1-6[DManpa1-3]DManpa1-6DManp[3<R1>]b1-4DGlcpNAcb1-ROH","MAN(6_G_)-BMA(5_G_)-[MAN(7_G_)]-MAN(4_G_)-BMA(3_G_)-NAG(2_G_)",52.6286,"","",""
"7F95","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL WITH INTERMEDIATE SUBSTRATE XYLOSE FOR 2 MIN","",2.43,41.66,"7f95_oligo4","DManpa1-2DManpa1-3[DManpa1-3[DManpb1-6]DManpa1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(8_I_)-[MAN(7_I_)]-MAN(6_I_)-[MAN(5_I_)-MAN(4_I_)]-BMA(3_I_)-NAG(2_I_)-NAG(1_I_)-ASN(272_C_)",67.6513,"","",""
"7F95","BIFUNCTIONAL XYLOSIDASE/GLUCOSIDASE LXYL WITH INTERMEDIATE SUBSTRATE XYLOSE FOR 2 MIN","",2.43,41.66,"7f95_oligo9","DManpa1-2DManpb1-6[DManpa1-3]DManpa1-6[DManpa1-2DManpa1-3]DManpb1-4DGlcpNAcb1-ROH","MAN(5_E_)-BMA(4_E_)-[MAN(6_E_)]-MAN(3_E_)-[MAN(8_E_)-MAN(7_E_)]-BMA(2_E_)-NAG(1_E_)",55.8041,"","",""
"7FH1","STRUCTURE OF THE HUMAN MECKELIN","10.1126/SCIADV.ABJ9748 ",3.34,0,"7fh1_oligo8","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_J_)-[BMA(4_J_)]-BMA(3_J_)-NAG(2_J_)-NAG(1_J_)",56.7076,"","",""
"7FH1","STRUCTURE OF THE HUMAN MECKELIN","10.1126/SCIADV.ABJ9748 ",3.34,0,"7fh1_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)",56.7076,"","",""
"7KQI","ANTIBODIES THAT ENGAGE THE HEMAGGLUTININ RECEPTOR-BINDING SITE OF INFLUENZA B VIRUSES","10.1021/ACSINFECDIS.0C00726 ",4.2,235,"7kqi_oligo2","DManpb1-4DGlcpNAcb1-6DGlcpNAcb1-ASN","BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(231_B_)",269.349,"","",""
"7L02","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO ONE COPY OF DOMAIN-SWAPPED ANTIBODY 2G12","10.1016/J.CELL.2021.04.042 ",3.2,"1.08527e-19","7l02_oligo13","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(709_C_)",138.591,"","",""
"7L06","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO TWO COPIES OF DOMAIN-SWAPPED ANTIBODY 2G12","10.1016/J.CELL.2021.04.042 ",3.3,"1.08527e-19","7l06_oligo5","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_P_)-[MAN(4_P_)]-BMA(3_P_)-NAG(2_P_)-NAG(1_P_)",37.0887,"","",""
"7L06","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND TO TWO COPIES OF DOMAIN-SWAPPED ANTIBODY 2G12","10.1016/J.CELL.2021.04.042 ",3.3,"1.08527e-19","7l06_oligo10","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_U_)-[MAN(4_U_)]-BMA(3_U_)-NAG(2_U_)-NAG(1_U_)",120.857,"","",""
"7L09","CRYO-EM STRUCTURE OF SARS-COV-2 2P S ECTODOMAIN BOUND DOMAIN-SWAPPED ANTIBODY 2G12 FROM MASKED 3D REFINEMENT","10.1016/J.CELL.2021.04.042 ",3.1,2050.01,"7l09_oligo13","DManpa1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_T_)-[MAN(4_T_)]-BMA(3_T_)-NAG(2_T_)-NAG(1_T_)-ASN(709_C_)",120.37,"","",""
"7L0N","CIRCULATING SARS-COV-2 SPIKE N439K VARIANTS MAINTAIN FITNESS WHILE EVADING ANTIBODY-MEDIATED IMMUNITY","10.1016/J.CELL.2021.01.037 ",2.78,86.1,"7l0n_oligo1","DManpb1-6DManpa1-6DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(6_G_)-[MAN(5_G_)-MAN(4_G_)-BMA(3_G_)-NAG(2_G_)]-NAG(1_G_)-ASN(343_R_)",111.652,"","",""
"7LDJ","SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH WNB-2","10.1073/PNAS.210191811 ",2.36,59.28,"7ldj_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_I_)-[BMA(3_I_)-NAG(2_I_)]-NAG(1_I_)-ASN(343_B_)",66.87,"","",""
"7LDJ","SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH WNB-2","10.1073/PNAS.210191811 ",2.36,59.28,"7ldj_oligo3","DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(4_K_)-[BMA(3_K_)-NAG(2_K_)]-NAG(1_K_)-ASN(343_C_)",66.1661,"","",""
"7LDJ","SARS-COV-2 RECEPTOR BINDING DOMAIN IN COMPLEX WITH WNB-2","10.1073/PNAS.210191811 ",2.36,59.28,"7ldj_oligo2","DGlcpNAcb1-4DManpa1-6DManpa1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_J_)-[NAG(5_J_)-MAN(4_J_)-MAN(3_J_)-NAG(2_J_)]-NAG(1_J_)-ASN(343_A_)",96.8809,"","",""
"7LEN","CRYSTAL STRUCTURE OF THE EPIDERMAL GROWTH FACTOR RECEPTOR EXTRACELLULAR REGION WITH R84K MUTATION IN COMPLEX WITH EPIREGULIN CRYSTALLIZED WITH TREHALOSE","10.1038/S41586-021-04393-3 ",2.9,86.62,"7len_oligo2","DGlcpNAcb1-6DGlcpNAcb1-ASN","NAG(2_G_)-NAG(1_G_)-ASN(151_B_)",138.256,"","",""
"7LKP","STRUCTURE OF ATP-FREE HUMAN ABCA4","10.7554/ELIFE.63524 ",3.27,"1.08527e-19","7lkp_oligo3","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(1529_A_)",111.255,"","",""
"7LKZ","STRUCTURE OF ATP-BOUND HUMAN ABCA4","10.7554/ELIFE.63524 ",3.27,"1.15243e-41","7lkz_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(1529_A_)",90.4164,"","",""
"7MXP","CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY LP5 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE","10.1002/AIC.17440 ",4.46,"5.50295e+11","7mxp_oligo6","[DGlcpNAcb1-2][DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_N_)-[BMA(7_N_)-[NAG(5_N_)-MAN(4_N_)]-[NAG(6_N_)]-BMA(3_N_)-NAG(2_N_)]-NAG(1_N_)-ASN(17_C_)",498.957,"","",""
"7MXP","CRYO-EM STRUCTURE OF NTD-DIRECTED NEUTRALIZING ANTIBODY LP5 FAB IN COMPLEX WITH SARS-COV-2 S2P SPIKE","10.1002/AIC.17440 ",4.46,"5.50295e+11","7mxp_oligo3","[DGlcpNAcb1-2][DManpb1-6]DManpb1-4DGlcpNAcb1-4[LFucpa1-6]DGlcpNAcb1-ASN","FUC(8_F_)-[BMA(7_F_)-[NAG(5_F_)-MAN(4_F_)]-[NAG(6_F_)]-BMA(3_F_)-NAG(2_F_)]-NAG(1_F_)-ASN(17_A_)",560.011,"","",""
"7OIX","STRUCTURE OF THERMOSTABLE HUMAN MFSD2A IN COMPLEX WITH THERMOSTABLE HUMAN SYNC2","10.1038/S41594-022-00786-8 ",3.6,"1.08527e-19","7oix_oligo1","DManpa1-3[DManpa1-6]DManpb1-6DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(5_C_)-[MAN(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(177_A_)",118.868,"","",""
"7OLY","STRUCTURE OF ACTIVIN A IN COMPLEX WITH AN ACTRIIB-ALK4 FUSION REVEAL INSIGHT INTO ACTIVIN RECEPTOR INTERACTIONS","10.1016/J.ISCI.2021.103590 ",3.27,112.9,"7oly_oligo2","DGlcpNAcb1-6DManpa1-6[DManpa1-3]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","NAG(5_B_)-MAN(4_B_)-[MAN(6_B_)]-MAN(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(65_C_)",175.163,"","",""
"7SLV","VANIN-1 COMPLEXED WITH COMPOUND 3","10.1021/ACS.JMEDCHEM.1C01849 ",2.13,53.28,"7slv_oligo1","DManpb1-3DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-BMA(4_D_)-[BMA(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(179_A_)",53.1135,"","",""
"7SLV","VANIN-1 COMPLEXED WITH COMPOUND 3","10.1021/ACS.JMEDCHEM.1C01849 ",2.13,53.28,"7slv_oligo6","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(294_A_)",92.1431,"","",""
"7SLX","VANIN-1 COMPLEXED WITH COMPOUND 11","10.1021/ACS.JMEDCHEM.1C01849 ",2.35,59.19,"7slx_oligo5","DManpb1-3DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcx1-","BMA(5_D_)-BMA(4_D_)-[BMA(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)",57.5398,"","",""
"7SLY","VANIN-1 COMPLEXED WITH COMPOUND 27","10.1021/ACS.JMEDCHEM.1C01849 ",2.17,65.13,"7sly_oligo6","DManpb1-3DManpb1-6[DManpb1-3]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_D_)-BMA(4_D_)-[BMA(6_D_)]-BMA(3_D_)-NAG(2_D_)-NAG(1_D_)-ASN(179_A_)",62.0695,"","",""
"7TBW","THE STRUCTURE OF ATP-BOUND ABCA1","10.1038/S44161-022-00022-Y ",3.1,"1.15243e-41","7tbw_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(1504_A_)",91.1685,"","",""
"7TBY","THE STRUCTURE OF HUMAN ABCA1 IN NANODISC","10.1038/S44161-022-00022-Y ",4,"1.15243e-41","7tby_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(1504_A_)",116.744,"","",""
"7TBZ","THE STRUCTURE OF ABCA1 Y482C","10.1038/S44161-022-00022-Y ",4.3,"1.15243e-41","7tbz_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(1504_A_)",177.528,"","",""
"7TC0","THE STRUCTURE OF HUMAN ABCA1 IN DIGITONIN","10.1038/S44161-022-00022-Y ",3.1,"1.15243e-41","7tc0_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)-ASN(1504_A_)",73.1611,"","",""
"7TCT","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH UR2922","10.1016/J.CELL.2022.08.008 ",2.5,62.64,"7tct_oligo3","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[BMA(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",89.3584,"","",""
"7TD8","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH TIROFIBAN","10.1016/J.CELL.2022.08.008 ",2.6,82.07,"7td8_oligo3","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[BMA(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",108.479,"","",""
"7TPD","INTEGRIN ALAPHIIBBETA3 COMPLEX WITH EF5154","10.1016/J.CELL.2022.08.008 ",2.6,63.63,"7tpd_oligo3","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_G_)-[BMA(4_G_)]-BMA(3_G_)-NAG(2_G_)-NAG(1_G_)-ASN(320_B_)",88.5156,"","",""
"7UGN","CRYO-EM STRUCTURE OF BG24 INFERRED GERMLINE FABS WITH GERMLINE CDR3S AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1- GT1 - CLASS 1","10.1038/S41467-022-33860-2 ",3.4,"1.35754e-19","7ugn_oligo23","DManpa1-3DManpa1-3[DManp[3<R1>]b1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(6_n_)-[MAN(5_n_)-MAN(4_n_)]-BMA(3_n_)-NAG(2_n_)-NAG(1_n_)-ASN(332_C_)",71.367,"","",""
"7UGO","CRYO-EM STRUCTURE OF BG24 INFERRED GERMLINE FABS WITH MATURE CDR3S AND 10-1074 FABS IN COMPLEX WITH HIV-1 ENV IMMUNOGEN BG505-SOSIPV4.1-GT1","10.1038/S41467-022-33860-2 ",4.1,"1.52628e-19","7ugo_oligo16","DManpb1-3[DManpb1-6]DManpa1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","MAN(606_C_)-[MAN(4_g_)]-BMA(3_g_)-NAG(2_g_)-NAG(1_g_)-ASN(262_C_)",77.2122,"","",""
"7WBQ","CRYSTAL STRUCTURE OF THE RECEPTOR BINDING DOMAIN OF SARS-COV-2 DELTA VARIANT SPIKE GLYCOPROTEIN IN COMPLEX WITH ITS RECEPTOR HUMAN ACE2","10.1016/J.CELL.2022.01.001 ",3.34,120.4,"7wbq_oligo2","LFucpb1-6DGlcpNAcb1-ASN","FUL(2_F_)-NAG(1_F_)-ASN(343_B_)",147.967,"","",""
"7WV5","ECTOTLR3-POLY(I:C)","10.1038/S41467-022-34602-0 ",3.1,"3.35873e+07","7wv5_oligo142","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(413_A_)",102.16,"","",""
"7WV5","ECTOTLR3-POLY(I:C)","10.1038/S41467-022-34602-0 ",3.1,"3.35873e+07","7wv5_oligo147","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_M_)-BMA(3_M_)-NAG(2_M_)-NAG(1_M_)-ASN(413_B_)",102.163,"","",""
"7Y5T","CRYOEM STRUCTURE OF PS1-CONTAINING GAMMA-SECRETASE IN COMPLEX WITH MRK-560","10.1038/S41467-022-33817-5 ",2.9,"1.35632e-19","7y5t_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(55_A_)",82.5651,"","",""
"7Y5X","CRYOEM STRUCTURE OF PS2-CONTAINING GAMMA-SECRETASE TREATED WITH MRK- 560","10.1038/S41467-022-33817-5 ",3,3397.21,"7y5x_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(55_A_)",62.7262,"","",""
"7Y5Z","CRYOEM STRUCTURE OF HUMAN PS2-CONTAINING GAMMA-SECRETASE","10.1038/S41467-022-33817-5 ",3.4,"2.15283e+08","7y5z_oligo4","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(55_A_)",97.0602,"","",""
"7Y9A","CRYSTAL STRUCTURE OF SDSCAM IG1-2 DOMAINS, ISOFORM BETA2V6","10.1038/S41467-023-38205-1 ",2.51,56.73,"7y9a_oligo1","DManpb1-4DGlcpNAcb1-4[LFucpb1-6][LFucpb1-3]DGlcpNAcb1-ASN","FUL(5_B_)-[BMA(3_B_)-NAG(2_B_)]-[FUL(4_B_)]-NAG(1_B_)-ASN(113_A_)",66.3542,"","",""
"7Y9A","CRYSTAL STRUCTURE OF SDSCAM IG1-2 DOMAINS, ISOFORM BETA2V6","10.1038/S41467-023-38205-1 ",2.51,56.73,"7y9a_oligo2","DManpb1-4DGlcpNAcb1-4[LFucpb1-6][LFucpb1-3]DGlcpNAcb1-ASN","FUL(5_C_)-[BMA(3_C_)-NAG(2_C_)]-[FUL(4_C_)]-NAG(1_C_)-ASN(73_A_)",101.403,"","",""
"7YQY","SARS-COV-2 BA.2.75 S TRIMER IN COMPLEX WITH S309 (STATE2)","10.1016/J.CHOM.2022.09.018 ",3.74,"1.08527e-19","7yqy_oligo8","DManpb1-4DGlcpNAcb1-4[DArapb1-6]DGlcpNAcx1-","FUC(4_Q_)-[BMA(3_Q_)-NAG(2_Q_)]-NAG(1_Q_)",196.724,"","",""
"8D87","FITTED CRYSTAL STRUCTURE OF THE HOMOTRIMER OF FUSION GLYCOPROTEIN E1 FROM SFV INTO SUBTOMOGRAM AVERAGED CHIKV E1 GLYCOPROTEIN DENSITY","10.1038/S41467-022-32431-9 ",27.2,"1.15243e-41","8d87_oligo1","DGlcpNAcb1-2DManpb1-3DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAcb1-ASN","FUL(6_D_)-[NAG(5_D_)-BMA(4_D_)-BMA(3_D_)-NAG(2_D_)]-NAG(1_D_)-ASN(141_A_)",134.071,"","",""
"8D87","FITTED CRYSTAL STRUCTURE OF THE HOMOTRIMER OF FUSION GLYCOPROTEIN E1 FROM SFV INTO SUBTOMOGRAM AVERAGED CHIKV E1 GLYCOPROTEIN DENSITY","10.1038/S41467-022-32431-9 ",27.2,"1.15243e-41","8d87_oligo2","DGlcpNAcb1-2DManpa1-3[DManpa1-6]DManpb1-4DGlcpNAcb1-4[LFucpb1-6]DGlcpNAca1-ASN","FUC(7_E_)-[MAN(6_E_)-[NAG(5_E_)-MAN(4_E_)]-BMA(3_E_)-NAG(2_E_)]-NDG(1_E_)-ASN(141_B_)",134.96,"","",""
"8DVN","CRYSTAL STRUCTURE OF LRP6 E3E4 IN COMPLEX WITH DISULFIDE CONSTRAINED PEPTIDE E3.10","10.1021/ACSCHEMBIO.2C00753 ",2.53,86.88,"8dvn_oligo4","DGlcpNAcb1-6DGlcpNAcx1-","NAG(2_F_)-NAG(1_F_)",131.754,"","",""
"8ENU","STRUCTURE OF THE C3BB PROCONVERTASE IN COMPLEX WITH LUFAXIN","",3.22,0,"8enu_oligo3","DManpb1-4DGlcpNAcb1-6DGlcpNAcb1-ASN","BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(239_A_)",89.6976,"","",""
"8F0P","STRUCTURE OF VSD4-NAV1.7-NAVPAS CHANNEL CHIMERA BOUND TO THE HYBRID INHIBITOR GNE-1305","10.7554/ELIFE.84151 ",2.2,"1.15243e-41","8f0p_oligo1","DManpb1-3[DManpb1-6]DManpb1-3DGlcpNAcb1-3DGlcpNAcb1-ASN","BMA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)-ASN(330_A_)",15.7485,"","",""
"8F0R","STRUCTURE OF VSD4-NAV1.7-NAVPAS CHANNEL CHIMERA BOUND TO THE ARYLSULFONAMIDE INHIBITOR GNE-3565","10.7554/ELIFE.84151 ",2.9,"1.15243e-41","8f0r_oligo2","DManpb1-3[DManpb1-6]DManpb1-3DGlcpNAcb1-3DGlcpNAcx1-","BMA(5_B_)-[BMA(4_B_)]-BMA(3_B_)-NAG(2_B_)-NAG(1_B_)",38.1534,"","",""
"8F0S","STRUCTURE OF VSD4-NAV1.7-NAVPAS CHANNEL CHIMERA BOUND TO THE HYBRID INHIBITOR GNE-9296","10.7554/ELIFE.84151 ",3.1,"1.15243e-41","8f0s_oligo1","DManpb1-3[DManpb1-6]DManpb1-3DGlcpNAcb1-3DGlcpNAcx1-","BMA(5_C_)-[BMA(4_C_)]-BMA(3_C_)-NAG(2_C_)-NAG(1_C_)",35.3938,"","",""
"8T2U","CRYO-EM STRUCTURES OF FULL-LENGTH INTEGRIN ALPHAIIBBETA3 IN NATIVE LIPIDS COMPLEXED WITH EPTIFIBATIDE","10.1038/S41467-023-39763-0 ",3.1,"1.15243e-41","8t2u_oligo4","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_E_)-BMA(3_E_)-NAG(2_E_)-NAG(1_E_)-ASN(320_B_)",315.041,"","",""
"8T2V","CRYO-EM STRUCTURES OF FULL-LENGTH INTEGRIN ALPHAIIBBETA3 IN NATIVE LIPIDS","10.1038/S41467-023-39763-0 ",3.4,"1.15243e-41","8t2v_oligo4","DManpb1-6DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(4_H_)-BMA(3_H_)-NAG(2_H_)-NAG(1_H_)-ASN(452_B_)",315.724,"","",""
"8T2V","CRYO-EM STRUCTURES OF FULL-LENGTH INTEGRIN ALPHAIIBBETA3 IN NATIVE LIPIDS","10.1038/S41467-023-39763-0 ",3.4,"1.15243e-41","8t2v_oligo2","DManpb1-3[DManpb1-6]DManpb1-4DGlcpNAcb1-4DGlcpNAcb1-ASN","BMA(5_F_)-[BMA(4_F_)]-BMA(3_F_)-NAG(2_F_)-NAG(1_F_)-ASN(371_B_)",293.528,"","",""
